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Abstract 
Selection of the T cell repertoire in the thymus is governed by the need to 
create a repertoire of peripheral T cells that can respond to any foreign 
antigen in the context of self-major histocompatibility complex (MHC), while 
enforcing central tolerance to self-antigens. Perturbations in signalling 
molecules, that reduce the affinity of thymic selection, can lead to the 
production of a peripheral repertoire with increased autoimmunity, as has 
been shown for mutations in the Zap-70 kinase. Upstream of Zap-70 is Lck, 
the most proximal tyrosine kinase required for T cell receptor (TCR) 
triggering upon TCR engagement by peptide:MHC.  
In order to study how Lck influences T cell activation, a transgenic mouse 
model (LckVA), in which Lck is expressed constitutively from a T cell specific 
transgene and mice have very low expression of Lck (~5% of WT) in both the 
thymus and periphery, was used.  
It has been shown that Lck is critical for successful T cell development, yet 
the results of this thesis show that even 5% of WT levels of Lck are sufficient 
for selection of thymic T cells on both polyclonal and F5 TCR transgenic 
backgrounds. 
Previous studies utilising mice expressing an inducible Lck transgene, which 
also had reduced Lck expression in the periphery, showed Lck to be critical 
in determining the activation threshold of T cells. In contrast, peripheral T 
cells in LckVA mice had similar activation thresholds to wild type T cells, as 
measured by in vitro upregulation of early activation markers. Further 
analysis of LckVA peripheral T cells revealed differential influences of low 
expression of Lck on downstream signalling pathways upon TCR 
engagement. For example, ERK signalling was impaired, while calcium flux 
and proliferation were enhanced in LckVA T cells. Finally, LckVA T cells were 
altered in their ability to differentiate, showing enhanced production of 
cytokines and retaining the capacity to form memory cells.  
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We assessed how T cells with low Lck expression formed memory cells in 
response to in vivo Listeria infections and whether they might be more robust 
at resisting a secondary infection. Both, the immunodominant primary and 
secondary effector responses were poorer in LckVA mice. However, the overall 
response to Listeria was similar in LckVA mice to LckWT mice. Additionally, 
proportionally more T cells that had incorporated BrdU upon primary 
infection, survived past the contraction phase in LckVA mice than in LckWT 
mice. These results are consistent with an increased potential to form 
memory cells and correlated with higher Bcl-2 expression seen both in vitro 
and in vivo in LckVA T cells. 
The results presented in this thesis firstly, further our understanding of how 
manipulation of T cell signalling can impact on T cell effector function and 
memory formation and secondly, have implications for strategies to optimise 
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Lay Summary  
The effector cells of the immune system, T cells, must be able to recognise 
and respond to any foreign pathogen without attacking self. T cells express a 
variety of T cell receptors (TCR) of different specificities that recognise 
pathogenic proteins. When a TCR engages with a pathogen several signalling 
cascades are initiated within the cell that lead to the expression is effector 
genes required for pathogen clearance and memory T cell formation, in case 
the pathogen be encountered again in the future. Many signalling molecules 
mediate the T cell signalling cascades and of these the most proximal is Lck. 
Without Lck T cells do not develop properly and there is very little T cell 
mediated immunity.  
In this thesis we studied the role of Lck T cell signalling during T cell 
development, activation and memory formation by making use of mice that 
express less than 5% of Lck (LckVA) compared to control mice. We showed 
that T cell development in LckVA mice is comparable to control mice. 
Although, some TCR signalling cascades were reduced, others were 
enhanced in LckVA mice. During bacterial infection, similarly, we found that 
some responses were reduced as compared to control mice, but others were 
similar. Finally we showed that the maintenance of a unique population of 
infection specific T cells into the memory phase was enhanced in LckVA mice.  
The results presented in this thesis firstly, further our understanding of how 
manipulation of T cell signalling can impact on T cell effector function and 
memory formation and secondly, have implications for strategies to optimise 
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Chapter 1 
  1 
Chapter 1:  Introduction 
1.1 Overview of the Immune System 
The mammalian immune system is constantly challenged by infections. A 
variety of effector cells and molecules of the two overlapping immune 
components: innate and adaptive immunity, work both independently and 
in synchrony to protect the host. Successful protection requires fulfilment of 
four main tasks: recognition of the foreign pathogen, its effective clearance, 
self-regulation of immunity and formation of immune memory.  
1.2 The Innate Immune System 
The first line of host defences are protective physical and chemical barriers, 
although these are not considered part of the immune system proper, their 
aim is to prevent microbes from entering the host in the first place. These 
include the skin, the internal epithelium and its mucus lining such as in the 
respiratory, gastrointestinal and reproductive tracts, as well as chemicals 
such as lysozyme in tears and saliva. The underlying tissues are rich in 
innate immune cells and as a pathogen overcomes the protective barriers, the 
immune system proper is engaged. Important innate cells are cells of the 
myeloid lineage such as macrophages, neutrophils, eosinophils, basophils, 
mast cells, dendritic cells (DCs), and some of the cells of the lymphoid 
lineage such as natural killer (NK) and natural killer (NKT) T cells. 
Macrophages are present in almost all tissues and are most often the first 
cells to respond to invading pathogens. They are able to recognise and ingest 
pathogens, particularly bacteria, by virtue of the receptors that recognise 
common constituents of pathogens. Upon recognition of pathogen the 
macrophages phagocytose it by enclosing it within the phagocytic 
membrane, which then becomes fused with the cellular destructive 
machinery forming a phagolysosome, where enzymes, such as lysozyme, 
mediate destruction of the pathogen.  
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Internal degradation of pathogens by macrophages leads to secretion of 
cytokines such as the interleukins (IL) - 1β, -6, -12, tumour necrosis factor 
alpha (TNFα) and chemokines such as chemokine (C-X-C) ligand 8 (CXCL8). 
These molecules orchestrate inflammation and recruit other innate cells as 
well as cells of the adaptive immune system. Activated macrophages also 
upregulate expression of surface molecules that enable them to act as 
antigen-presenting cells alongside DCs to T cells (Fearon and Locksley, 1996). 
1.3 The Adaptive Immune System  
The mammalian bone marrow harbours pluripotent hematopoietic stem cells 
(pHSC), from which all the different types of blood cells develop. The pHSC 
give rise to more specialised precursors such as the common lymphoid 
progenitors (CLP), which develop into B lymphocytes (B cells), T 
lymphocytes (T cells) or NK cells, and the common myeloid progenitors 
(CMP), which develop into granulocytes (Prohaska et al., 2002).   
The adaptive immune system comprises of B and T cells that are 
characterised by their unique cell surface antigen receptors (BCR and TCR, 
respectively). Both BCRs and TCRs develop with an exceptionally wide 
variability in their antigen-binding regions to recognise any potential foreign 
invaders. Key difference between B and T cells is that mature B cells (plasma 
cells) can produce and secrete antibodies of the same antigen specificity as 
the BCR, whereas the TCR is not secreted (Fearon and Locksley, 1996). 
Antibodies can interact with pathogens, and their secreted products, in 
extracellular spaces of the body and recruit immune cells and molecules to 
destroy them. 
1.3.1 The Generation of BCR and TCR Diversity 
The BCR is comprised of paired heavy and light polypeptide chains, 
conventionally termed immunoglobulin (Ig). An Ig of the same specificity as 
the bound form is secreted as an antibody molecule. An antibody molecule 
has two identical variable regions made up two antigen-binding sites, each of 
which is in turn made up of a heavy and a light chain. The heavy and light 
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chains have variable regions that form hypervariable loops, creating a 
surface complementary to antigen, hence, these are also known as 
complementarity-determining regions 1, 2, and 3 (CDR1, CDR2, CDR3).  The 
constant region of an antibody molecule determines its isotype and the 
functional properties. The constant region is composed of the carboxy-
terminal domains of the heavy chains, denoted by Greek letters: δ, &, γ, α, 
and ε and determining the five antibody classes IgD, IgM, IgG, IgA, and IgE, 
respectively. IgM is mainly found in blood and lymph, it can bind bacterial 
capsular polysaccharides and activate the complement system. IgD is present 
present at very low levels and is usually co-expressed with IgM.                                                                                          
IgA is mainly found in secretions like the epithelium lining of the respiratory 
tracts.  IgG operates mainly in body tissue where it can recruit accessory 
cells. Finally, IgE, is present at low levels but is bound by mast cells and 
sensitises them to release chemical reaction inducing mediators causing 
sneezing, vomiting etc. to expel pathogens. 
The TCR is similar to the Ig molecule in that the protein structure also has 
variable and constant regions. The majority of TCRs express two 
transmembrane spanning α and β polypeptide chains as a heterodimer. Each 
polypeptide chain has a variable region and a constant region and the two 
variable regions together form one antigen-binding site. A minority of TCRs 
are made of alternative γ and δ chains (Rudolph et al., 2006). The γδ T cells 
have been shown to carry out specific immune functions in epithelial layers 
of tissues and they have a much smaller TCR repertoire (Xiong and Raulet, 
2007). The core focus of the current thesis is on the αβ T cells and therefore, 
when referring to TCR henceforth we mean the αβ TCR, unless otherwise 
specified. 
The generation of diversity of lymphocyte receptors is largely similar in T 
and B cells. The genes for Ig variable regions are inherited as sets of variable 
(V), joining (J) and diversity (D) gene segments, which are randomly 
assembled in each cell individually by DNA recombination, mediated by 
recombinase-activating genes 1 and 2 (RAG1/RAG2), and joined to a number 
of constant (C) regions creating almost unlimited diversity. In the absence of 
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RAG genes, in Rag knockout (RagKO) mice, there is a complete block in 
lymphocyte development (Mombaerts et al., 1992). The generation of 
diversity is further enhanced by junctional diversity, where nucleotides are 
added or subtracted in the joining process of gene segments by Terminal-
deoxynucelotide transferase (Tdt) (Cabaniols et al., 2001).  
1.3.2 B Cells 
B cells undergo a developmental program in the bone marrow from pro-B 
cells, pre-B cells, to immature B cells that have a membrane-bound 
immunoglobulin BCR for antigen. Pro-B cells first undergo rearrangement of 
the immunoglobulin heavy-chain locus with DH to JH joining, followed by a 
second rearrangement of a VH gene segment to a DJH sequence. If this is 
successful, ~55% of the time, intact & heavy chains are produced, further 
rearrangement ceases, and the pro-B cell becomes a pre-B cell. In the pre-B-
cell stage the lamda (λ) and kappa (κ) light-chains only undergo gene 
rearrangements by V to J joining, they lack D segments. Successful light-
chain progeny combine with the & chain and form an immature B cell 
expressing IgM molecules (Pieper et al., 2013). Immature B cells migrate to 
the spleen where they can undergo further differentiation into naïve, 
follicular, or marginal zone B cells (Pieper et al., 2013). Both the heavy chain 
and the light chain rearrangements are subject to allelic exclusion, ensuring 
that only one of the two alleles of a gene is expressed. Light chains also 
display isotypic exclusion ensuring that either the λ or κ chain is expressed 
by an individual cell, not both (Pieper et al., 2013). Upon stimulation by 
antigen, B cells can undergo class-switching and express Ig of a different 
class. Further diversity in the rearranged V regions can be introduced by 
somatic hypermutation, which occurs at high rates in mature B cells, that 
have already been activated by their corresponding antigen, and is known as 
affinity maturation. This ensures clones with the highest affinity are 
preferentially selected for survival and mature into antibody-producing cells 
(Pieper et al., 2013). 
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1.3.3 T Cells 
Briefly, T cells also originate from the pHSC in the bone marrow but undergo 
their development into mature CD8+ or CD4+ T cells in the thymus. The α and 
β chains of the TCR, like the BCR, also undergo RAG mediated gene 
rearrangement events to generate receptor diversity. T cells, unlike B cells, 
function by detecting the presence of intracellular pathogens by peptide 
presentation on body’s own antigen presenting cells (APCs) in the context of 
the major histocompatibility complex (MHC) class I or class II molecules.  
1.3.4 The MHC Molecules 
The MHC molecules are encoded as a large cluster of genes, therefore, they 
are polygenic, but also highly polymorphic, as a single MHC locus can have 
allelic variants differing by up to 20 amino acids. The majority of differences 
are found in the peptide-binding groove, which influences diversity. Both 
class I and class II MHC molecules are heterodimers with two Ig-like 
domains, an α helix/β sheet superdomain, that forms the peptide-binding 
site (Rudolph et al., 2006). MHC class I and II molecules bind peptides 
differently. The MHC class I molecule binds peptides of 8-10 amino acids 
long and the peptide ends are buried in the peptide-binding groove, 
whereas, in a class II molecule peptide length is typically 13-17 amino acids, 
but is not constrained, and the peptide ends are not buried in the peptide-
binding groove (Murphy et al., 2008; Rudolph et al., 2006). Therefore the 
kinds of peptides that the two MHC class molecules bind are also different. 
The TCR recognises both the peptide being presented and the MHC molecule 
that is presenting it on the APC. CD4+ T cells recognise MHC class II and 
CD8+ T cells recognise MHC class I molecules, meaning that T cell clones are 
MHC restricted. The CDR1 and 2 loops of the Vα chain of the TCR interact 
with the peptide MHC complex around the amino terminus of the peptide, 
conversely the Vβ chains CDR 1 and 2 loops interact with the carboxyl 
terminus of the peptide. In the case of the MHC I molecule, both the Vα and Vβ 
chains interact with its α helices. The CDR3 loops of both Vα and Vβ chains of 
the TCR interact with the central amino acids of the peptide. MHC class I 
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molecules are found on most nucleated cells, as they can be infected by 
viruses, and MHC class I restricted CD8+ T cells differentiate into cytotoxic T 
cells (CTLs) that are specialised to kill infected cells. CD4+ T cells can adopt a 
variety of immunological functions upon binding peptide presented by MHC 
class II molecules by differentiating into distinct effector subsets. Depending 
on the context in which CD4+ T cells are activated they recruit the appropriate 
effector cells (Murphy et al., 2008; Rudolph et al., 2006). 
1.3.5 The Src-Family Kinases 
The TCR is associated with its signal transduction unit CD3 (δ chain, γ chain, 
two ε chains), with two ζ chains and with a cell surface co-receptor either 
CD4 or CD8. The cytosolic components of the CD3 complex contain 
immunoreceptor tyrosine-based activation motifs (ITAMs). The TCR itself 
has no intrinsic enzymatic activity. Upon the binding of peptide:MHC 
(p:MHC) to the TCR the first molecules activated are Src-family kinases 
(SFKs) p56lck (Lck) and p59fyn (Fyn) (Zamoyska et al., 2003). The structures of 
Lck and Fyn are similar.  They each have an N-terminal unique domain, Src 
homology 2 (SH2) and SH3 domains, a tyrosine kinase domain (SH1), and a 
C-terminal negative regulatory domain (Palacios and Weiss, 2007). The 
unique domain in Lck contains a di-cysteine motif that enables it to associate 
with CD4 and CD8 coreceptors (Salmond et al., 2011). The unique domain in 
Fyn also determines its intracellular localisation such as colocalisation with 
centrosomal and mitotic structures (Palacios and Weiss, 2004; zur Hausen et 
al., 1997). In order to target Lck to the plasma membrane and lipid rafts, 
modifications such as addition of fatty chains of myrisitc and palmityc acid 
moieties, as well as S-acetylation of the cysteine residues on the N-terminal 
sites of the Lck molecule are required (Palacios and Weiss, 2004). The SH2 
and SH3 domains of Lck and Fyn mediate intra- and inter-molecular protein-
protein interaction via recognition of polyproline or phosphotyrosine motifs 
allowing the SFKs to act as adapter molecules (Palacios and Weiss, 2004).  
Genetic evidence, that Lck plays a role in TCR signalling, came from studies 
on mutant Jurkat subclone cells (JCam1) lacking functional Lck, which failed 
to transmit TCR signals but transfection of LCK cDNA restored TCR 
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signalling (Straus and Weiss, 1992). Further studies of thymocyte signalling 
in LckKO mice found Lck to be critical for ITAM ζ-chain phosphorylation and 
consequent recruitment and activation of the intracellular kinase ζ-associated 
protein of 70 kDa (Zap-70) (van Oers et al., 1996a). 
The roles of Lck and Fyn in thymocyte development and T cell activation, 
and their regulation are discussed in turn in the relevant sections below. 
1.4 T Cell Development  
T cell development occurs in the thymus.  The αβ T cells can give rise to CD4+ 
and CD8+ T cells, NKTs, and regulatory T cells (TRegs) (Rothenberg et al., 2008). 
The process of development is guided by the thymic microenvironment as 
well as TCR rearrangements and different stages of development are marked 
by changes in gene expression and developmental potential (Fig.1.1). The 
combinatorial expression patterns of various surface markers on developing 
thymocytes allow us to follow their progression during development.  
The thymus is an epithelial-mesenchymal tissue, structurally divided into a 
cortex and a medullary region with functionally distinct stromal cells known 
as cortical thymic epithelial cells (cTECs) and medullary thymic epithelial 
cells (mTECs), respectively (Anderson and Takahama, 2012). At mid-
gestation, the CLPs from the bone marrow, that will develop into T cells, are 
recruited into the thymus by adhesion molecules like P-selectin on thymic 
endothelial cells (Rossi et al., 2005), and chemokines like chemokine CC 
ligand (CCL) 21, CCL25, and CXCL 12, which are expressed on the TECs (Liu 
et al., 2005). The CLPs express selectin-like receptors, such as P-selectin 
glycoprotein ligand-1 (PSGL-1), in order to be able to respond to these 
signals (Rossi et al., 2005). The progenitors are exposed to the thymic 
microenvironment in the thymic cortex containing IL-7, and the Notch Delta-
Like Ligand 4 (DLL4), that induce their proliferation and differentiation 
(Anderson and Takahama, 2012; Schmitt and Zuniga-Pflucker, 2002). IL-7 
signals are transduced via the IL-7R receptor (IL-7R), which is comprised of 
the α-chain (CD127) and the common cytokine-receptor γ-chain (CD132) 
(Mazzucchelli and Durum, 2007). The early progenitor T cells, as they 
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migrate through the thymic cortex, are progressing through the CD4- and 
CD8- double negative (DN) stages of development (Rothenberg et al., 2008). 
At the DN stage of development, it is crucial for T cells to receive IL-7 signals 
for maturation and thus CD127 expression is high (Sudo et al., 1993). The DN 
stages can be further subdivided by CD25 and CD44 expression: DN1 are 
CD25-CD44+, DN2 are CD25+CD44+, DN3 are CD25+CD44- and DN4 are CD25-
CD44-. DN1, 2 and 3 are very heterogeneous and do not only consist of early-
T cell progenitors (ETPs). ETPs, as opposed to the NKT cells, and γδ T cells 
can be purified using the high expression of receptor tyrosine kinase, KIT at 
the DN1 stage. DN2 stage can also be further subdivided into DN2a (KIThi) 
and DN2b (KITmed), the latter is characterised by loss of dendritic cell 
potential. Finally at the DN3 stage cells can be subdivided into DN3a (CD27lo) 
pre-β or γδ- chain selection and DN3b (CD27hi) post-selection thymocytes 
(Rothenberg et al., 2008). During the DN stages thymocytes continually 
migrate towards the capsule, once committed to the T-cell lineage, at the 
DN3 stage, cells undergo the first developmental checkpoint of TCR β chain 
selection and also express an invariant TCR pre-α chain. This pre-TCR- αβ 
complex must associate with CD3ζ complex at the cell surface and be able to 
transmit signals for further maturation (Germain, 2002). A small number 
cells that achieve this will proliferate through DN4 and differentiate into 
CD4+ and CD8+ double positive (DP) thymocytes. During the DP stage 
thymocytes stop proliferating and CD127 expression is downregulated (Sudo 
et al., 1993; Yu et al., 2006). The Tcrb locus, encoding the TCR β protein, 
becomes inaccessible, and the RAG1 and RAG2 genes are activated to initiate 
rearrangement at the Tcra locus, encoding the TCR α chain, in quiescent DP 
thymocytes (Hogquist et al., 2005). In polyclonal wild type mice 
approximately 80-90% of all thymocytes are at the DP stage and have 
successfully rearranged a TCR α chain (Germain, 2002; van Oers et al., 
1996b). DP thymocytes undergo TCRα chain recombination, positive 
selection and CD4/CD8 lineage divergence, whilst migrating back through 
the cortex towards the medulla where they started as ETPs (Fig.1.1) (Petrie 
and Zuniga-Pflucker, 2007; Rothenberg et al., 2008). Positive selection in the 
cortex is mediated by cTECs that present self-MHC associated antigens to 
Chapter 1 
  9 
assess immunocompetence of the newly produced αβ TCR. Only 1-5% of 
TCRs make appropriate affinity interactions and are induced to survive and 
differentiate into CD4+ or CD8+ SP thymocytes (Anderson and Takahama, 
2012). If thymocytes do not recognise self-MHC complexes they die by 
neglect (Werlen et al., 2003).  
If the pre-TCR is unable to associate with the CD3ζ complex cell 
development stops at the DN3 stage. Additionally, if there are defects in the 
Rag1, Rag2 genes causing failure of β chain rearrangement, or defects in pre-
TCRα, TCRβ, or CD3ε genes that also hinder pre-TCR- αβ signaling complex 
formation and expression, no signal transduction occurs and cell 
development is arrested at the DN3 stage (Fehling et al., 1995; Malissen et al., 
1995; Mombaerts et al., 1992; Shinkai et al., 1992). 
Interactions with cTECs induce the expression of C-C chemokine receptor 7 
(CCR7) on T cells and receptor activator of nuclear factor kappa-B ligand 
(RANKL).  The ligands for CCR7 are CCL19 and CCL21 and are highly 
expressed on mTECS, as is the receptor for RANKL. Together, the effects of 
these molecules ensure that the positively selected thymocytes migrate into 
the medulla (Anderson and Takahama, 2012; Petrie and Zuniga-Pflucker, 
2007). In the medulla mTECs carry out promiscuous expression of tissue 
restricted genes, facilitated by nuclear protein Aire, and by means of cross-
presentation to DCs enable DCs to cooperate in the fine-tuning of negative 
selection. Together mTECs and DCs ensure deletion of tissue specific self-
reactive thymocytes (Petrie and Zuniga-Pflucker, 2007).  
This final checkpoint ensures self-tolerance and also contributes to the 
production of naturally occurring TRegs (Anderson and Takahama, 2012). 
Finally, SP thymocytes express sphingosine-1-phosphate receptor 1 (S1P1), 
the ligand for which is S1P that is ubiquitously expressed in the circulation. 
This attracts thymocytes to the circulation and facilitates their egress from 
the thymus (Anderson and Takahama, 2012) 
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Fig. 1.1 T cell development in the thymus (from Rothenberg et al 2008) 
Cross-section through a thymus depicting the maturation of thymocytes from ETPs through 
to CD4+ and CD8+ SP thymocyte stage as they migrate through the thymic environment. Blood 
vessels near the cortico-medullary junction allow the entry of thymocyte precursors from the 
bone marrow. At the DN2a and DN2b stages cells can still adopt alternative phenotypes. All 
non-T cell options are lost by the DN3a stage where TCRβ or γδ gene rearrangement occurs. 
Positive selection of the αβTCR takes place at the DP stage in the cortex and upon success 
the final pre-egress maturation of CD4+ and CD8+ SP thymocytes occurs in the medulla. 
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1.4.1 The Roles of Lck in Thymocyte Development 
At both the DN stage (β - chain selection) and the DP stage 
(positive/negative selection), signalling via the TCR determines whether a 
cell will survive and progress, or die (Germain, 2002). The first key molecule 
in TCR signal transduction is Lck. Lck is functionally and physically 
associated with the CD4 and CD8 co-receptors (Barber et al., 1989; Rudd et 
al., 1988; Veillette et al., 1988). Both the affinity and the dwell time of the TCR 
interaction with p:MHC are influenced by the CD4 and CD8 co-receptors, 
which, facilitate the recruitment of Lck (Artyomov et al., 2010; Palmer and 
Naeher, 2009). Lck phosphorylates ITAMs in the TCR/CD3ζ complex. 
Phosphorylated ITAMs create a binding site for the SH2 domains of Zap-70, 
which is then phosphorylated by active Lck. The cascade continues with 
active Zap-70 phosphorylating Linker of Activated T cells (LAT) and many 
other enzymes and adaptors. Ultimately this signaling cascade leads to the 
increase of intracellular calcium (Ca2+) promoting the nuclear translocation of 
nuclear factor of activated T cells (NFAT) and subsequent activation of the 
Mitogen-Activated Protein Kinase (MAPK) pathways (Germain, 2002).  
The importance of Lck in thymocyte development was evidenced by studies 
where both, transgenic overexpression of wild type Lck (LckY505) or 
constitutively active Lck (LckF505), led to the development of thymic tumours 
(Abraham et al., 1991). The thymocytes in LckY505 and LckF505 mice were 
immature, indicating that Lck activity needs to be maintained under 
stringent control during development (Abraham et al., 1991). The first LckKO 
mouse study, described by Molina and colleagues, showed that the mice 
manifest with profound thymic atrophy due to an incomplete block at the 
DN stage of development, which reduces the numbers of thymocytes 
progressing to the DP stage to one-tenth of wild-type levels (Molina et al., 
1992). Very few SP thymocytes, predominantly CD8+, populate the periphery 
in LckKO mice, which is in line with the signal-strength model of thymocyte 
selection (Molina et al., 1992). Lck was shown to have a vital role in 
thymocytes for sensing appropriate rearrangement of the TCRβ chain, which 
explains the block at the DN stage of development seen in LckKO mice (Levin 
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et al., 1993). Fyn can compensate for Lck during thymic development to some 
extent as LckKO mice exhibit an incomplete block and double knockout mice, 
FynKOLckKO, have a complete block in thymocyte development (van Oers et al., 
1996b). Lack of Fyn alone did not impact on thymic development suggesting 
its minor role (Appleby et al., 1992; Stein et al., 1992). 
1.4.2 Signalling for Positive and Negative Selection  
In the above section I described how thymocyte development occurs in a 
stepwise manner. Two key questions that have puzzled immunologists for 
years are, what mechanisms determine that only TCRs with useful ligand 
specificities are expressed and how do DP thymocytes make a lineage choice.  
The T cell repertoire in the thymus is governed by the need to create a 
repertoire of peripheral T cells that can respond to any foreign antigen in the 
context of self-MHC, while enforcing central tolerance to self-antigens. The 
TCR is thus a unique receptor, able to distinguish very fine differences in 
affinities (analogue input), and translate them into distinct biological 
outcomes (digital output), such as life or death in positive and negative 
selection, respectively (Daniels et al., 2006). One proposed signalling 
pathway involved in positive and negative selection is the ERK/MAPK 
pathway. TCR ligation leads to the activation of low molecular weight G 
protein Ras, which mediates MAPK signalling via MEK (MAPK kinase) 
(Fig.1.2). 
In an in vitro culture system, where thymocytes could either develop into 
CD8+ T cells or die by negative selection, Mariathasan et al. showed that low 
level but sustained extracellular signal related kinase (ERK) signaling 
downstream of MAPK, promoted positive selection, but strong and transient 
ERK activation led to negative selection (Mariathasan et al., 2001). The 
localisation of these signalling molecules within the cell is also influenced by 
signal strength (Daniels et al., 2006). Positively selecting, low-affinity signals 
induced less CD3ζ phosphorylation and recruitment of LAT, and had no 
effect of growth-factor receptor–bound protein 2 (Grb2) and the guanine   
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Fig. 1.2 TCR signalling pathways involved in positive vs negative selection of DP 
thymocytes (from Hernandez et al 2010). 
TCR signalling in DP thymocytes discriminates very fine differences in affinities (analog 
input) high vs low, and translate them into distinct biological outcomes (digital output), by 
differential regulation of signalling pathways downstream of MEK. High-avidity signals 
lead to Grb2-SOS recruitment to the membrane, activation of JNK and p38, which repress 
anti-apopotic Bcl2 and up-regulate the pro-apopotic molecule Bim, altogether causing cell 
death by allowing Bax and Bak to cause mitochondrial dysfunction. Positively selecting, 
low-affinity signals activate RasGRP-Ras-Raf1 and ERK1/2 at the Golgi. In the absence of 
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nucleotide exchange factor Son of Sevenless (SOS) recruitment to the 
membrane, but instead activated the Ras guanyl nucleotide-releasing protein 
(RasGRP) – Ras - Raf1 and ERK pathway at the Golgi (Daniels et al., 2006). 
Negatively selecting, high-affinity signals, induced 3 times higher 
concentrations of Zap-70 at the membrane than positive selecting signals, 
and enhanced LAT phosphorylation, resulting in recruitment of Grb2-SOS 
and activation of Ras-Raf1-ERK at the plasma membrane (Daniels et al., 2006; 
Mallaun et al., 2010). Negatively-selecting signals also activate c-Jun N-
terminal kinase (JNK), which represses expression of anti-apopotic Bcl-2 and 
up-regulates the pro-apopotic molecule Bim (Dong et al., 2002; Morris and 
Allen, 2012) to induce cell death. The sequestration of ERK to the membrane 
may be permissive for JNK activation as haplo-insufficiency of Grb2 
compromised negative selection and JNK activation, but not ERK activation, 
suggesting that JNK has a higher activation threshold (Gong et al., 2001). 
Additional work, using Foerster resonance energy transfer (FRET) 
microscopy, has shown that CD8 and TCR interactions induced by 
negatively selecting signals lead to FRET signals that accumulate faster and 
are more short-lived than the positively selecting ligands (Mallaun et al., 
2008). This is in line with the studies suggesting ERK signalling needs to be 
sustained for positive selection (Mariathasan et al., 2001). 
Perturbations in signalling molecules downstream the TCR, such as in Zap-
70, can lead to the production of a peripheral repertoire with increased 
autoimmunity. The Sakaguchi lab discovered the SKG strain of mice that had 
a spontaneous mutation in the SH2 domain of Zap-70 causing reduced 
expression of Zap-70 and spontaneous autoimmune arthritis (Sakaguchi et 
al., 2003). The mutated Zap-70 molecule is more rapidly degraded and is less 
efficient at downstream tyrosine phosphorylation (Tanaka et al., 2010). These 
mice were used to address how changing the abundance of functional Zap-70 
could impact on thymic selection. To this end Sakaguchi and colleagues 
compared wild-type (WT) (+/+), heterozygous (skg/+), homozygous 
(skg/skg) and hemizygous (skg/-) mice and found that autoimmune clones of 
T cells, normally deleted due to increased TCR affinity, were selected into the 
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peripheral repertoire in mice with SKG mutations due to reduced Zap-70 
signalling and the consequent ‘selection shift’ (Tanaka et al., 2010). A graded 
expression of mutated Zap-70, that acts directly downstream of Lck, was 
therefore shown to result in alterations in positive and negative selection of T 
cells in the thymus (Tanaka et al., 2010). 
1.4.3 Models of Lineage Divergence in DP Thymocytes 
Many models have been put forward to explain how the CD4 versus CD8 
lineage choice is determined in bipotential DP thymocytes that express both 
CD4 and CD8 co-receptors. Two classical models of lineage choice are 
stochastic and instructive, depending on whether termination of co-receptor 
transcription is thought to be random or instructed (Singer et al., 2008). The 
stochastic model proposes a two-step mechanism of lineage choice by which 
termination of co-receptor expression occurs randomly, and a second TCR 
signal rescues either CD4+ or CD8+ cells (Davis et al., 1993). For example, 
Davis et al. biased T cell development toward class II specificity by 
constitutive, transgenic CD4 expression and showed CD4 signals rescued a 
long-lived CD8+ T cell population with mismatched MHC class II (Davis et 
al., 1993). The instructive model proposes a one step mechanism of selection 
dependent on the strength of the TCR signal. It posits that in DP thymocytes 
with mismatched co-receptors, Cd8 or Cd4 gene expression is instructively 
terminated because co-receptor engagement with MHC is class restricted and 
the co-receptors transduce qualitatively different signals. It has been shown 
that the CD8 co-receptor binds Lck with a lower affinity than CD4 (Bramson 
et al., 1991) thereby transducing weak signals, whereas the CD4 co-receptor 
can transduce strong signals. Itano et al. made use of a chimeric co-receptor 
transgene encoding CD8α molecules expressing the cytosolic domain of CD4 
(Itano et al., 1996). The expression of the chimeric CD8-CD4 molecule 
resulted in development of MHC I restricted CD4+ T cells. Experiments with 
bispecific antibodies that co-ligate TCR/CD3 with either CD4 or CD8 
molecules, showed that agonist signals bringing Lck to the signalling 
complex, both CD3/CD4 or CD3/CD8, direct CD4+ SP maturation, however 
these experiments were unable to determine how CD8+/CD4+ SP maturation 
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was triggered (Bommhardt et al., 1997). Additionally, Hernandez-Hoyos and 
colleagues bred mice with a catalytically inactive Lck with a class II-restricted 
transgenic (AND) mice and mice with constitutively active Lck with class I-
restricted transgenic (OT-I) mice (Hernandez-Hoyos et al., 2000). They 
hypothesised, that if Lck being brought to the signalling complex is 
determinative, then lack of Lck in AND mice would change lineage 
commitment toward CD8+ SP, and conversely, excessive Lck on an OT-I 
background will change commitment towards CD4+ SP. Their results showed 
that regardless of class restriction, amount of Lck was indeed responsible for 
determining the fate of thymocytes (Hernandez-Hoyos et al., 2000). These 
studies collectively suggested that DP thymocytes are instructed into the 
CD4 or CD8 lineage depending on the strength of the signal, defined by the 
abundance of Lck, that TCR and co-receptor binding to class I or II MHC can 
transduce intracellularly.  
However, several studies have since shown that by altering the signal 
intensity of the co-receptor molecules themselves it was possible to induce 
increased thymic selection of MHC class-I restricted T cells as well, without 
impacting the CD4/CD8-lineage choice. For example, Erman et al. 
engineered the endogenous CD8a gene to encode the cytosolic tail of CD4 
and cause strong-signalling via the stronger interaction with Lck. This 
increased positive selection of MHC class-I restricted thymocytes cells but 
overall had no impact on CD4/CD8-lineage choice (Erman et al., 2006). 
Additionally, Bosselut et al. replicated the initial study done by Itano et al. 
but in CD8α deficient mice with CD8-CD4 chimeric co-receptors (Bosselut et 
al., 2001). They also found that, the strength-of-signal, mediated by amount 
of Lck, did not determine the CD4/CD8 lineage choice but influenced the 
proportions of developing cells (Bosselut et al., 2001). Collectively, these 
studies showed that the enhanced interaction between the CD4 co-receptor 
and Lck in the thymus leads to the development of higher proportions of 
CD4+ SPs than CD8+ SPs. 
Attempts to disprove models have led to the development of new models, 
one of them being the non-classical kinetic signalling model of CD4/CD8 
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lineage choice. The kinetic signalling model proposes that regardless of MHC 
restriction in DP thymocytes, TCR signalling can induce arrest of the Cd8 
gene transcription creating an intermediate CD4loCD8- population, which 
retain the potential to become either CD4+ or CD8+ T cells. Lineage choice is 
based on whether CD8 downregulation induces a ‘break’ in TCR signalling 
or not. If it does, then IL-7 signaling, which is reciprocal with TCR signalling 
(Hong et al., 2012), would induce ‘co-receptor’ reversal and CD8 re-
expression leading to the CD8+ SP lineage. If it does not induce a ‘break’ in 
TCR signalling the cell would become a CD4+ SP thymocyte (Brugnera et al., 
2000; Singer et al., 2008).   
The kinetic signalling model is supported by the more intricate control, at a 
transcriptional level, of CD4 and CD8 lineage choice. TCR signalling in DP 
thymocytes can induce arrest of Cd8 gene transcription (by suppressing the 
Cd8 gene enhancer E8III) and upregulate expression of DNA-binding protein 
TOX, thereby maintaining Cd4 expression and facilitating the development 
of the intermediate CD4loCD8- population (Singer et al., 2008). If TCR 
signalling does not cease, suggesting that the signal is MHC II restricted, the 
expression of nuclear factors GATA-3 and ThPOK increase promoting the 
development of the CD4 lineage by suppressing IL-7 signals and the 
expression of genes defining the CD8 lineage (Xiong and Bosselut, 2012). If, 
on the other hand, the TCR signalling ceases, suggesting that it is MHC I 
restricted, IL-7 signals and enhanced expression of transcription factor Runx3 
promote the development of CD8+ T cells by suppressing the expression of 
the Cd4 gene and ThPOK (Woolf et al., 2003; Xiong and Bosselut, 2012). 
Runx3KO mice are impaired in making the CD4 versus CD8 lineage decision, 
and peripheral T cells express both co-receptors, supporting the importance 
of this transcription factor in lineage decisions (Woolf et al., 2003).  
A recent study made a case for both signal strength (quantitative) and kinetic 
signalling models (co-receptor reversal) of development acting in concert 
during lineage development (Alarcon and van Santen, 2010; Saini et al., 
2010). The study by Saini et al. showed that Zap-70 expression is 
developmentally and temporally regulated in the thymus and it creates 
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distinct temporal windows for each lineage to be selected at different TCR 
signaling thresholds (Saini et al., 2010). CD4 development happened earlier 
and in response to stronger TCR signals (CD5hiTCRmed) than the CD8 lineage 
(CD5medTCRhi), which was delayed by ~3 days, and CD8 lineage commitment 
required accumulation of Zap-70 and thus a higher sensitivity to TCR 
ligation (Saini et al., 2010). 
1.5 Peripheral T Cell Signaling 
Peripheral T cells are the key mediators of the adaptive immune response. 
Upon exposure to antigen, T cells differentiate, acquire effector function, 
proliferate and finally form memory. T cells are selected in the thymus based 
on their responsiveness to self-p:MHC. Therefore, mature peripheral T cells 
have the potential to be self-reactive. This is an important feature for T cell 
survival in a resting state, as they must receive tonic, low-affinity signals 
from self-p:MHC complexes as well as signals via the IL-7R (Seddon and 
Zamoyska, 2002). The threshold of activation must be precisely set in T cells 
in order for them to respond to any foreign antigens, whilst enforcing central 
tolerance to self-antigens. Fate decisions thus ultimately depend on 
interpretation of the combined environmental cues by the T cell receptor 
(TCR) – signal 1, signals from co-stimulatory molecules – signal 2, and 
cytokine receptors – signal 3 (Salmond et al., 2009b; Zamoyska et al., 2003).  
It is convenient to think of the TCR signalling cascades and regulatory 
modules according to the classifications assigned to the TCR signalosome 
(the entire TCR signaling machinery) by Acuto et al. (2008). The first is the 
SFK regulation module, including Lck and the associated positive and 
negative regulators of Lck activity. The second is the signal triggering 
module consisting of ten ITAMs in the dimeric CD3 chains of the TCR 
complex, and Zap-70. The third and final module is the signal diversification 
and regulation module (Acuto et al., 2008). The intricate connectivity, inter-
regulation and abundance of the molecules in these different modules give 
the TCR the unique fine-tuning ability to discriminate between signals. The 
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following sections will look at each of TCR signal initiation, propagation and 
ultimately regulation. 
1.5.1 Module 1: Kinase Regulation  
Lck activity is tightly regulated, independently of TCR engagement, by the 
phosphorylation states of its two tyrosine (Y) residues - the inhibitory 
residue LckY505 in the C-terminal domain and the activatory LckY394 in the kinase 
domain (Salmond et al., 2009b). LckY505 is phosphorylated by C-terminal Src 
kinase (Csk), permitting the molecule to adopt a closed conformation with 
the inhibition of kinase activity. LckY505 is dephosphorylated by CD45, 
resulting in upregulation of kinase activity. The kinase domain LckY394 is 
regulated by autophosphorylation and dephosphorylated by phosphatases 
CD45, protein tyrosine phosphate non receptor type 6 (PTPN6 also known as 
Shp1), and PTPN22 (Cloutier and Veillette, 1999).  
Mice deficient in Csk show hyperactivity of Lck (Imamoto and Soriano, 1993; 
Schmedt et al., 1998), and CD45 deficient mice display severe defects in 
thymic development due to hyperphosphorylation of LckY505, which renders 
Lck inactive and prevents TCR triggering (Byth et al., 1996; Hermiston et al., 
2003). The reconstitution of CD45 deficient mice with graded expression 
levels of CD45, demonstrated that low activity of CD45 led to reduced TCR 
signalling, and intermediate CD45 activity caused hyperactivation of CD4+ 
and CD8+ T cells (McNeill et al., 2007).  These studies indicated the 
importance of the dynamic regulation of Lck, and identified CD45 and Csk 
as gatekeepers of TCR activation. 
In naïve cells, 40% of Lck was shown to be constitutively doubly 
phosphorylated on both the Y505 and Y394 residues, and in an open 
conformation ‘poised’ for activation. Tonic signaling in T cells maintains 
partial phosphorylation of TCR ζ -chains by Lck (Nika et al., 2010; Stefanova 
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1.5.2 Module 2: Zap-70 
Upon TCR engagement with p:MHC, the negative regulators are thought to 
be excluded from the synapse, and Lck can phosphorylate the ITAMs 
without immediate dephosphorylation (Fig.1.3) (Springer, 1990). When two 
ITAMs in a dimeric CD3 chain (γε, δε and ζζ) of the TCR complex are 
phosphorylated they bind the SH2 domain of Zap-70 (van Oers et al., 2000).  
The binding of multiple Zap-70 molecules to ITAMS is thought to ‘unlock’ 
Zap-70 from an inactive configuration (Deindl et al., 2007), allowing it to be 
autophosphorylated and phosphorylated by Lck to subsequently continue 
the cascade of downstream phosphorylation events (Smith-Garvin et al., 
2009). In resting cells some unphosphorylated Zap-70 is associated with 
partially phosphorylated ITAM ζ-chains due to tonic self-p:MHC signalling, 
allowing for a quicker signal transduction upon TCR agonist-ligand 
engagement (van Oers et al., 1994). 
The first direct targets of Zap-70 are the transmembrane adapter protein LAT 
and the cytosolic adapter SH2 domain-containing leukocyte phosphoprotein 
of 76kDa (SLP-76). The absence of either LAT or SLP-76 results in a loss of T-
cell signaling as they are critical for the spatiotemporal arrangements of 
subsequent effector molecules (Smith-Garvin et al., 2009). Zap-70 is therefore 
instrumental in controlling the connectivity of the TCR signalosome. 
1.5.3 Module 3: Signal Diversification  
Phosphorylation of 9 tyrosine residues on LAT upon TCR engagement leads 
to its binding of phospholipase C gamma (PLC-γ), phosphoionositide 3-
kinase (PI3K), the adapters Grb2 and Grb2-related adapter downstream of 
Shc (Gads) (Patel and Mohan, 2005; Smith-Garvin et al., 2009). It is via the 
recruitment of Gads, that LAT binds SLP-76.  SLP-76 has an N-terminal 
acidic domain with three tyrosines that when phosphorylated interact with 
SH2 domains of Vav1, Nck, and IL-2 induced tyrosine kinase (Itk). SLP-76 
also has a proline-rich domain that binds Gads and PLC-γ and finally its C-
terminal SH2 region facilitates the binding of adhesion and degranulation-
promoting adaptor molecule (ADAP) and hematopoietic progenitor kinase 1 
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(HPK1) (Koretzky et al., 2006). Itk is required for the recruitment of Vav1, 
whilst Vav1 is itself required for Itk activation and optimal phosphorylation 
of SLP-76. Similarly, PLC-γ interacts with LAT, Vav1, SLP-76 and Itk, most 
probably to stabilise the complex.  
Downstream of PLC-γ are Ca2+, diacylglycerol (DAG) and Ras (a guanyl 
nucleotide-binding protein) mediated pathways. PLC-γ hydrolyses 
phosphatidylinositol-4,5-bisphosphate (PIP2) producing inositol 1,4,5 – 
trisphosphate (IP3) and DAG.  
The PLC-γ mediated IP3 production stimulates Ca2+-permeable ion channel 
receptors (IP3R) on the membrane of the endoplasmic reticulum (ER) leading 
to Ca2+ flux into the cytoplasm. When ER Ca2+ is depleted, CRAC channels are 
activated and lead to Ca2+ influx by the ‘store-operated’ mechanisms of Ca2+ 
entry through the plasma membrane (Oh-hora and Rao, 2008). Ca2+ is an 
important second messenger by causing the activation of several 
transcription factors among which are NFAT, and Ca2+-calmodulin 
dependent kinase (CamK) (Smith-Garvin et al., 2009). These mediate gene 
regulation resulting in cell proliferation and cytokine gene expression (Oh-
hora and Rao, 2008). 
DAG is important for PKC mediated pathways. There are several PKC family 
enzymes, but the best known is PKCθ.  PKCθ mediates phosphorylation of 
caspase recruitment domain (CARD) and membrane-associated guanyl 
kinase (MAGUK)-containing scaffold protein (CARMA1) (Hayashi and 
Altman, 2007). CARMA1 forms a complex with mucosa-associated lymphoid 
tissue lymphoma translocation gene 1 (MALT1) and Bcl10. This large 
complex recruits and activates the IKK complex thereby allowing the IKK 
complex to phosphorylate IκB. IκB is normally bound to the p50-p65 
subunits of nuclear factor kappa B (NFκB), but the phosphorylation of IκB 
degrades it and releases NFκB. Consequently, NFκB translocates to the 
nucleus and binds specific κB sequences on DNA which control transcription 
of genes involved in inflammation, cell survival and cell division 
(Gerondakis et al., 2014). 
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DAG also recruits Ras guanyl nucleotide-releasing protein  (RasGRP), which 
is phosphorylated by PKCθ to activate Ras (Houtman et al., 2005). Ras 
mediates MAPK pathway activation via Raf-1 culminating with the 
activation of ERK1 and ERK2 (Smith-Garvin et al., 2009). MAPK pathways 
ultimately lead to gene regulation by activating transcription factors such as 
activator protein 1 (AP1) (Oh-hora and Rao, 2008; Smith-Garvin et al., 2009). 
TCR stimulation also impacts on actin reorganisation and inside-out integrin 
mediated cell adhesion pathways. Upon ligation by p:MHC on an APC, the T 
cell undergoes morphological changes that lead to cell polarisation and 
formation of the immunological synapse (IS) as well as the cessation of T cell 
mobility to facilitate stronger contacts with the APC. For these purposes 
Vav1 dephosphorylates ezrin, radixin and moesin (ERM) proteins to increase 
the fluidity of the plasma membrane by unlinking it from the actin 
cytoskeleton (Smith-Garvin et al., 2009). TCR signal mediated activation of 
the small GTPase-Ras-proximity 1 (Rap1) enhances T cell binding in an 
ADAP dependent manner to intracellular adhesion molecule (ICAM) via 
leukocyte function-associated antigen 1 (LFA-1) (Peterson et al., 2001; Smith-
Garvin et al., 2009) 
1.5.4 Module 3 Continued: Negative Regulation of TCR 
Signalling  
Dysregulation at any stage of T cell activation can result in immune 
disorders, including autoimmune diseases, and therefore T cell activation is 
actively negatively regulated. Negative regulation assures that TCR 
signalling is controlled appropriately, in terms of the strength and duration 
of the signal, and makes up the final component of the third module of signal 
diversification and regulation of the TCR signalosome. Many different 
negative regulation pathways and molecules that act at different stages of the 
TCR signalling cascade have been described, including inhibitory 
membrane-bound receptors such as cytotoxic T lymphocyte antigen 4 
(CTLA4), programmed cell death 1 receptor (PD1), and CD5 that recruit 
protein tyrosine phosphatases (PTPs) (Acuto et al., 2008). An accumulation of 
activated T cells in CTLA4KO mice (Waterhouse et al., 1995) and lupus like 
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disease in PD1KO mice (Nishimura et al., 2001) underline their importance in 
terminating TCR signalling. CD5 deficiency does not cause any immune 
disorders, although mice display altered T-cell development (Tarakhovsky et 
al., 1995).  
Mice lacking inhibitory membrane-bound scaffold proteins such as 
phosphoprotein associated with glycosphingolipid-enriched microdomains 
(PAG) and Lck-interacting membrane protein (LIME), do not show overt 
phenotypes despite these molecules recruiting protein and lipid kinases and 
phosphatases as a means of controlling TCR signalling, suggesting there are 
sufficient compensatory mechanisms (Acuto et al., 2008). However, a 
mutation in PTPN22, a cytoplasmic negative regulator, that disrupts its 
binding with Csk is associated with an increased risk for autoimmune 
disease in humans (Begovich et al., 2004; Bottini et al., 2006; Zhang et al., 
2011). It is thought that PTPN22 is associated with Csk and thereby recruited 
to the plasma membrane to negatively regulate SFKs (Cloutier and Veillette, 
1999). Upon TCR ligation Fyn dephosphoryalates PAG, which releases Csk 
and subsequently allows for Lck to start the TCR signalling cascade, 
particularly in effector and memory T cells. However, PAG association with 
Csk is most likely not the only mechanism by which PTPN22 gets to the 
membrane, as PAG-/- mice do not show an overtly lymphoproliferative 
phenotype (Smida et al., 2007).   
An important TCR-dependent proximal negative feedback mechanism, 
induced directly in response to TCR signaling, is the cytoplasmic PTPase 
SHP1. Antagonist-p:MHC signals recruit SHP1 rapidly to the TCR signalling 
complex, and cause its activation by Lck, which in turn leads to SHP1 
downregulating Lck activity (Stefanova et al., 2003). SHP1-/- mice develop 
autoimmune disease due to dysregulated thymocyte selection and T-cell 
activation (Lorenz et al., 1996). Negative regulation by SHP1 therefore acts as 
an additional regulator of TCR signals. More proximal components of the 
signalosome are negatively regulated by Dok1 and Dok2 adaptor proteins 








Fig. 1.3 Proximal T cell signalling cascades (from Brownlie et al 2013). 
TCR engagement with p:MHC leads to co-receptor associated Lck recruitment. Lck is responsible for phosphorylation of the ITAMs, which recruit Zap-
70. Zap-70 recruits and phosphorylates LAT and SLP-76, which form the LAT signalosome with PLC-γ, Gads, Itk, Nck1, Vav1, ADAP and Grb2. From 
the LAT signalosome three major TCR signalling pathways are triggered: the Ca2+, MAPK and NFκB pathways via PtdIns(4,5)P2, Ras, and DAG, 
respectively. These lead to gene expression changes influencing actin reorganisation and integrin mediated cell adhesion pathways.  
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Schoenborn et al. described a potential interaction between Dok1 and Csk 
that may contribute to negative regulation of Lck activity in response to TCR 
ligation (Schoenborn et al., 2011). Indeed, Dok1-/-Dok2-/- mice have increased 
TCR-induced IL2 production, and proliferation correlating with increased 
phosphorylation of Zap-70, LAT and ERK, suggesting the Dok proteins have 
an important role in TCR signalling, however, their exact mechanism of 
action has yet to be determined. 
In addition to these early/immediate regulatory mechanisms in response to 
TCR-signalling, there is a more downstream mechanism: the HPK1-SLP-76-
14-3-3 pathway (Di Bartolo et al., 2007) In response to TCR stimulation, Lck 
phosphorylates HPK1, which then binds and phosphorylates SLP-76Ser376, 
which in turn associates with 14-3-3 proteins. HPK1 phosphorylation of SLP-
76 occurs after 10-15min of TCR stimulation, and lasts up to an hour (Ling et 
al., 2001). HPK1 deficiency results in increased TCR-dependent tyrosine 
phosphorylation of SLP-76, PLCγ, LAT, Vav1, and Zap-70, leading to a more 
severe form of experimental autoimmune encephalomyelitis, again 
highlighting the importance of negative regulation (Shui et al., 2007). 
1.5.5 Initiating TCR signal transduction 
The TCR is unique in its ability to discriminate between a high level of self 
p:MHC molecules (noise) and a lower level of foreign p:MHC ligands 
(signal) (van der Merwe and Dushek, 2011). It demonstrates extensive 
versatility and structural diversity when binding multiple ligands with 
different affinities and producing different biological outcomes (van der 
Merwe and Dushek, 2011). Several models have been proposed to explain the 
mechanisms behind TCR triggering. The following section will briefly 
summarise the three main models of aggregation, conformational change, 
and segregation. 
Aggregation 
Two types of aggregation can occur for TCR triggering – co-receptor 
heterodimerisation or pseudodimer formation. The co-receptor 
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heterodimerisation model proposes that the co-receptor can bind to the same 
p:MHC complex as the TCR and recruit Lck into proximity with the CD3 
complex and ITAMs, thereby initiating the TCR signaling cascade (van der 
Merwe and Dushek, 2011).  On the other hand the pseudodimer formation 
model suggests that one TCR complexes with an agonist-p:MHC and a  
neighbouring TCR complexes with a self-p:MHC thereby enhancing the TCR 
trigger to low density agonist-p:MHC ligands (van der Merwe and Dushek, 
2011).   
Conformational Change 
Studies have looked at the conformation of TCR in bound and unbound 
states and found that there may be a conformational change in the TCRα 
chain constant domain (Kjer-Nielsen et al., 2003). In order for this model to 
explain how the TCR can transduce different signals to the cell interior it was 
suggested that there are differences in dimerisation upon conformation 
change, therefore combining the conformation change model with the 
aggregation model (Kjer-Nielsen et al., 2003). It has also been suggested that 
the conformational change occurs at the level of the CD3 residues associated 
with the TCR. Subtle repositioning of CD3ε cytoplasmic domains may 
release them from lipid bilayer of the plasma membrane, lead to exposure of 
the cryptic epitope in CD3ε and make them available as substrates for Lck 
(Minguet et al., 2007). Indeed, the level of CD3 phosphorylation was shown 
to be incomplete with low affinity stimulation of TCR ligands (Sloan-
Lancaster et al., 1993). Additionally, it has been proposed that the sheer 
mechanical force of MHC binding to the TCR that is transduced through the 
CD3γε heterodimer causes conformational changes and in that scenario the 
discrimination between different ligands would be mediated by the duration 
of ligand binding (Kjer-Nielsen et al., 2003).  
Segregation 
Models of segregation suggest that the distribution of TCR-CD3 complexes 
with respect to other cell membrane-associated proteins control TCR 
triggering. The kinetic segregation model suggests that the TCR is positioned 
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in Lck rich areas of the lipid membrane, and due to large ectodomains of the 
negative regulator CD45, upon MHC binding it is excluded from these areas 
of close-contact (Acuto et al., 2008; Springer, 1990; van der Merwe and 
Dushek, 2011). Exclusion of negative regulators increases half-lives of 
phosphorylated ITAMs which then recruit Zap-70 and trigger the 
downstream signalling cascade (Davis and van der Merwe, 2006). The half-
life of the TCR-MHC interaction however influences the extent of ITAM 
phosphorylation (Davis and van der Merwe, 2006).  
In summary it is possible that a combination of different models most 
accurately describes TCR triggering. Indeed, Van der Merwe and Dushek 
proposed the following sequence of events: 1. p:MHC binding to TCR tilts 
the balance of phosphorylation/dephosphorylation of Lck such that its 
kinase activity is increased, by exclusion of local phosphatase activity. 2. TCR 
engagement also causes conformational change in the TCR-CD3 complex 
enhancing the susceptibility to phosphorylation and activation. 3. Given that 
the ligand enagegement is lasting microclusters of 10-100 TCRs are formed. 4. 
The large clusters enable discrimination of rare antigenic-p:MHC complexes 
from abundant self-p:MHC complexes by cooperative interactions (van der 
Merwe and Dushek, 2011).  
1.6 T Cell Effector Function 
The CD8+ T cell response has two goals; firstly, to quickly generate enough 
cytotoxic T lymphocytes (CTLs) to clear the infection and, secondly, to retain 
a subset of memory cells that can act faster, should the same pathogen be 
encountered again. A CD8+ T cell requires antigen stimulation, CD28-
dependent co-stimulation, and IL-12 or Type I interferons (IFNs) for 
activation and commitment to clonal expansion and effector cell 
differentiation (Williams and Bevan, 2007). CTLs are characterised by 
extensive proliferation, the ability to produce granzymes and perforin to kill 
target cells, as well as the secretion of antiviral cytokines such as IFNγ and 
TNFα (Kaech and Cui, 2012; Mescher et al., 2006). 
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Upon TCR activation in a naïve T-cell, rapid and transient secretion of IL-2 is 
seen, which induces expression of the IL-2 receptor (IL-2R). IL-2 is a well-
known and important cytokine as on one hand it induces T-cell expansion, 
survival, effector differentiation, and memory cell survival.  On the other 
hand it also controls the contraction of inflammatory responses by promoting 
growth and survival of TRegs and stimulating activation induced cell death 
(AICD) (Martins and Calame, 2008). IL-2 signaling leads to activation of the 
transcription factor Stat5 and its own negative-feedback loop (Malek, 2008). 
Among other molecules IL-2 also induces expression of Blimp-1 (Martins et 
al., 2008). The expression of IL-2 and Blimp-1 upon TCR stimulation is 
inversely correlated. Indeed, it has been shown that Blimp-1 represses the Fos 
gene (Martins et al., 2008). The Fos protein is a component of the IL-2 
inducing transcriptional pathway mediated by AP-1. Therefore, the IL-2 gene 
is repressed by Blimp-1 via its control of Fos (Martins et al., 2008).   
Activated CD8+ T cells produce TNFα that can mediate antiviral effects by 
binding to TNFα receptors on cells and enhancing the expression of 
transcription factors NFκB and AP-1, which induce expression of pro-
inflammatory and immunomodulatory genes (Herbein and O'Brien, 2000).  
Co-stimulation by IL-12 leads to the production of the type II interferon, 
IFNγ, which binds the IFNγ-receptor (IFNGR) and signals through the Jak-
Stat pathway (Schroder et al., 2004). IFNγ enhances MHC class I expression 
on the cell surface and causes the expression of the ‘immunoproteasome’ 
instead of the constitutively expressed proteasome (Schroder et al., 2004). It is 
thought that the enhanced MHC class I expression increases the abundance 
and variety of peptides presented on the cell surface, increasing the chances 
of recognition by CTLs (Schroder et al., 2004). IFNγ can also upregulate the 
expression of class II MHC molecules, and enhance peptide presentation to 
and activation of CD4+ T cells (Schroder et al., 2004).  
The aim of CD8+ T cells is to eliminate infected target cells by inducing their 
apoptosis. Cell apoptosis is mediated by caspases, a family of cysteine 
proteases (Nicholson and Thornberry, 1997). CTLs activate the caspase 
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pathway in target cells upon making contact and releasing granules of 
specialised secretory lysosomes containing cytolytic effector proteins, such as 
perforin, granzymes, FasL as well as lysosomal hydrolases (Jenkins and 
Griffiths, 2010). In the cleft between the target and the CTL the presence of 
Ca2+ causes polymerisation of perforin, which damages the target cell 
membrane and can mediate granzyme entry (Russell and Ley, 2002). 
Granzyme B has many substrates, such as apoptotic nucleases that can 
induce DNA fragmentation as well as pro-caspases, that lead to the 
activation of the caspase mediated death pathway, and ultimately also to 
DNA fragmentation (Russell and Ley, 2002). FasL induces apoptosis of Fas 
expressing target cells. Fas engagement by FasL causes the assembly of death 
inducing signaling complex (DISC), which induces activation of caspases. 
Part of DISC formation is Fas mediated recruitment of Fas associated death 
domain (FADD) and caspase 8 (Nicholson and Thornberry, 1997). 
1.6.1 Co-stimulation and the Role of Cytokines 
Ligation of the TCR alone leads to T cell anergy (Schwartz, 2003). For full 
activation a T cell requires co-stimulation signals in addition to TCR 
engagement. CD28 on T cells binds CD80 (B7.1) and CD86 (B7.2) on APCs, 
which are upregulated during activation, and this engagement enhances 
TCR mediated signaling. CD28 signaling enhances proliferation and survival 
by promoting production of IL-2 (Sharpe and Freeman, 2002). The 
importance of the CD28 co-stimulatory pathway is exemplified by CD28 
blockade being used clinically to treat autoimmune disease (Kremer et al., 
2003). There are also additional co-stimulatory molecules OX40 (CD134), 4-
1BB (CD137), and CD27, that are said to aid continued cell division that was 
initially started by CD28 (Croft, 2003; Williams and Bevan, 2007). 
Optimal T cell activation also requires a third signal that can be delivered by 
IL-12, type I IFNs and TLR ligands (Williams and Bevan, 2007). IL-12 
promotes effector function development by enhancing IFNγ and granzyme B 
production (Croft, 2003; Williams and Bevan, 2007). Type I IFNs have been 
shown to promote T cell survival during activation in a manner distinct from 
the functions of IL-2 or CD28 (Marrack et al., 1999). 
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1.7 Regulatory T Cells (TRegs) 
TRegs are a subset of CD4+ T cells that are important for maintaining immune 
tolerance by countering adaptive immune responses (Liston and Gray, 2014; 
Setoguchi et al., 2005). TRegs are commonly further split into two subsets of 
natural TRegs that develop in the thymus and peripheral or induced TRegs that 
develop in the periphery. Natural TRegs are thought to develop in the thymus 
in response to enhanced sensitivity to self and they commonly express high 
levels of IL-2Rα and represent ~5-10% of CD4+ T cells (Klein and Jovanovic, 
2011; Setoguchi et al., 2005). Indeed, IL-2 has been shown to play an 
important role in maintenance of natural TReg populations (Setoguchi et al., 
2005). Extrathymic development of induced TRegs from naïve CD4+ T cells was 
found to be tumour growth factor β (TGFβ) mediated (Apostolou and von 
Boehmer, 2004). Both subsets of TRegs are characterised by the expression of the 
X chromosome-encoded member of the winged-helix family of transcription 
factors (Foxp3) (Williams and Rudensky, 2007). Foxp3 deficiency in humans 
leads to severe immune dysregulation (Gambineri et al., 2003) and similarly, 
IL-2 deficiency substantially reduces proportions of natural TRegs causing 
lymphoproliferative inflammatory disease in mice (Papiernik et al., 1998).  
1.8 T Cell Memory  
The ability to form immunological memory is the hallmark of the adaptive 
immune system. Memory cells are characterised by their ability to mount 
more rapid and enhanced immune responses upon secondary encounters 
with pathogens, a consequence of their increased sensitivity to antigen, as 
they can be activated by 10 to 50-fold lower peptide concentrations than 
naïve T cells (Pihlgren et al., 1996).  
Many different mechanisms have been proposed that provide memory cells 
the higher signalling efficiency than that of naïve cells (Zehn et al., 2012). One 
potential explanation is that antigen-experienced CD8+ T cells have an altered 
and more efficient signal transduction cascade, potentially due to the 
differential spatial reorganisation of negative regulators and TCR signal 
mediators (Borger et al., 2013). In addition to negative regulators of TCR 
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signaling being redistributed away from the site of TCR engagement in CD8+ 
memory T cells, it was shown that Lck was more efficiently recruited to the 
site of TCR engagement (Borger et al., 2013), possibly because of the reported 
increased localisation with the CD8 co-receptor (Bachmann et al., 1999). In 
contrast, however, Tewari et al. have reported that memory CD8+ T cells were 
Lck-independent with less stringent requirements for antigen-specific TCR 
signaling to activate them (Tewari et al., 2006). It has also been proposed that 
memory cells have more lipid rafts with a higher content of important 
signalling molecules like LAT, ERK and JNK compared to naïve cells, that 
could account for their more rapid activation (Kersh et al., 2003).  Another 
proposed mechanism, for the enhanced activation of memory cells, is the 
epigenetic modulation of effector molecule genes, that are ‘poised’ for rapid 
polymerase accessibility and transcriptional activation (Youngblood et al., 
2013). For example, it has been shown that the IFNγ locus is highly 
methylated in naïve cells, while the methylation was only partial in memory 
cells, allowing for a more rapid production of IFNγ upon stimulation (Kersh 
et al., 2006). The same has been shown to be true for other effector molecules 
such as perforin and granzyme B (Araki et al., 2008). Epigenetic regulation of 
pro-survival genes (Araki et al., 2009), and genes encoding molecules that 
mediate inhibitory signals, have also been shown to play a role in regulating 
the sensitivity of memory cells to activation (Youngblood et al., 2011). 
Approximately 90-95% of the initial heterogenous effector cell pool 
generated during a primary immune response die and only the remaining 
small percentage become memory cells. Recent years have seen a great 
increase in research defining phenotypic markers to discriminate between 
terminal effector and memory precursor effector cells and characterising the 
mechanisms behind effector versus memory fate decisions (Kaech and Cui, 
2012). Conventionally, CD44 and CD62L surface expression are used to 
identify central memory T cells (TCM) and effector memory T cells (TEM) as 
CD44hiCD62Lhi and CD44hiCD62Llo, respectively (Sallusto et al., 1999). 
Additionally, a subset of effector cells that develop into memory cells, 
memory precursor effector cells (MPECs), can be characterised by their 
CD127hi, CD27hi, Bcl-2hi and decreased expression of killer cell lectin-like 
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receptor G1lo (KLRG-1) phenotype, conversely, a terminally differentiated 
short-lived effector cell (SLEC) is typically CD127lo and KLRG-1hi (Joshi et al., 
2007; Sarkar et al., 2008).  
Several models have been proposed to explain what determines whether a 
cell becomes a terminal effector cell or a memory cell summarized in brief 
below. 
Separate Precursor Model 
This model proposed that naïve T cells are ‘pre-programmed’ in the thymus 
to adopt either an effector fate or memory cell fate upon activation. However, 
studies showing that individual naïve CD8+ T cells give rise to both effector 
and memory cells when transferred (Stemberger et al., 2007). Additionally, 
cellular barcoding experiments, in which cells were retrovirally transduced 
with a unique semirandom stretch of noncoding DNA and could therefore be 
identified by a barcode-microarray, demonstrated that a common pool of 
precursors could give rise to different pools of effector cells (Schepers et al., 
2008). 
Asymmetric Cell Fate Model 
According to this model a single cell could give rise to multiple cell fates by 
asymmetric division (Chang et al., 2007). The proposition is based on the 
finding that a daughter cell that inherits the immunological synapse receives 
stronger signals and the subsequent cells over several division thus become 
effector cells. The asymmetric cell fate model thus indicates that a lineage 
decision is made as early as in the first cell division (Jameson and Masopust, 
2009). 
Decreasing Potential Model 
The decreasing potential model is also known as the linear progression 
model, where all T cells pass through an early effector phase, but those 
receiving additional signals after priming undergo terminal differentiation 
and adopt the effector cell fate, and the T cells that do not receive these 
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signals become memory T cells (Ahmed and Gray, 1996). Indeed, Sarkar et al. 
showed curtailing antigenic stimulation near the end of an acute infection 
enhanced memory cell formation (Sarkar et al., 2008). Similarly, studies 
where antibiotic treatment was used to restrict inflammation, showed that 
this encouraged memory cell formation (Badovinac et al., 2004).  
Signal-Strength Model 
This model is similar to the asymmetric cell division model in that the first 
signals encountered could determine the lineage fate by distinguishing 
effector cells that develop in response to strong signals, and memory 
precursor cells that develop in response to weaker signals (Lanzavecchia and 
Sallusto, 2002). However, the signal-strength model also uniquely maintains 
that there is plasticity throughout the effector phase. Both effector and 
memory cells harbour effector cell properties initially and through the 
development of the immune response memory precursors could still become 
short-lived effector cells. Studies have shown that high expression of CD127, 
can distinguish a pool of effector cells at the peak of the primary response 
that are more likely to become memory cells later (Kaech et al., 2003). 
Additional studies supporting the signal-strength model have shown, that 
the amount of inflammation cells are exposed to can modulate the expression 
of Tbet (Joshi et al., 2007). High levels of Tbet were found to promote effector 
cell differentiation and conversely low levels to promote memory cell 
formation. Thus, studies consistent with the decreasing potential model are 
also consistent with the signal-strength model in that restricted inflammation 
can promote memory cell formation. Thus, the signal-strength model 
accounts for the development of effector cell heterogeneity early on but also 
maintains that the ultimate fate decisions depend on continual integrated 
interpretation of the environmental cues by the TCR – signal 1, signals from 
co-stimulatory molecules – signal 2, and cytokine receptors – signal 3 (Kaech 
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1.8.1 Transcriptional Regulation of Memory Development 
How differences in the signals that T cells receive can determine different cell 
fates was described by Best et al (2013), who recently published an extensive 
profiling of gene-expression signatures throughout infection i.e. the CD8+ T 
cell transcriptome (Best et al., 2013). They grouped different factors into 
clusters based on their kinetic patterns of expression and the biological 
processes associated with them (Best et al., 2013). For example, they showed 
that cells biased toward memory precursor potential had lower expression of 
genes of cell cycle and division cluster, and of short-term effector memory 
cluster, than their short-lived effector memory counterparts (Best et al., 2013). 
T-bet and eomesodermin (Eomes) are two T-box transcription factors, 
characterised by their homologous T-box DNA-binding domain, that have 
important roles in the formation and function of effector and memory CD8+ T 
cells (Kaech and Cui, 2012). T-bet, encoded by Tbx21, regulates many genes 
encoding effector molecules such as the expression of IL-2 and IFNγ 
(Intlekofer et al., 2005), and as such belongs to the memory formation cluster, 
along with Blimp1 and IL-12R (Best et al., 2013). T-bet expression is governed 
by IL-12 signaling. Abundance of IL-12 has been shown to enhance CD8+ 
effector cell formation but decrease memory cell formation (Cui et al., 2009), 
further highlighting how the 3 signals in T cell effector and memory fate 
development are intricately linked. Eomes has cooperative and redundant 
functions to T-bet in regulating effector gene transcription (Intlekofer et al., 
2005). Mice with mutations in both Eomes and T-bet expression (Eomes+/- 
Tbet-/-) were shown to have defects in memory CD8+ T cell development and 
cytotoxic effector programming (Intlekofer et al., 2005). 
Another set of transcription factors, implicated in memory CD8+ T cell subset 
formation, are DNA-binding inhibitors Id2 and Id3 (Yang et al., 2011). A 
deficiency in both Id2 and Id3 leads to a loss of CD8+ effector and memory 
populations. Cells expressing high levels of Id3 become long lived memory T 
cells, and upregulate markers associated with memory potential such as 
CD127 (Yang et al., 2011).  Id3 expression is regulated in response to TCR 
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signals as well as environmental cues. Interestingly, Blimp-1 has been shown 
to antagonise Id3 expression (Savitsky et al., 2007). 
More recently the TCM and TEM balance was also shown to be influenced by Elf4 
an E-twenty-six (ETS) family transcription factor (Mamonkin et al., 2013). 
Upon L.monocytogenes infection Elf4-/- formed lower numbers of effector cells 
despite developing a normal pool of TCM cells. 
1.8.2 Role of Cell Metabolism in Memory Cell Formation 
The signals that control the transcriptional programme of T cell 
differentiation have also been shown to coordinate T cell metabolism. In 
comparison to naïve cells, effector cells have increased cellular nutrient 
uptake and energy production to sustain the increased proliferation. It has 
been proposed that upon T cell activation, the subsequent changes to T cell 
metabolism dictate the memory versus effector T cell fate decision (Finlay 
and Cantrell, 2011). This view stems from the observation that AKT and 
mammalian target of rapamycin (mTOR) are potentially at the core of 
integrating signals from antigens, cytokines and co-receptors (Finlay and 
Cantrell, 2011). For example experiments where mTOR was inhibited 
showed increased memory cell production from effector cells (Araki et al., 
2009). One potential explanation is that mTOR is able to also influence the 
migration pattern of T cells by regulating expression patterns of CD62L and 
CCR7 (Sinclair et al., 2008), or expression patterns of Tbet and Eomes (Rao et 
al., 2010). Importantly, there are different magnitudes of AKT activity, 
potentially influenced by strength of TCR triggering. Low levels of AKT 
activity were sufficient for T cell growth and proliferation but not enough to 
change the chemokine and adhesion receptor profile of naïve cells to that of 
CTLs (Waugh et al., 2009). 
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1.9 Thesis Aims 
The overarching aim of this thesis is to characterise the role of Lck in 
thymocyte development, peripheral T cell activation and memory formation. 
Lck is the first proximal SFK to be activated upon TCR ligation by p:MHC 
and it has been shown that Lck is important wherever TCR signaling is 
required during a T cells life span. Previous studies with transgenic mice 
with reduced Lck expression have shown that 5% of wild-type (WT) levels of 
Lck (LckVA mice) were sufficient to rescue thymic development. We therefore 
used the LckVA mice to address the following central aims of this thesis:   
· To characterise the positive selection, thymocyte maturation, TCR 
sensitivity and the resulting naïve peripheral T cell pool in LckVA mice 
to better understand what effect abundance of Lck has on T cell 
development.  
· To elucidate the role of Lck abundance in CD8+ T cell activation and the 
generation of effector functions in vitro. 
· To assess the impact of Lck abundance on effector to memory cell 
differentiation during in vivo bacterial infection in LckVA mice. 
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Chapter 2:  Materials and Methods 
2.1 Mouse Models 
All mouse strains used were maintained and bred under pathogen-free 
conditions in the University of Edinburgh animal facilities according to 
Home Office regulations. All mice were bred on the C57BL/6 background, 
which were therefore also used as controls, henceforth referred to as LckWT. 
2.1.1 Lckind 
To study the time and concentration dependent roles of Lck, the Zamoyska 
group designed a mouse model with inducible Lck expression (Legname et 
al., 2000). A tetracycline-inducible transactivator domain (rtTA) was 
expressed constitutively as a T-cell specific transgene driven by human CD2 
(huCD2) regulatory regions together with an Lck transgene under the control 
of a tetracycline-responsive/minimal cytomegalovirus (CMV) promoter 
(Fig.1). In the absence of the tetracycline derivative doxycycline there is no 
Lck expression in animals with the endogenous Lck knocked out (LckindOFF), 
and they lack peripheral T-cells. Upon doxycycline administration Lck 
expression is switched on (henceforth termed Lckind mice) and the T-cell 
development in restored. Lckind mice express a range of Lck levels in the 
thymus, but only 15-20% of Lck compared to LckWT mice in the periphery 
(Legname et al., 2000; Lovatt et al., 2006). 
2.1.2 LckVA 
The Zamoyska group also designed a transgenic Lck mouse model with 
constitutively low levels of Lck expression (LckVA) (Salmond et al., 2011). The 
transgene (LckVA.1) was expressed in LckKO mice on the C57BL/6 
background. LckVA.1 confers constitutive expression of less than 5% of WT 
Lck levels in both the thymus and the periphery.  
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2.1.3 F5 TCR Transgenic Mice 
The LckVA, Lckind and LckWT mice were crossed with F5TCR transgenic Rag1 – 
knockout (Rag1KO) mice. The F5 Rag1KO mice are transgenic for a class I MHC-
restricted T-cell receptor, F5, and only develop CD8+ T cells. The soluble 
cognate high-affinity peptide antigen is derived from an influenza virus 
nucleoprotein 68 (NP68) NP68 is a 9-mer peptide (Ala, Ser, Asn, Glu, Asn, 
Met, Asp, Ala, Met) corresponding to amino-acid residues 366-374 from 
strain A/NT/60/68 (H3N2) (Mamalaki et al., 1992). The low affinity peptide 
NP34 is also a 9-mer (Ala, Ser, Asn, Glu, Asn, Met, Glu, Thr, Met) 
corresponding to amino acid residues 366-374 from strain A/PR/8/34 
(Mamalaki, Norton et al. 1992) Both, NP68 and NP34 are presented to T cells 
in the context of H2-Db (Mamalaki et al., 1992; Townsend et al., 1986). The 
peptides were synthesised by the Division of Protein Structure at the NIMR, 
Mill Hill, UK.  
 
Fig. 2.1 Doxycycline inducible Lck expression in Lckind mice (from Zamoyska et al., 
2003).  
Mice transgenic for the rtTA, constitutively expressed under the control of the T-cell specific 
huCD2 promoter, were crossed to transgenic mice that expressed Lck under inducible 
control of Tet-response elements upon administration of tetracycline or its derivatives. Both 
mouse lines were on the LckKO background.  
2.2 Mouse Genotyping  
2.2.1 Genotyping by Blood  
ACK Lysis Buffer 
150 mM Ammonium Chloride (Sigma-Aldrich, UK) 
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10 mM Potassium Bicarbonate (Sigma-Aldrich, UK) 
0.1 mM EDTA (Sigma-Aldrich, UK) 
50 &L of blood was collected by tail bleed into 50 &L of heparin (1000 U mL-1) 
(Sigma-Aldrich, UK). After a PBS wash, 3 mL of ACK lysis buffer was added. 
Blood was thoroughly mixed and incubated for 5 minutes, followed by a PBS 
wash and subsequent antibody staining for flow cytometry (section 2.7).  
2.2.2 Genotyping by PCR 
Ear Digestion Buffer 
100 mM Tris HCI pH 8.5 (Fisher – Scientific, UK) 
5 mM EDTA (Sigma-Aldrich, UK) 
0.2 % SDS (Bio-Rad, USA) 
200 mM NaCl (Fisher Scientific, UK) 
PCR Mastermix  
5 &L - 10x Buffer (Invitrogen) 
1.5 &L - 50 mM MgCl2 (Sigma-Aldrich, UK) 
1 &L - 10 mM dNTP (Promega, USA) 
2.5 &L - 20 &M Primer (1OD)  
0.4 &L -Taq polymerase (Life Technologies, USA) 
dH2O – make up to 49 &L/sample (depending on number of primers used) 
F5 Primers (Product: 435bp) (Life Technologies, USA) 
Forward: 5’ - CTCCCTCTTCAAGCCAAAAGGAGCC – 3’ 
Reverse: 5’ – TGAAAATCAGAAGGAAGCTGGCTACAAA – 3’ 
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VA primers (Product: 265bp) (Life Technologies, USA) 
Forward: 5’ – ATAAAAAGCACTGTGGATTTCTGC – 3’ 
Reverse: 5’ – AGAGGGGACAGGAAATCTCTAAGA – 3’ 
PCR Program 
1. 94.0°C for 3:00 
2. 94.0°C for 1:00 
3. Annealing temp for 0:30 (57°C for VA, 61°C for F5) 
4. 72 for 1:00 
5. Go to 2, 29 times 
6. 72.0 for 10:00 
7. 4.0 for 10:00 
8. End 
TAE (50x) 
242 g Tris Base (Fisher – Scientific, UK) 
57.1 mL Acetic Acid (Fisher – Scientific, UK) 
100 mL - 0.5 M EDTA pH 8.0 (Sigma- Aldrich UK) 
Make to 1 L with dH2O 
Agarose Gel 2% (100 mL) 
2 g Agarose (Life Technologies, USA) 
100 mL of 1xTAE  
2 &L Gel Red (Biotium, USA) 
Loading Buffer (50mL) 
25 mL of 20% Ficoll (type 400) (Sigma-Aldrich, UK) 
12.5 mL of 25% Glycerol (Sigma-Aldrich, UK) 
0.5 mL of 1 M Tris pH 7.6 (Fisher – Scientific, UK) 
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0.1 mL of 0.5 M EDTA pH 8.0 (Sigma- Aldrich UK) 
0.125 g of Bromophenol Blue (Sigma-Aldrich UK) 
0.125 g of Xylene Cyanol (Sigma-Aldrich UK) 
Stock was stored at -20°C and the aliquot in use was stored at 4°C. 
General Polymerase Chain Reaction (PCR) Protocol 
100 &L of Lysis Buffer and 5 &L mL-1 of Proteinase K (New England Biolabs, 
USA) were added per ear sample, and incubated overnight with agitation at 
56°C in a waterbath. The following day samples were vortexed and 1 &L was 
used for PCR analysis. 49 &L of PCR master mix and 1 &L of sample DNA 
were aliquoted into PCR tubes (Starlab, USA). The tubes were centrifuged in 
a desktop microcentrifuge (Spectrafuge, Labnet International, USA) prior to 
being transferred to the PCR block and run with the appropriate program. 
Agarose Gel Electrophoresis 
An agarose gel was prepared. 10 &L of PCR product with 1 &L loading buffer 
was loaded onto the gel and run at 120 V for no more than 30 minutes. The 
results on the gel were visualised using InGenius gel documentation 
equipment (Syngene, USA). A 1kb DNA ladder was used to estimate 
molecular weights of DNA bands (New England Biolabs, UK). 
2.3 Cell Culture  
Cell Culture Medium 
Iscove’s Modified Dulbecco’s Medium (IMDM) (Sigma-Aldrich, UK) 
5% Heat Inactivated Fetal Calf Serum (FCS) (Serotec, UK) 
100 U mL-1 Penicillin (Sigma-Aldrich, UK) 
100 &g  mL-1 Streptomycin (Sigma-Aldrich, UK) 
2x10-3 M L-Glutamine (Sigma-Aldrich, UK) 
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5x10-5 M 2β-mercaptoethanol (Sigma-Aldrich, UK) 
Isolation of thymocytes and peripheral T cells for in vitro analysis 
Mice were dissected for axillary, brachial, superficial cervical, inguinal and 
mesenteric lymph nodes (LN), which were collected into culture medium on 
ice. For some experiments thymus and spleen were also collected. Under 
sterile conditions organs were gently pushed through a sterile 70 &m nylon 
cell strainer (BD Falcon, USA) with the end of a syringe plunger and cells 
were suspended in culture medium. Splenocytes were always subjected to 
ACK lysis (5 mL for 5 minutes), after which they were washed, re-filtered, 
and used as required. An aliquot of cells was counted using the CASY-1 
automated cell counter according to the manufacturer’s instructions (Scharfe 
System, Germany).   
2.4 Cell Labelling for Proliferation Analysis 
Cell labelling with CFSE 
Carboxyfluorescein diacetate N-succinimidyl ester (CFSE) (Sigma-Aldrich, 
UK) is an intracellular dye used as a marker for cell proliferation. Prior to 
subjecting cells to conditions inducing proliferation, CFSE was added at a 
concentration of 1 &M in PBS to cells at a density of 20x106 cells mL-1 at room 
temperature for 8 minutes in the dark. The dye was quenched with equal 
volume of complete medium and 10% v/v FCS for 5 minutes at room 
temperature. The cells were subsequently washed, re-suspended in culture 
medium, and recounted. 
Cell labelling with Cell Trace 
Cell labelling with Cell Trace Violet (Life Technologies, USA) was performed 
according to the manufacturer’s instructions, modified such that the dye was 
added to lymphocytes at a concentration of 2.5 &M in pre-warmed PBS at a 
cell density of 3x106 cells mL-1 at 37°C/5% CO2 for 20 minutes in the dark. The 
dye was quenched with an equal volume of complete medium for 5 minutes 
at room temperature. The cells were subsequently centrifuged to wash off 
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any excess dye, re-suspended in culture medium, and recounted before 
downstream application. 
2.5 In Vitro T Cell Activation Assays 
2.5.1 Phospho-protein Analysis 
(pZap493, pShc, pSrc416, pLck505, pERK, pS6, pp38, pFoxo1) 
CFSE labelled and 1:1 pooled cells were resuspended in serum-free IMDM 
medium (containing all additives except FCS) at 4x107 cells mL-1. 1x106 cells 
were plated in 96 U-well plate (Corning Inc., USA) in triplicate when cell 
numbers permitted. Depending on the experiment the following control 
treatments were included: unstimulated, PP2, pervanadate, PdBU, UO126 
SB203580, Ly29004, and the required time course of 1 &M NP68 peptide 
stimulation. When only some samples received a treatment, equal volume of 
serum-free IMDM was added to all others. At desired time points samples 
were fixed with 2% v/v PFA (Acros, USA) and incubated for a minimum of 
15 minutes at RT prior to downstream application. For intracellular staining 
samples in PFA were centrifuged at 1700 rpm for 3 minutes, PFA was 
aspirated and samples were resuspended in 100 &L of prewarmed BD 
Phosflow Lyse/Fix (Cat. 558049, BD Biosciences, USA). After an incubation 
of 10 minutes at 37°C/5% CO2, samples were centrifuged (1700 rpm for 3 
minutes) and resuspended in 100 &L of BD Phosflow Permeabilization Buffer 
I (Cat. 557885, BD Biosciences, USA).  Samples were incubated for 20 minutes 
at RT after which they were centrifuged (1700 rpm for 3 minutes). Samples 
were subsequently stained with intracellular antibodies for flow cytometry in 
BD Phosflow Permeabilization Buffer I as described in section 2.7.2. 
PP2 Treatment  
As a negative control 1x106 cells at a concentration of 40x106 mL-1 were treated 
with 1 &M PP2 (Cat. PHZ1223, Life Technologies, USA) a SFK inhibitor, for 
15 minutes at 37°C/5% CO2 prior to addition of NP68 peptide stimulation.  
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UO126 Treatment  
As a negative control, when assessing ERK phosphorylation, 1x106 cells at a 
concentration of 40x106 mL-1, were treated with 10 &M UO126 (Calbiochem, 
UK) a MEK inhibitor, for 15 minutes at 37°C/5% CO2 prior to addition of 
NP68 peptide stimulation.  
SB203580 Treatment  
As a negative control, when assessing p38 phosphorylation, 1x106 cells at a 
concentration of 40x106 mL-1 were treated with 1 &M SB203580 (Cell 
Signalling, USA) a p38 inhibitor, for 30 minutes prior to addition of NP68 
stimulation for 6 hours at 37°C/5% CO2.  
Ly294002 Treatment 
As a negative control, when assessing Foxo1 phosphorylation, 1x106 cells at a 
concentration of 40x106 mL-1 were treated with 1 &M Ly29004 (Cell Signalling, 
USA) that blocks PI3K dependent Akt phosphorylation and Foxo1 
phosphorylation, for 30 minutes prior to addition of NP68 stimulation for 6 
hours at 37°C/5% CO2.  
Pervanadate Treatment 
As a positive control, 1x106 cells at a concentration of 40x106 mL-1 were treated 
with 50 &L pervanadate (Na3VO4H2O2) for 10 minutes at 37°C/5% CO2.  
Two individual stocks were made:  
stock 1: 100 &L Na3VO4 (Sigma-Aldrich, UK) + 250 &L PBS 
stock 2: 10 &L H2O2 (30%v/v) (Sigma-Aldrich, UK) + 90 &L PBS 
At 15 minutes prior to use: 150 &L of stock 1 + 789 &L PBS + 61 &L of Stock 2 
were combined in an eppendorf and incubated in the dark before use.  
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PdBU Treatment 
As a positive control in pERK or pS6 experiments, 1x106 cells at a 
concentration of 40x106 mL-1 were treated with 100 nM Phorbol 12, 13-
dibutyrate (PdBU) (Sigma-Aldrich, UK) for 15 minutes at 37°C/5% CO2. 
NP68 Stimulation  
1x106 cells at a concentration of 40x106 mL-1 were treated with 1 &M NP68 for 
required lengths of time at 37°C/5% CO2. 
2.5.2 Ca2+ - Flux Assay 
The entire assay was performed at RT (except for specific incubations), this 
included pre-warming all reagents and keeping the organs at RT from 
dissection onwards.  The assay required the ability to distinguish two cell 
populations in the same 5 mL polystyrene round bottom tube (BD 
Biosciences, USA), so that the start of stimulation was the same. Therefore, 
cells were first labelled with low (0.01 and 0.1 &M) concentrations of CFSE 
(Section 2.4). 2x107 of CFSE labelled cells (10x106 of each genotype) were 
loaded with 2 &M Indo-1 (Life Technologies, USA) at a concentration of 1x107 
cells mL-1 of PBS. Sample was incubated at 37°C/5% CO2 for 40 minutes after 
which 1% cell culture medium (with 1% v/v FCS) was added in excess and 
sample was washed by centrifuging. Sample was split into requried groups 
for antibody staining (e.g. Group 1: TCRbio and CD8bio, Goup 2: TCRbio 
alone) in 100 &L of 1% cell culture medium 15 minutes at RT. Thereafter 
samples were resuspended in 600 &L of 1% culture medium for acquisition 
on a flow cytometer. After 45 seconds of running the sample on the LSR II 
(BD Biosciences, USA) streptavidin APC was added for crosslinking of 
biotinylated antibodies. As a positive control after 8 minutes of acquisition 1 
&g mL-1 of Ionomycin (Sigma-Aldrich, UK) was added. 
2.5.3 Overnight T cell Activation for Analysis by Flow 
Cytometry 
0.1-0.3x106 total LN cells or thymocytes treated with either CFSE, Cell Trace 
or left untreated were seeded in a 96-well U-bottom tissue culture plate in 
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cell culture medium. A titration of specific doses of soluble NP68 or NP34 
peptide was then added and plates were incubated at 37°C/5% CO2. Cell 
cultures were terminated at desired time points for analysis by centrifuging 
the plates (1700 rpm for 3 minutes) and aspirating the medium. Samples 
were then stained for flow cytometry analysis as described in section 2.7. 
2.5.4 Overnight T cell Activation for Cytokine Production 
Analysis 
30x106 total LN cells or ACK purified spleen cells were seeded in T25 flasks 
(Corning Inc., USA) in 15 mL of complete cell culture medium and 100 nM of 
NP68. At a desired time point cells were washed, stained with Live/Dead 
reagent, CD8 and CD44 surface antibodies (section 2.7) and seeded at a 
density of 0.1-0.3x106 cells in 100 &L per well in a 96 well U-bottom tissue 
culture plate. Cells were restimulation with specific concentrations of NP68 
in the presence of 5 &g mL-1 of Brefeldin-A (Sigma-Aldrich, UK) for 6 hours. 
Controls in the restimulation included unstimulated samples, 0.05 &g mL-1 
PdBU and 0.5 &g mL-1 Ionomycin combined, and 20 ng mL-1 IL-2. After 6 hours 
plates were centrifuged and samples were stained for intracellular cytokines 
(section 2.7.2). 
Alternatively cells were washed after culture with 100 nM of NP68, a sample 
taken for analysis by flow cytometry, and 5x106 cells were cultured in T75 
flasks (Corning Inc., USA) with 25 mL of cell culture medium and 20 ng mL-1 
of IL-2 (Peprotech, USA) for a further 2 days. Thereafter cells were collected, 
washed, recounted and treated as described above for measuring 
intracellular cytokines after recall. 
Note: whenever F5Lckind cells were cultured, 2 !g mL-1 of doxycycline was 
always added to the wells for all samples (including F5LckWT and F5LckVA). 
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2.6 In Vivo Listeria monocytogenes Infection 
LmOVA was always kindly prepared by David Wright. 
Attenuated recombinant Listeria monocytogenes (L.monocytogenes) expressing 
chicken ovalbumin (LmOVA) was kindly provided by Prof. Hao Shen 
(University of Pennsylvania School of Medicine). A 500 mL stock culture was 
prepared in Brain Heart Infusion (BHI) Medium containing 5 &g mL-1 
erythromycin hydrate (Cat. 856193, Sigma-Aldrich, UK) and cultured in 
shaking incubator (37oC, 120 rpm) until reaching OD600 = 0.43. 50 mL of 
culture was mixed 1:1 with 80% glycerol solution and frozen at -80°C in 1 mL 
aliquots. Average aliquot Colony formation unit (CFU) was calculated by 
thawing 3 aliquots, titrating 100 &L of each in a 10-fold serial dilution, and 
plating 105 dilution on Brain Heart Infusion Agar (Cat.70138, Sigma-Aldrich, 
UK) containing 5 &g mL-1 erythromycin hydrate. Colony formation was 
counted 24 hours after incubation at 37°C/5% CO2 with an average of 7.85 x 
108 CFU mL-1. This was used as a basis for dilutions required for injection. 
On days of injections, 1 mL aliquots were thawed, centrifuged at 13000 rpm 
for 2min and resuspended in 1 mL PBS. 900 &L of this was diluted for 
injection in PBS based on the formula:  
CFU x dilution factor x volume plated x volume injected  
volume of diluent added 
Remaining 100 &L was titrated as before to confirm CFU for injection. CFU 
remained relatively consistent (±10%) throughout the course of injections. 
The primary infection was induced by intravenous (i.v.) tail vein injection of 
1x106 LmOVA in 200 &l of PBS per mouse. The secondary infection was also 
induced by i.v. injection but with 10x106 LmOVA in 200 &l of PBS per mouse. 
The primary T cell immune response to LmOVA was assayed on day 7 post-
infection. The memory response was assayed on day 42 post-infection (in 
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some cases day 39) and a secondary infection was induced, which was 
assayed 4 days later.  
2.6.1 Assessing the CD4 and CD8 Immune Responses to 
LmOVA 
Designed based on kind advice from Robert Salmond, Ph.D.  
Briefly, spleens were harvested, single cell suspensions were made, red blood 
cells (RBCs) were lysed, and cells counted using a CASY counter (section 
2.3).  
To assess the cytokine production in response to the total LmOVA infection, 
LmOVA was resuspended at 2x107 bacteria mL-1 and heat killed at 90°C for 30 
minutes (henceforth referred to as heat killed listeria (HKL)). An overnight 
stimulation with a titration of HKL in 24 well plates with 4x106 splenocytes 
per well in 1 mL of complete cell culture medium was performed. At desired 
time point plates were centrifuged and the culture medium was collected 
and frozen for ELISAs (section 2.8).  
To assay the ex vivo phenotype of cells 3x106 splenocytes were seeded in 96-
well plates and incubated for 10 minutes at 4°C with Fc block (CD16/32, 
Biolegend, USA) and Live/Dead Aqua reagent in 50 &L of PBS. Thereafter to 
assay the number and proportion of OVA-specific CD8 T cells dextramer-PE 
(Dex) staining (Immudex, Denmark) was used. Excess Fc block and 
Live/Dead were washed off and cells were incubated in 20 &L flow buffer 
with 5 &L Dex for 15 minutes at 4°C, thereafter 25 &L of surface staining 
antibody mix was added directly to Dex staining and samples were 
incubated another 15 minutes at 4°C.  
To assess peptide-specific cytokine production in CD8 T or CD4+ T cells on 
day 7 and day 46, 3x106 splenocytes were seeded in 96-well culture plates in 
200 &L of cell culture medium alone or with different concentrations of either 
the N4 peptide for CD8+ T cells, or the listeriolysin O protein (LLO190-201) for 
CD4 T cells in the presence 5 &g mL-1 of Brefeldin-A for 4 hours at 37°C/5% 
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CO2. Thereafter intracellular staining for TNFα and IFNγ was done as 
described in section 2.7.2.  
2.6.2 BrdU Treatment 
Designed based on kind advice from Stefano Caserta, Ph.D. 
Bromodeoxyuridine (BrdU) stock (Cat. B5002-5G, Sigma-Aldrich, UK) was 
dissolved in 500 mL dH2O (Millipore, USA) and filter sterilized with 
Stericup (Millipore, USA). 50 aliquots of 10 mL (10 mg mL-1) in 15 mL Falcons 
were prepared and frozen at -20°C until needed. For intraperitoneal (i.p.) 
injections on day 4, the required amount of BrdU aliquots were defrosted at 
RT and a mix of 1.2 mg of BrdU in 200 &L of PBS per mouse was prepared. 
BrdU was given on days 4-10 in drinking water at a concentration of 0.8 mg 
mL-1 in 100 mL per cage. 
2.7 Analysis of T Cell Function by Flow Cytometry 
Flow Buffer 
1x PBS (Gibco BRL, UK) 
0.05% Sodium Azide (Sigma-Aldrich, UK) 
0.5% Bovine Serum Albumin (Sigma-Aldrich, UK) 
2.7.1 Surface Staining 
The expressions of cell surface markers in ex vivo and in vitro activated or 
treated cells were assessed by flow cytometry. 1x106 cells in 100 &L were 
pipetted into 96-well plates (Greiner Bio-One, Germany), centrifuged (1700 
rpm for 3 minutes), and resuspended in 30 &L PBS with 1/750 dilution of 
Live/Dead Aqua reagent. Live/Dead Aqua staining was incubated for 10 
minutes, 100 &L PBS was then added to wash off excess Live/Dead by 
centrifugation. Samples were then resuspended in 30 &L flow buffer with 
antibodies to surface markers of interest in specific dilutions (Table 2.3). In 
experiments with splenocytes, 3x106 cells were used and stained in a total 
volume of 50 &L.  
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Surface staining was incubated for 15 minutes on ice, followed by a flow 
buffer wash. If required, cells were resuspended in 30 &L with secondary 
streptavidin conjugated antibodies to reveal biotinylated antibody binding.  
Samples were again incubated for 15 minutes on ice, followed by a wash. 
Finally, samples were resuspended in 100-250 &L for flow cytometry 
acquisition performed either with LSR II (BD Biosciences, USA), Canto (BD 
Biosciences, USA) or MacsQuant (Miltenyi Biotec, Germany) flow cytometry 
instruments.  
2.7.2 Intracellular Staining  
Surface staining was performed as normal and after a final wash, removing 
excess secondary antibodies, one of the following intracellular staining 
protocols was used: 
Foxp3 Intracellular Staining Kit (Cat. 00-5523-00, eBioscience, USA) 
This kit was used in accordance to manufacturers recommendations when 
staining for: Lck, Foxp3, Tbet, Eomes, IFNγ, TNFα, Granzyme B.   
Briefly, cells were resuspended in 100 &L of Fixation/Permeabilization 
Buffer. Samples were incubated for a minimum of 30 minutes at 4°C in the 
dark (or left overnight at 4°C if required). Thereafter the samples were 
centrifuged (1700 rpm for 3 minutes), buffer was aspirated and samples were 
washed in 100 &L of Permeabilization Buffer. Samples were stained with 
primary intracellular antibodies for 30 minutes at 4°C in the dark in 
Permeabilization Buffer. Thereafter, samples were resuspended in 
appropriate secondary antibody for 30 minutes at 4°C in the dark in 30 &L of 
Permeabilization Buffer. Finally, cells were washed once in Permeabilization 
Buffer, once in flow buffer, and resuspended in 100-250 &L flow buffer for 
acquisition by flow cytometry. 
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Intracellular Staining for BrdU 
Method kindly provided by Dominik Ruckerl, Ph.D. 
After staining for Dex and other cell surface markers, samples were 
resuspended in 100 &L of Fixation/Permeabilization Buffer from the Foxp3 
Intracellular Staining Kit described above, and left at 4°C overnight (note: 
shorter incubations did not work). The following day samples were 
centrifuged and washed twice in Permeabilization Buffer (from the same 
Foxp3 kit). Cells were resuspended in 100 &L DNase-I solution (300 &L 
DNase –I Stock at 1 mg mL-1 (Cat. D5025-15KU, Sigma-Aldrich, UK), in 700 
&L dPBS (Cat. D8537, Sigma-Aldrich, UK) and 0.42 M MgCl2) and incubated 
at 37°C/5% CO2 for 30 minutes wrapped in aluminium-foil. Thereafter cells 
were washed once in Permeabilization Buffer and stained with 5 &L of anti-
BrdU FITC antibody (Cat. 556028, BD Biosciences, USA) in 15 &L 
Permeabilization Buffer and incubated at RT for 30 minutes. Finally cells 
were washed twice with Permeabilization Buffer and resuspended in 250 &L 
flow buffer for acquisition on a flow cytometer. 
Intracellular Staining for Bcl-2 
Method kindly provided by Stefano Caserta, Ph.D. 
Cells were washed with 100 &L of 0.03% Saponin Buffer (Stock: 150 &L of 
10% Saponin (Sigma-Aldrich, UK) in 50 mL dH2O diluted in flow Buffer). 
After centrifugation (1700 rpm for 3 minutes) the buffer was aspirated and 
samples were resuspended in a mix of 40"&L 0.03% Saponin buffer and 10"&L 
Bcl-2 per well for 20 minutes at 4°C in the dark. After the incubation samples 
were washed once in excess 0.03% Saponin Buffer, and thereafter once in 
flow buffer. Samples were resuspended in 100-250 &L flow buffer for 




  52 
Table 2.1 Flow Cytometry Antibodies – Surface Staining 
Surface Staining 
Primary Antibodies 











































3.8 Anti-Mouse  
CD4 































53-6.7 Rat PerCP Biolegend, 
USA 
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H1.2F3 Hamster  Biotin BD Biosciences, 
USA 
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(Cat.557004) 
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5.14 Streptavidin   PeCy7 Biolegend, 
USA 
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Table 2.2 Flow Cytometry Antibodies - Intracellular Stainings  
Intracellular Primary Staining 
Fig. Specificity Clone Species Conjugate Supplier 
4.3 pZapY493  Rabbit 
mAb 
 Cell Signalling, USA 
4.3 pSrcY416  Rabbit 
mAb 
 Cell Signalling, USA 
4.3 pShcY239/240  Rabbit 
polyclona
ly 






 Cell Signalling, USA 
4.5 pS6S235/236  Rabbit 
mAb 
 Cell Signalling, USA 
3.3; 
4.1;  
Lck 3A5 Mouse 
mAb 



















































NGZB Rat PE eBioscience, USA 
5.3; 5.4 Anti-Mouse 
Ki-67 





Rat PacBlu eBioscience, USA 
4.14 Pp38Thr180/Tyr182 3D7 Rabbit 
mAb 
 Cell Signaling, USA 
4.15 pFoxO1Ser - 256  Rabbit 
mAb 
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Table 2.3 Flow Cytometry Antibodies - Intracellular Stainings Continued. 
Intracellular Secondary Staining 
Fig. Specificity Clone Species Conjugate Supplier 
3.3 Anti-Mouse IgG  Chicken Alexa Fluor 
647 
Life Technologies, USA 
3.3; 
4.1;  




Anti-Rabbit IgG  Goat Alexa Fluor 
647 
Life Technologies, USA 
 
2.7.3 Flow Cytometry Data Analysis 
Flow cytometry data was analysed using FlowJo software v.9.6 (TreeStar 
Inc.). All samples were first gated on intact lymphocytes, thymocytes or 
splenocytes using forward scatter (FSC) and side scatter (SSC). Wherever 
possible cells were then gated as singlets on FSC area (FSC:A) and FSC 
height (FSC:H). Additionally, when possible, cells were gated as live based 
on low Live/Dead Aqua incorporation. Subsequent gating was dependent 
on populations and markers of interest used in each experiment. 
2.7.4 Proliferation Data Analysis 
To analyse data from CFSE or Cell Tracer Violet labelling assays, the 
proliferation index parameter in FlowJo was applied. Cells that had 
undergone division rounds lost fluorescence and several peaks, representing 
rounds of division, were visualised. The proliferation index is a measure of 
the total number of cell divisions divided by the number of cells that went 
into division. This measure only takes into account the cells that underwent 
at least one division. 
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2.8 Enzyme Linked Immunosorbent Assay (ELISA)  
2.8.1 ELISA Reagents 
ELISA Coating Buffer 
1 L dH2O 
1.59 g Sodium Carbonate (anhydrous, 15 mM) pH 9.4-9.6 (Sigma-Aldrich, 
UK) 
2.93 g Sodium Bicarbonate (anhydrous, 35 mM) (Sigma-Aldrich, UK) 
0.05% Sodium Azide (Sigma-Aldrich, UK) 
ELISA Wash Buffer 
1x PBS (Gibco BRL, UK) 
0.05% Tween-20 (Scientific Laboratory Supplies Ltd) 
ELISA Blocking Buffer 
1x PBS (Gibco BRL, UK) 
10% Heat Inactivated Fetal Calf Serum (FCS) (Biosera, USA) 
ELISA Stop Buffer 
0.18 M Sulphuric Acid (Carl Roth, Germany) 
2.8.2 ELISA General Protocol 
Cytokine ELISAs were performed on supernatants that were previously 
harvested from culture plates and stored at -20ºC. IL-2 and TNFα production 
was measured with the mouse IL-2 Ready-Set-Go Kit (Cat. 88-7024, 
eBiosciences, UK) and mouse TNFα Ready-Set-Go Kit (Cat.88-7324-88, 
eBioscience, USA), respectively. Kits were used according to the 
manufacturer’s protocols. For measuring IFNg production, anti-IFNg 
primary antibody (R46A2) was kindly provided by the MacDonald 
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Laboratory (The University of Edinburgh) and buffers used are described in 
section 2.8.1. 
Capture antibodies (Table 2.4) were coated onto 96-well plates (NUNC, 
Maxisorp, Denmark) in 50 &L/well of coating buffer overnight.  The 
following day plates were blocked for 1 hour at room temperature. 
Supernatants and doubling dilutions of recombinant protein standards were 
added in 50 &L/well of blocking buffer. Standards were always assayed in 
duplicate. Plates were incubated for 2 hours RT. Secondary-biotinylated 
antibodies were added in 50 &L blocking buffer and plates were incubated 
for 45 minutes at 37°C/5% CO2. Streptavidin-peroxidase was added in 50 &L 
of blocking buffer and incubated for 30 minutes at 37°C/5% CO2, after which 
50 &L of TMB (Calbiochem, USA), a colorimetric substrate of peroxidase, was 
added. When the blue colour change was noted (or maximum 15 minutes 
later), the stop solution 0.18 M H2SO4 was added and plates were read at 450 
nm within 30 minutes. Plates were washed 3-8 times between steps with 
ELISA wash buffer. 
Table 2.4 ELISA Antibodies 
Specificity Conjugated Clone Host Usage Conc. Manufacturer 
Standard 
IL-2 Recombinant    eBioscience, USA 
TNFα Recombinant    eBioscience, USA 
IFNγ Recombinant   50 ng mL-1 Biolegend, USA 
Capture Antibody (For coating) 
IL-2 Purified    eBioscience, USA 
TNFα Purified    eBioscience, USA 
IFNγ Purified R46A2  2 &g mL-1 MacDonald Laboratory 
Secondary Antibody 
IL-2 Biotinylated    eBioscience, USA 
TNFα Biotinylated    eBioscience, USA 
IFNγ Biotinylated XMG1.2 Rat 0.2 &g mL-1 eBioscience, USA 
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2.9 Radiation Bone Marrow Chimaeras 
Rag1KO mice were sub-lethally irradiated (800 rads). Femurs and tibia from 
C57BL/6 (Ly5.1) and LckVA (Ly5.2) mice were collected into medium and 
cleaned of as much muscle as possible. In specific experiments Lckind (Ly5.2) 
were also used. Under sterile conditions, the ends of the bones were cut off 
and a syringe was used to flush out the bone marrow (BM) into a clean petri 
dish. Extracted bone marrow was then filtered into a 50 mL centrifuge tube 
(Sarstedt, Germany) and resuspended at a concentration of 3x107 mL-1 in 
culture medium. Cells were stained with antibodies for CD8 (clone: 3.168) 
and CD4 (clone: RL172.4) for 15 minutes at 37°C/5% CO2. 1 mL of 
Complement (Cedarlane, USA) was added and the samples were incubated 
for a further 45 minutes at 37°C/5% CO2. Finally cells were washed and 
recounted. The efficiency of complement lysis was assessed by flow 
cytometry, comparing pre-complement and post-complement samples for 
TCR+ populations. 
Irradiated Rag1KO mice were injected i.v. with 1x107 mixed BM cells from 
C57BL/6 (Ly5.1) and LckVA (Ly5.2) mice in a 1:9 or 1:20 ratio. In specific 
experiments 1x107 mixed BM cells from C57BL/6 (Ly5.1) and Lckind (Ly5.2) 
mice in a 1:9 or 1:20 ratio were also used. Peripheral reconstitution of mice 
was assessed by flow cytometry analysis of blood samples taken at 4 weeks 
and 8 weeks post BM transplantation.  
2.10 Western Blot (WB) 
2.10.1 General Reagents 
Western Blot Lysis Buffer 
1% NP-40 (Fluka – Sigma -Aldrich UK) 
1% Maltoside (Merck Millipore) 
150 mM Sodium Chloride (Sigma- Aldrich UK) 
20 mM EDTA pH8.0 (Sigma- Aldrich UK) 
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10 mM Tris-Cl pH7.5 (Fisher – Scientific, UK) 
dH2O 
Inhibitors added immediately before use: 
1 mg mL-1 Protease Inhibitor Cocktail (Sigma-Aldrich UK) 
1 mM Sodium Fluoride (Sigma-Aldrich UK) 
1 mM Sodium Orthovanadate (Sigma-Aldrich UK) 
Western Blot 4x Reducing Sample Buffer 
40% v/v Glycerol (Sigma-Aldrich, UK) 
10% v/v SDS (Sigma-Aldrich, UK) 
0.05% w/v Bromophenol Blue (Sigma-Aldrich UK) 
8% v/v 2β-mercaptoethanol (Sigma-Aldrich, UK) 
0.4 M Tris-HCl pH 6.8 (Fisher – Scientific, UK) 
12.5 mM EDTA (Sigma- Aldrich UK) 
2.10.2 Sample Preparation 
Cells were pelleted by centrifugation (1700 rpm for 3 minutes) and 
supernatant discarded. The pellet was resuspended at 10x107 cells per 1 mL 
of lysis buffer with protease inhibitors and incubated for 30 minutes on ice. 
Lysates were subsequently microfuged at 13000 rpm for 10 minutes at 4°C to 
pellet nuclei. The post-nuclear supernatants were transferred to clean 1.5 mL 
centrifuge tubes and if not used immediately then stored at -20°C. Samples 
were defrosted and an 10 &L aliquot of 1x106 cells was mixed with 2 &L dH2O 
and 4 &L sample buffer prior to running it on a gel. 
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2.10.3 Western Blot (pre cast gel) 
Western Blot Running Buffer (I)  
NuPAGE® MOPS SDS Running Buffer 20x for Bis-Tris Gels only (Life 
Technologies, USA) 
Gel running 
NuPage Novex Bis-Tris 4-12% (Life Technologies, USA) was placed in 
electrophoresis system with running buffer  (Novex, Life Technologies, 
USA). The protein ladder (Precision Plus Protein Standards All Blue, Bio-
Rad, US) and samples were loaded. The gel was run at 200 V for 1 hour.  
2.10.4 Western Blot (Laemmli gel) 
Western Blot Resolving Gel 8% Buffer 
27.75 mL dH2O 
16.05 mL 30% Acrylamide/Bis Solution (Bio-Rad, UK) 
15 mL 1.5 M Tris-Base (pH 8.8) (Fisher – Scientific, UK) 
0.6 mL 10% APS (Sigma-Aldrich, UK) 
0.6 mL 10% v/v SDS (Sigma-Aldrich, UK) 
0.036 mL TEMED (Sigma-Aldrich, UK) 
Western Blot Stacking Buffer 
13.6 mL dH2O 
3.4 mL 30% Acrylamide/Bis Solution (Bio-Rad, UK) 
2.5 mL 1.0 M Tris-Base (pH 6.8) (Fisher-Scientific, UK) 
0.2 mL 10% v/v SDS (Sigma-Aldrich, UK) 
0.2 mL 10% APS (Sigma-Aldrich, UK) 
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0.02 mL TEMED (Sigma-Aldrich, UK) 
Western Blot Running Buffer 10x (II)  
30.3 g Tris-Base (Fisher – Scientific, UK) 
144.2 g Glycine (Fisher – Scientific, UK) 
10 g SDS (Fisher-Scientific, UK) 
Make up to 1 L with dH2O  
pH 8.3 
Gel Preparation & Running  
Gel electrophoresis was performed using twin vertical electrophoresis 
system (Galileo, Bioscience, USA). A resolving gel was poured into glass 
plates and covered with isopropanol. Once the gel was polymerized the 
isopropanol was discarded. The stacking gel was laid over the resolving gel 
with a comb placed inside. Once the stacking gel was polymerized the 
protein ladder (Precision Plus Protein Standards All Blue, Bio-Rad, US) and 
samples were loaded. Gel electrophoresis was run at 30V overnight or 100-
120 V for 2-3 hours. 
2.10.5 Western Blot Transfer  
Western Blot Transfer Buffer 10x  
30.2 g Tris-Base (Fisher – Scientific, UK) 
144 g Glycine (Fisher – Scientific, UK) 
Made to 1 L with dH2O 
100 mL of 10x transfer buffer was added to 700 mL dH2O and 200 mL 
methanol. This was made fresh prior to each use. 
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Western Blot Wash Buffer 
1x PBS 1 L (Gibco BRL, UK) 
0.1% Tween-20 (Scientific Laboratory Supplies, UK) 
Transfer Protocol 
Resolved proteins were transferred onto PVDF membranes (Millipore, USA) 
using a wet transfer apparatus (Bio-Rad, UK). First PVDF was soaked in 
methanol for 30 seconds and then equilibrated in cold transfer buffer. Three 
pieces of filter paper (Whatman Ltd, UK) and two sponges were immersed in 
transfer buffer. The gel, PVDF, filter paper, and sponges were packed into 
the transfer cassette and air bubbles were carefully avoided. Transfer was 
performed at 100V for 2 hours (Pre-cast gel) or 4 hours (Laemmli gel) at 4°C.  
The blotted membrane was blocked for 1h at room temperature in Odyssey 
blocking buffer (Li-Cor, UK).  Incubation with primary antibodies was 
performed in Odyssey blocking buffer overnight at 4°C. Membrane was 
washed in wash buffer three times for 5 minutes then it was incubated with 
the appropriate secondary antibodies in 20 mL wash buffer and 3% BSA for 1 
hour RT. Membrane was washed and acquired in PBS using the Odyssey (Li-
Cor, UK). 
2.10.6 WB Analysis and Quantification 
The Odyssey infrared fluorescence imaging system was used to quantify all 
blots.  The benefits of the Odyssey system are that fluorescent signal is 
directly proportional to the amount of target protein over a wide range of 
concentrations, and that two different targets can be identified 
simultaneously with spectrally distinct secondary fluorescent antibodies 
(Table 2.5).  
Following acquisition, relative band intensities were compared by 
densitometry using the Li-Cor Odyssey software. The background was 
automatically calculated as median of background of above and below each 
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rectangle and subtracted. The resulting integrated intensity (counts per mm2) 
was recorded. 
Table 2.5 Western Blot Antibodies 
Specificity Conjugated Clone Host Manufacturer 
Primary Antibody 
Lck  3A5 Mouse  Millipore, USA 
β-actin  13E5 Rabbit Cell Signaling, USA 
V5 Probe  E10 Mouse mAb Santa Cruz Biotech, USA 
V5 Probe   Mouse 
mAb 
Life Technologies, USA 
α-Tubulin  TU-02 Mouse mAb Santa Cruz Biotech, USA 
Secondary Antibody 
Anti-Rabbit  IRDye800  Donkey  Cat. 611-731-127, Rockland, USA 
Anti-Mouse Alexa Fluor 680  Goat  Cat. A21058, Life Technologies, USA 
Anti-Goat  Alexa Fluor 680  Donkey  A21084,  
Life Technologies, USA 
Anti-Rabbit Alexa Fluor 680  Goat A21109,  
Life Technologies, USA 
 
2.11 Statistical Analysis of Results 
Statistical analyses were carried out using Prism 6 software (GraphPad 
Software Inc, USA).  
When comparing two samples significance was calculated using the 
parametric student’s t-test, unpaired, and two-tailed. Significance was 
denoted with the following cutoffs: *P<0.05, **P<0.01, ***P<0.001. 
Multiple samples were compared using one-way ANOVA with post-
ANOVA Holm-Sidak or Tukey’s methods for multiple t-tests with the 
following cutoffs: * p ≤ 0.05.  
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Chapter 3:  The Role of Lck Abundance in 
Thymocyte Development 
3.1 Introduction 
Thymic development ensures production of a repertoire of mature CD4+ and 
CD8+ SP thymocytes with clonally expressed, somatically generated TCRs 
with a huge variety of specificities, that are least likely to induce 
autoimmunity, but highly capable of responding to a very large array of 
foreign pathogens (Germain, 2002). At both the DN stage (β - chain selection) 
and DP stage (positive/negative selection) signalling via the TCR determines 
whether a cell is directed to survive and progress, or die. Lck is the most 
proximal kinase activated upon TCR activation and it is critical at all stages 
of development where TCR signaling is required. 
It is thought that weak signals lead to positive selection and strong signals to 
cell death in the thymus (Hogquist et al., 1994; Jameson and Bevan, 1998). 
Both the affinity and the dwell time of the TCR interaction with p:MHC are 
influenced by the CD4 and CD8 co-receptors, which facilitate the recruitment 
of Lck (Palmer and Naeher, 2009). Signalling differences potentially lead to 
distinct biological outcomes by inducing differential signaling pathways i.e. 
negatively-selecting signals induce ERK phosphorylation at the plasma 
membrane and positively-selecting signals induce ERK phosphorylation at 
the Golgi (Daniels et al., 2006).  
The development of the inducible Lck transgenic mouse (Lckind) enabled the 
study of the impact of Lck abundance on TCR signal transduction (Legname 
et al., 2000). Lckind mice, bred onto an LckKO background, have tissue-specific 
expression of Lck induced upon doxycycline administration (Legname et al., 
2000). Legname and colleagues found, that Lckind mice have restored the 
expansion of early thymocytes and maturation of CD4+ T cells, both absent in 
LckKO mice. Compared to WT thymocytes, Lckind CD4+ SP cell numbers were 
fully restored, however, CD8+ SP thymocyte numbers were partially restored, 
although increased compared to LckKO mice. These data showed that Lck 
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expression is important for the development of both CD4+ and CD8+ lineages 
(Legname et al., 2000). Interestingly, Lckind mice have a range of Lck 
expression in DP thymocytes, from one-tenth to 10-times as much as seen in 
WT thymocytes, but in the peripheral T-cells Lck expression is only 10-20% 
of WT levels (Legname et al., 2000). The impact of the range in Lck 
abundance on thymocyte selection was not studied and instead the group 
focused on consequences on peripheral activation, cell survival and memory 
formation (Caserta et al., 2010; Legname et al., 2000; Lovatt et al., 2006; 
Seddon et al., 2000).  
Intriguingly, expression of mutated Zap-70, directly downstream of Lck, was 
shown to result in graded alterations in positive and negative selection of T 
cells in the thymus (Tanaka et al., 2010). This caused autoimmune clones of T 
cells, normally deleted due to increased TCR affinity for self, to be selected 
into the repertoire because of reduced Zap-70 signalling and a ‘selection 
shift’ (Tanaka et al., 2010). Complimentary work from the Seddon laboratory 
has shown, that in addition to controlling TCR sensitivity, the abundance of 
Zap-70 also distinguishes CD4+ and CD8+ SP thymocyte development in a 
temporal manner (Saini et al., 2010). Saini and colleagues showed that CD4+ 
SP T cells emerge from the DP population earlier than CD8+ SP T cells (Saini 
et al., 2010). Collectively these results showed that the affinity of the selection 
window in the thymus is very narrow and is influenced by TCR signaling 
thresholds set by abundance of Zap-70.  
If Zap-70 abundance can have such profound effects, what is then the impact 
of Lck abundance on different stages of thymic development? How does Lck 
abundance impact on TCR signaling thresholds and positive selection in the 
thymus? If lack of Lck leads to an incomplete block (Molina et al., 1992) and 
Lck overexpression leads to thymic tumours (Abraham et al., 1991) then why 
in Lckind mice were cells with 10-20% of Lck selected, rather than cells with 
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Chapter 3: Aims 
In addition to the Lckind mouse, the Zamoyska laboratory have developed the 
LckVA transgenic mouse line, in which expression of Lck on an LckKO 
background is constitutively low, approximately 5% of WT Lck levels in both 
thymus and periphery (Salmond et al., 2011). Salmond et al. developed the 
LckVA mice as a control for the experiments described in their article, and 
thymic development was only briefly addressed, but this low level of Lck 
was also shown to rescue thymocyte development as compared to LckKO mice 
(Salmond et al., 2011). However, given that Lck has been shown to influence 
various stages of thymocyte development (Hernandez-Hoyos et al., 2000; 
Legname et al., 2000; Nakayama et al., 1989) it was intriguing that only 5% of 
WT levels of Lck can rescue apparently normal thymic development. The 
central focus of this chapter was to characterise, in detail, the positive 
selection, thymocyte maturation, TCR sensitivity and the resulting naïve 
peripheral T cell pool in LckVA mice and compare this to the Lckind mice, to 
better understand what effect abundance of Lck has on T cell development. 
Our data showed, as previously published, that reduced Lck expression can 
rescue thymocyte development, as compared to an LckKO mouse. Interestingly, 
variable levels of Lck expression during thymocyte differentiation in Lckind 
mice led to increased thymocyte sensitivity to TCR triggering, whereas 
constitutively low Lck expression in LckVA mice did not. Additionally we 
found positive selection proceeded normally in both LckVA and Lckind mice, 
however, SP thymocytes were less mature than in LckWT cells.  
3.2 Results: Thymocyte Development in LckVA and 
Lckind Mice 
3.2.1 Thymic development was reconstituted in LckVA and 
Lckind mice  
Previous studies have shown that in both the Lckind mice and LckVA mice 
thymic development is rescued and the peripheral T cell compartment 
restored compared to LckKO mice (Legname et al., 2000; Lovatt et al., 2006).  
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Before we assessed the impact of reduced Lck expression in LckVA mice on 
thymocyte selection we confirmed levels of Lck expression by WB in thymi 
of LckWT, LckVA and Lckind mice (Fig.3.1A). Analysis by WB and normalization of 
band fluorescence showed, that LckVA had 4% and Lckind had 152% of Lck 
expression as compared with LckWT (100%). These results were in line with 
previously published data (Legname et al., 2000; Salmond et al., 2011).  
To further dissect thymocyte development in the LckVA and Lckind mice, CD4 
versus CD8 dot plots were studied to assess the proportions of developing 
CD4+ and CD8+ SP thymocytes (Fig.3.1B). Staining for CD4 and CD8 
distinguishes the four developmental stages: DN, DP, CD4+ SP and CD8+ SP. 
In agreement with previously published data, we showed that LckKO had very 
small proportions (5-fold less than LckWT) of CD4+ SP thymocytes, indicating 
the importance of Lck for the development of the CD4 compartment 
(Legname et al., 2000; Molina et al., 1992). Although, CD8+ SP proportions 
varied little between LckWT (1.2%±0.11), LckVA (1.01%±0.05), Lckind (0.73%±0.06), 
and LckKO mice (1.05%±0.11), it was evident from the comparison of total 
thymocyte numbers (Fig.3.2), that LckKO have severely compromised thymic 
development. It is worth noting that CD4 and CD8 co-receptor expression in 
SP thymocytes is lower in LckVA and Lckind mice than in LckWT thymocytes as 
has been previously published (Legname et al., 2000; Lovatt et al., 2006; 
Salmond et al., 2011).  
These data showed that LckVA and Lckind mice had restored thymic 
development although the thymi were 2-fold smaller than in LckWT mice 
(Fig.3.2). These ratios were approximately maintained at all stages of 
development except the DN stage. The higher than LckWT proportions of DN 
cells in LckVA and Lckind mice (Fig.3.1B) indicated a partial DN block as 
previously published (Lovatt et al., 2006; Salmond et al., 2011). A more 
detailed investigation of the DN subsets by staining for CD25 and CD44 
showed that the proportions of cells in DN3 were increased 2.3-fold in LckKO 
(59.6%±4.5), and 1.5-fold in Lckind (37.4%±17.1) compared to LckWT (24.5%±1.0). 
There was a large standard deviation (SD) in LckVA mice (25.3%±10) but from 
the total number of DP cells recovered (Fig.3.2) it was  
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Fig. 3.1 LckVA and Lckind mice reconstituted thymic development. 
(A) Thymocyte lysates were analysed from age-matched (7-10 weeks) polyclonal LckWT, Lckind, 
and LckVA mice by western blot (pre-cast gel). The blot was probed with anti-Lck (Upstate) 
and anti-Tubulin antibodies overnight at 4°C, and then with anti-mouse (for Lck) and anti-
rabbit (for Tubulin) fluorescent secondary antibodies for 1 hour. The blot was subsequently 
scanned using the Li-Cor system. Relative expression of Lck was calculated by normalizing 
fluorescence of all bands to LckWT band fluorescence. Data are representative of 3 
independent experiments. Full blot is shown in Appendix 7.1. (B) Single-cell suspensions 
from thymi of age-matched (7-10 weeks) LckWT, Lckind, and LckVA mice were analysed by flow 
cytometry for CD4 and CD8 expression, determining DN, DP, CD4+ or CD8+ SP thymocyte 
proportions. (C) The DN cells were gated on TCR and immature TCR- cells were further 
analysed for DN1: CD44+CD25-, DN2: CD44+CD25+, DN3: CD44-CD25+, and DN4: CD44-CD25- 
populations. Numbers on dot plots are averages of a minimum of 3 individual animals ± SD. 
Data are representative of 3 independent experiments with 3 mice per group. Replicate 
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clear they too had a partial DN developmental block as LckKO, Lckind and LckVA 
mice had significantly fewer DP cells than LckWT mice.  
Overall, these results confirmed, as previously published, that in Lckind and 
LckVA mice thymic development was restored as compared to LckKO mice, 
although total thymocyte numbers and CD4+ and CD8+ SP numbers were 
significantly lower than in LckWT mice (Fig.3.2).  
3.2.2 Positive selection was efficient despite low Lck 
expression  
Signals via the TCR are critical for determining positive versus negative 
selection at the DP stage of development, particularly important is the 
affinity of the selecting TCR signal (Gascoigne and Palmer, 2011). Reduced 
Lck expression levels in peripheral CD4+ T cells in Lckind mice were shown to 
increase TCR signaling thresholds (Lovatt et al., 2006). Meaning, that higher 
concentrations of peptide are required, for example, to phosphorylate ERK to 
the same extent as in LckWT mice. Thymocytes from LckVA and Lckind mice may 
therefore have altered signaling thresholds that will affect how the cells 
progress through positive selection in the thymus. The following section 
investigated the impact Lck abundance had on positive selection of 
thymocytes.  
The process of positive selection can be dissected by staining for CD69 and 
TCR in the total live thymocyte population, as shown in Fig.3.3A (Azzam et 
al., 1998; Yamashita et al., 1993). The CD69-TCR- cells in gate 1 (purple) 
represented mostly pre-selection CD4+CD8+ cells. The cells that expressed 
intermediate levels of CD69 and TCR are CD4+CD8+ cells initiating positive 
selection and were in gate 2 (red). In gate 3 were CD69hiTCRhi cells, which 
corresponded to CD4+CD8+ cells undergoing positive selection (green) and 
finally in gate 4 were the mature CD69-TCRhi CD4+ or CD8+ SP cells (blue) 
(Fig.3.3A).  
It must first be noted, that when comparing LckWT, Lckind, LckVA and LckKO cells 
for positive selection, the gates (CD69 versus TCR) for all genotypes were 
slightly different (Fig.3.3B).  In the complete absence of Lck, as in LckKO,  
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Fig. 3.2 Thymocyte numbers were lower in mice with reduced Lck expression. 
The cells numbers were calculated for the different developmental subsets using the 
percentages from flow cytometry analysis (as shown in Fig.3.1B) and the total thymocyte 
counts obtained with the CASY counter.  Data shown are pooled from 3 independent 
experiments with n=3 per genotype each time. Bar chart shows averages ± SD. Statistical 
significance was calculated in Prism with One-Way ANOVA and Tukey’s post-ANOVA 
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TCR was higher in pre-selection thymocytes (gate 1), as TCR mediated 
signaling and thus Lck are required for TCR downregulation (Azzam et al., 
1998; D'Oro et al., 1997; Saini et al., 2010; Salmond et al., 2011). Although the 
gates in LckVA and LckKO were therefore shifted to accommodate for this effect, 
all 4 gates in all genotypes were always back-gated to check that the 4 
populations reflect the 4 stages of positive selection as indicated in Fig.3.3A.  
The proportions of events in each gate were averaged from 3 individual 
animals and tabulated in Fig.3.3C. The LckKO thymus (right most panel in 
Fig.3.3B) was included in this experiment as a control, to show that lack of 
Lck caused an incomplete block in the DN to DP progression and 
consequently positive selection was severely restricted. There were very few 
cells undergoing positive selection in LckKO mice, as there were barely any 
events in gate 2 (0.6%) and none recorded in gates 3, and 4 (Fig.3.3B and C).  
Despite the slightly increased TCR expression in LckVA and the decreased 
upregulation of CD69 in Lckind thymocytes the proportions of cells in the 
different positive selection quadrants were similar to LckWT thymocytes 
(Fig.3.3C). This observation suggested, that there potentially was an effect of 
Lck abundance on thymocyte development, as evidenced by the change in 
TCR expression, however, it did not affect the progression of thymocytes 
through the four stages of positive selection. 
Cells in each of the 4 gates (CD69 versus TCR) were qualitatively assessed by 
histogram analysis for Lck expression levels (Fig.3.3D). The filled grey 
histogram showed Lck staining in gate 1 of LckKO thymocytes and this was the 
negative control. Lck expression in LckWT thymocytes was shown in blue, and 
it was consistently high at all 4 stages of positive selection. Lck expression in 
LckVA thymocytes was shown in purple, and it was consistently lower than in 
LckWT but higher than in LckKO thymocytes. As previously published (Legname 
et al., 2000), Lckind thymocytes had variable Lck expression at the DP stage, 
and this was evident in Fig.3.3D in gates 1 and 2. From Fig.3.3D it was clear 
that during active positive selection, represented by gate 3, Lckind thymocytes 
no longer had bimodal Lck expression, and in  
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Fig. 3.3 Reduced Lck expression did not impede DP to SP progression of thymocytes. 
(A) Four stages of positive selection can be followed by flow cytometry when gating live 
cells for CD69 and TCR staining. Gate 1: CD69-TCR- (pre selection double-positive 
thymocytes), gate 2: CD69+TCR+ (double-positive cells initiating positive selection), gate 3: 
CD69hiTCRhi (positive selection), and gate 4: CD69loTCRhi (single positives). (B) Representative 
contour plots show CD69 and TCR profiles for LckWT, LckVA, Lckind, and LckKO thymocytes. (C) 
Table shows average proportions of thymocytes ± SD for the indicated mouse strains in 
gates 1, 2, 3 and 4. (D) Representative histograms show the Lck expression profile during 
positive selection in the four gates.  Data in B and C are representative of 4 independent 
experiments, and data in D are representative of 3 independent experiments. In all 
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gate 4, the single positive stage, only cells with low Lck expression were 
found. 
There were two possible interpretations of these data. One was that Lckind 
cells, through the positive selection process, downregulated Lck expression. 
An individual cell could not, however, be followed through the positive 
selection process in this experiment. The second possibility was that Lckind 
thymocytes with higher Lck expression than LckWT thymocytes were 
negatively selected. As previously published, very high Lck activity is 
detrimental to thymocyte development (Abraham et al., 1991) and if 
increased abundance of Lck increases TCR signaling, in a similar manner to 
increased levels of Zap-70 does (Saini et al., 2010; Tanaka et al., 2010), then it 
could have led to negative selection. Intriguingly, there were Lckind cells that 
had the same Lck expression levels as LckWT cells, evidenced by overlapping 
histograms (Fig.3.3D), but by the SP stage, Lck expression in Lckind 
thymocytes was more similar to LckVA cells than to LckWT cells. 
3.2.3 LckVA mice had normal DP to SP conversion of 
thymocytes 
LckVA and Lckind had decreased numbers of SP thymocytes compared to LckWT 
mice (Fig.3.2), potentially explained by a defect in DP to SP conversion. 
Salmond et al. showed that the efficiency of maturation from DP to SP, 
measured by dividing the number of mature TCR+ SP cells by total DP cells, 
is comparable between LckWT and LckVA mice (Salmond et al., 2011). This 
possibly indicated, that as long as some Lck is expressed, thymocytes can 
progress efficiently through positive selection. To assess whether the same is 
true in Lckind mice the DP to SP conversion was calculated for Lckind thymocyte 
numbers (Fig.3.4).  
The results in Fig.3.4A and B showed, for CD4+ and CD8+ SP, respectively, 
that there were no significant differences in efficiency of maturation from DP 
between LckWT and LckVA T cells as previously published (Salmond et al., 2011). 
The efficiency of maturation from DP to SP in Lckind mice was also 
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Fig. 3.4 LckVA had normal DP to SP conversion of thymocytes.  
The efficiency of the generation of SP thymocytes from DP thymocytes was calculated by 
dividing the TCR+ mature SP cell count by the total DP cell count. (A) The average 
proportions ± SD of CD4+ and (B) CD8+ SP thymocytes relative to DP cells are shown in bar 
charts. Significance was calculated using One-Way ANOVA with post-ANOVA Holm-Sidak 
test for multiple comparisons, p<0.05. Data are representative of 3 independent experiments 
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similar to LckWT mice, despite the change in Lck expression from the DP to SP 
stage of development (Fig.3.3 and 3.4). 
3.2.4 The impact of altering Lck expression on CD4+ SP and 
CD8+ SP maturation 
Although we showed that positive selection proceeded unimpeded (Fig.3.3) 
as did DP to SP conversion (Fig.3.4), in Lckind and LckVA mice, we noted that 
TCR expression was altered in LckVA and Lckind thymocytes compared to LckWT 
thymocytes (Fig.3.3B). Expression of TCR and also CD5 are developmentally 
regulated in the thymus (Azzam et al., 1998). Both, TCR and CD5 expression 
levels increase from DN to DP to SP stages of development, therefore 
thymocytes at temporally distinct stages of maturation can be distinguished 
by gating on CD5 versus TCR expression levels (Azzam et al., 1998). We thus 
assessed, whether abundance of Lck expression impacted on TCR and CD5 
expression during thymocyte development.  
The DP subset can be divided into three sub-populations by CD5 and TCR 
staining: DP1 (TCRlo CD5lo), DP2 (TCRint CD5hi) and DP3 (TCRhi CD5int) (Saini et 
al., 2010). Saini et al. showed that the CD4+ SP population emerged from the 
DP2 subset at ~48h and that the CD8+ SP population emerged from the DP3 
no earlier than day 3 (Saini et al., 2010). To assess the maturation state of 
cells, expression of heat-stable antigen (CD24) can be used as a marker, 
because it is highly expressed on immature cells and its expression is lost as 
cells mature (Wenger et al., 1993; Wilson et al., 1988).  
Live thymocytes were divided into three gates based on expression of CD5 
and TCR as measured by flow cytometry (Fig.3.5A). As a side note, Saini et 
al. applied gates for the 3 populations on DP cells only (Saini et al., 2010) but 
here, for clarity, we gated on total live thymocytes, as that enabled us to 
show, for each gate, the progression of thymocyte maturation on a CD4 
versus CD8 gate and so the gates were labelled 1, 2 and 3 (Fig.3.5A). 
Complete lack of Lck in LckKO mice disrupted CD4 and CD8 lineage 
maturation and there were only very small proportions of events in any of 
the three gates (Fig.3.5A). Both, LckVA (1: 59.7%±1.0; 2: 11.0%±1.1; 3: 9.5%±1.1) 
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and Lckind mice (1: 54.8%±2.7; 2: 8.7%±0.9; 3: 5.8%±0.7) had similar proportions 
of thymocytes in each of the three gates as compared to LckWT mice (1: 
62.6%±0.4; 2: 7.2%±0.6; 3: 8.8%±1.5).  
Fig.3.5B shows the CD4 versus CD8 profile of each of the 3 CD5 vs. TCR 
gates. Gate 1 included almost exclusively DP cells in LckWT, LckVA and Lckind 
mice. Gate 2 revealed a CD4loCD8- population in LckWT and Lckind thymi, but 
this was almost absent in the LckVA thymus. This CD4loCD8- population may 
represent intermediate thymocytes that initially terminate Cd8 transcription 
and if TCR signaling persists they become CD4+ SPs, if it ceases the 
intermediate thymocytes can undergo ‘co-receptor reversal’ in which Cd8 
transcription will be reinitiated and they become CD8+ SP thymocytes 
(Brugnera et al., 2000). It was curious that LckVA lacked the intermediate 
CD4loCD8- population, yet in gate 3 we found that a majority of DP 
thymocytes had developed into SP T cells. In gate 3 the distribution of CD4+ 
and CD8+ SP cells were similar in all strains of mice.  
There are several potential interpretations of these data. Given that CD4+ and 
CD8+ T cells develop in normal proportions in LckVA mice in the absence of the 
intermediate CD4loCD8- population, suggests that progression through the 
CD4loCD8-  stage is not an absolute prerequisite for development. Indeed, in 
the case of signaling by low-affinity MHC class I-restricted TCRs, 
intermediate thymocytes have been shown to still appear as CD4+CD8+ cells 
(Lundberg et al., 1995). Alternatively, the development of CD4 and CD8 
populations may be delayed because CD4 development requires stronger 
TCR signals and these may need to accumulate over time in LckVA cells. In 
support of this latter view, is the observation that Lckind cells behaved like 
LckWT cells in gate 2 in that they had an intermediate CD4loCD8- population. 
Indeed, we showed that a majority of cells in gate 2 are still DP and Lckind T 
cells still expressed Lck bimodally at this stage (Fig.3.3D). The cells in Lckind 
mice expressing WT levels of Lck may be behaving like LckWT thymocytes 
making the proportions of CD4loCD8- cells similar.   
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Fig. 3.5 CD4+ SP and CD8+ SP thymocytes were more immature in LckVA and Lckind 
mice. 
(A) Representative dot plots show CD5 versus TCR profiles of LckWT, LckVA, Lckind, and LckKO 
thymocytes gated on live cells (top row). (B) Representative dot plots show CD4 versus CD8 
staining for gates indicated by numbers 1- CD5loTCRlo, 2 – CD5hiTCR+, 3 – CD5hiTCRhi. (C) 
Representative dot plots show CD4 versus CD8 gating (top row), with CD4+ SP (middle row) 
and CD8+ SP cells (bottom row) gated on CD24 versus TCR to assess maturation. Data are 
representative of 3 independent experiments with n=3 in each group. 
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The observations made above raised the question whether reducing Lck 
expression might impact on thymocyte maturity. In order to assess the 
maturity of the cells in the CD4+ SP and CD8+ SP gates, thymocytes were 
stained with TCR and CD24 antibodies (Fig.3.5C) (Wenger et al., 1993). 
Gating on CD4+ SP cells revealed a CD24hiTCRhi population, clearly present in 
LckWT and Lckind thymi, but much reduced in the LckVA thymus, which is 
therefore likely to also be the intermediate CD4loCD8- population (Brugnera et 
al., 2000). Amongst the TCRhi cells in the SP gates, all strains had clear CD24hi 
and CD24lo populations representing, respectively, less mature and fully 
mature SP thymocytes. The relative proportions of the CD24hi and CD24lo cells 
in CD4+ SP gates were similar between LckWT and LckVA strains (~1.5:1) but in 
Lckind the ratio was 1:1.  
Curiously, the CD8 gate showed a different pattern between the three strains 
of mice with a distinct CD24hiTCRlo population present in the Lckind and LckVA 
thymi, which was largely absent from LckWT mice but very abundant also in 
LckKO mice and was therefore, likely to be pre-DP CD8+ immature SP (iSP) 
population (Xiong et al., 2011). 
In summary, these data showed that reduced expression of Lck in CD4+ SP 
cells in Lckind mice led to a more immature phenotype. Yet, despite the 
absence of the intermediate CD4loCD8- population in LckVA mice, constitutively 
low expression of Lck was sufficient for maturation of CD4+ SP thymocytes. 
The CD8+ SP population had more immature thymocytes in both LckVA and 
Lckind mice. Finally, it was evident that gating for CD4+ and CD8+ SP cells on 
the whole thymus is not sufficient to discriminate between different 
maturation stages during thymocyte development. 
The CD4loCD8- intermediate thymocytes become CD4+ SPs if TCR signal 
persists during down regulation of CD8 expression, but if it ceases the 
intermediate thymocytes can undergo ‘co-receptor reversal’ in response to 
IL-7 signaling, which reinitiates Cd8 transcription and they will become CD8+ 
SPs (Brugnera et al., 2000). Since our data indicated that LckVA mice may have 
delayed maturation of CD4+ SP cells (Fig.3.5B) and both LckVA and Lckind SP 
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thymocytes may be more immature than LckWT SP thymocytes (Fig.3.5C), we 
analysed CD127 expression on TCRhi CD24lo and TCRhi CD24hi cells (Fig.3.6).  
The results in Fig.3.6 showed, that compared to LckWT, less mature TCR+CD24hi 
thymocytes from LckVA mice expressed ~1.2-fold less CD127 in both CD4+ SP 
and CD8+ SP populations and Lckind thymocytes expressed ~2-fold less CD127. 
In the more mature TCR+CD24lo thymocytes, a similar pattern of reduced 
CD127 expression in LckVA and Lckind mice relative to LckWT mice was seen in 
CD8+ SP thymocytes, but in more mature TCR+CD24lo thymocytes CD4+ SP 
thymocytes all strains expressed similar levels of CD127 again (Fig.3.6). 
Collectively these data suggested that the reduced CD127 expression may 
have either contributed to the immaturity seen in LckVA and Lckind thymocytes 
due to reduced sensitivity to IL-7 signalling or it might have been reduced 
because of the more immature phenotype of LckVA and Lckind thymocytes 
compared to LckWT thymocytes. 
Thymocyte development and the CD4 versus CD8 lineage decision is heavily 
influenced by TCR sensitivity and the expression of signalling molecules 
such as Lck and Zap-70 (Hernandez-Hoyos et al., 2000; Legname et al., 2000; 
Saini et al., 2010). CD5 expression can be used as a surrogate marker for TCR 
sensitivity (Mandl et al., 2013). The observations that TCR expression levels 
are altered in LckVA and Lckind mice (Fig.3.3), together with the changes in CD4 
and CD8 maturation (Fig.3.5) and CD127 expression patterns (Fig.3.6) 
suggested that TCR sensitivity may be affected in LckVA and Lckind mice. 
Therefore we next assessed CD5 expression in TCRhiCD24lo and TCRhiCD24hi 
SP thymocytes (Fig.3.7).  
Fig.3.7 showed that Lckind and LckVA CD4+ SP thymocytes expressed 1.3 and 
1.8-fold less CD5 respectively, than LckWT thymocytes regardless of maturity. 
This was in agreement with published data that have shown reduced Lck 
expression reduced CD4+ T cell TCR signaling affinity in the periphery 
(Lovatt et al., 2006). Interestingly, in mature TCR+CD24lo CD8+ SP there were 
no differences in CD5 expression between the strains.   
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Fig. 3.6 CD127 expression was reduced in Lckind and LckVA SP thymocytes. 
Histograms show CD127 expression in LckWT, LckVA, and Lckind CD4+ SP and CD8+ SP 
thymocytes. SP thymocytes were divided into less mature TCR+CD24hi and more mature 
TCR+CD24lo populations. Average ± SD of CD127 mean fluorescence intensity (MFI) is shown 
for indicated gates. Data are representative of 2 independent experiments with n=3 in LckWT 
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The above data suggested that the bimodal expression of Lck in the DP stage 
of development in Lckind mice (Fig.3.3D) did not impede positive selection 
(Fig.3.3 and 3.4) or CD4/CD8 lineage development (Fig.3.5B). Yet, the SP 
thymocytes in Lckind mice expressed low levels of Lck (Fig.3.3), and were 
more immature (Fig.3.5C) suggesting they may be slower to mature. 
Additionally, Lcklo CD24loTCR+ SP thymocytes in Lckind mice had lower CD5 
expression (Fig.3.7), which may be compensating for the reduced signalling 
potential through the TCR . These data suggested that there might have been 
selection against thymocytes expressing abnormally high quantities of Lck, 
potentially due to too high a TCR sensitivity, since the cells in Lckind mice that 
expressed higher than WT levels of Lck in the DP stage of development were 
not present in the SP stages (Fig.3.3D). 
Our data also showed that constitutively low Lck expression in LckVA 
thymocytes allowed positive selection to proceed as it does in LckWT cells 
(Fig.3.3 and Fig.3.4). Although, LckVA mice lacked the intermediate CD4loCD8- 
population the development and maturation of CD4+ SP cells was unaffected 
(Fig.3.5), the CD8+ SP population that formed in LckVA thymi had more of the 
less mature CD24+TCRlo thymocytes than found in LckWT cells, potentially due 
to the weaker IL-7 signals they might receive as immature SP thymocytes 
(Fig.3.6). However, the TCR sensitivity was ultimately similar between 
mature CD8+ SP LckVA and LckWT thymocytes, when measured by CD5 
expression (Fig.3.7).  
3.2.5 The impact of reduced Lck abundance on the Vα and Vβ 
repertoires 
A large variety of TCRs is generated by somatic recombination and random 
V(D)J gene segment joining. Only a fraction of successful TCRαβ 
combinations is selected into the repertoire depending on signal strength 
(Gascoigne and Palmer, 2011). Our results showed that changes in Lck 
expression during thymocyte development influenced maturation (Fig.3.5) 
and TCR sensitivity (Fig.3.7). We therefore next asked whether the TCR 
repertoire was altered in LckVA and Lckind mice.  
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Fig. 3.7 CD5 expression was reduced in CD4+ SP thymocytes in Lckind and LckVA mice. 
Histograms show CD5 expression in LckWT, LckVA and Lckind CD4+ SP and CD8+ SP thymocytes. 
SP thymocytes were divided by their maturity into less mature TCR+CD24hi and more mature 
TCR+CD24lo populations. Average ± SD of CD5 MFI is shown for indicated gates. Data are 
representative of 2 independent experiments with n=3 in LckWT and LckVA strains, 
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We assessed the TCRβ repertoire, using a panel of 15 Vβ-specific antibodies, 
in LckWT, Lckind and LckVA mice. Legname et al. showed that the TCRβ usage 
repertoire was not different between Lckind and LckWT mice (Zamoyska et al., 
2003) . The TCRβ repertoire of LckVA mice has not been assessed before. Two 
independent experiments were done and the results are shown in Fig. 3.8.  
Vβ17 is not expressed in the C57BL/6 strain of mice (Wade et al., 1988) 
therefore, no staining was expected or observed in all genotypes  (Fig.3.8A, B 
and C) although in one of the experiments a low level of background 
staining, ~2.5% was identified (Fig.3.8D). Overall it was difficult to make 
firm conclusions from this study, due to the variability in the two 
experiments, for example Fig.3.8A suggested that 5% of cells in LckVA mice 
expressed Vβ13, however, in the repeat experiment (Fig.3.8B) the expression 
of Vβ13 was ~1% and similar in all three genotypes. Qualitative observations 
suggested that there were no consistent and striking differences between the 
three mouse strains. 
Signaling via the TCR in the thymus is critical for allelic exclusion of TCRα- 
and TCRβ-chains (Hogquist et al., 2005; Yamasaki and Saito, 2007). Lck was 
shown to play an important role at these different developmental stages 
(Molina et al., 1992), in allelic exclusion of TCRβ-chains (Anderson et al., 
1993) and TCRα-chains (Niederberger et al., 2003). Failure to properly initiate 
allelic exclusion can result in the surface expression of two Vα genes on a 
single T cell. In order to test whether Vα allelic exclusion might be 
compromised in the presence of low Lck levels, we chose two of the most 
abundantly expressed Vα alleles and looked for the presence of thymocytes 
that were positive for both in thymi and lymph nodes of LckWT and LckVA mice 
(Fig.3.9). The results for Vα2 and Vα8 expression in CD8+ and CD4+ T cells 
showed that LckWT mice expressed either Vα2 or Vα8, not both, on CD8+ and 
CD4+ thymocytes and peripheral T cells (Fig.3.9A). Thus, LckWT mice were a 
positive control for successful allelic exclusion of the Vα-chain. 
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Fig. 3.8 The TCR Vβ repertoire in mature LckVA, Lckind, and LckWT thymocytes. 
The bar charts show the percentage of indicated Vβ receptors in mature CD4+CD5+ (A and B) 
and in mature CD8+CD5+  (C and D) thymocytes for LckWT (blue), LckVA (red), and Lckind (green). 
Data in A and C are from one experiment, n=1 for each strain. Data in B and D are from a 
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Fig. 3.9 LckVA mice had normal allelic exclusion of Vα proteins in CD8+ and CD4+ T 
cells. 
Ex vivo expression of Vα 2 versus 8 (A) and Vα 8 versus 11 (B) were assessed in CD8+ and 
CD4+ mature SP thymocytes and mature lymphocytes in LckWT and LckVA mice. Dot plots are 
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Constitutively reduced Lck expression in CD8+ and CD4+ T cells in LckVA mice, 
did not affect the selection of the α-chain as Vα2 and Vα8 expression were 
also mutually exclusive, despite slightly lower proportions of Vα8 being 
expressed overall (Fig.3.8A and B). Interestingly, LckWT T cells expressed some 
Vα11, however, we did not find any Vα11 expression on thymic or 
peripheral, CD4+ or CD8+ T cells in LckVA mice (Fig.3.8B). This could be due to 
differences in how many times the mice were backcrossed. 
Although these experiments need to be repeated to confirm the results, 
collectively these data suggested that despite very low levels of Lck 
expression, allelic exclusion of Vα and Vβ chains occurs as normal during 
thymic development. The ~2 fold reduction in Vα8 expression in both CD8 
and CD4 LckVA T cells and differences in expression levels of some Vβ chains, 
such as increased Vβ2 in CD4+ T cells and Vβ4 in CD8+ T cells, indicated that 
there may be differences in the complete TCR repertoire and these may be 
relevant during immune responses. 
3.2.6  Lck abundance influenced TCR sensitivity in 
thymocytes 
During thymic selection TCR signaling thresholds determine positive versus 
negative selection (Gascoigne and Palmer, 2011). The data presented so far in 
this chapter indicated that Lck expression levels might affect the TCR 
signaling thresholds as we observed changes in TCR and CD5 expression 
levels during maturation (Fig.3.3 and 3.5). We wanted to test whether there 
were differences in TCR sensitivities in LckVA and Lckind thymocytes compared 
to LckWT thymocytes. To this end we chose to use F5 TCR transgenic mice.  
Crossing mice with F5 TCR transgenic Rag1KO LckKO mice ensures exclusive 
differentiation of T cells to the CD8+ lineage (Mamalaki et al., 1992). The F5 
TCR utilises Vβ11 and Vα4 chains and we could stimulate the cells with 
known affinity peptides: a negatively selecting cognate agonist peptide 
NP68, and a positively selecting antagonist peptide NP34 (Mamalaki et al., 
1993; Smyth et al., 1998).  
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First, we assessed thymic development in F5 TCR transgenic LckWT, LckVA and 
Lckind mice (Fig.3.10). Our data confirmed that the F5 TCR ensured the 
development of CD8+ SP thymocytes and only very small proportions <2% of 
CD4+ SP developed in all strains, which were probably very immature 
(Fig.3.10A). The CD8+ SP thymocytes were gated for TCRhi cells and the 
surface expression of TCR and CD5 in these were found to be similar 
between LckVA and LckWT mice. CD5 expression in F5TCRhi CD8+ Lckind 
thymocytes was 1.3-fold lower than in LckWT mice, which was in agreement 
with our results in polyclonal mice (Fig.3.7). Increased proportions of DN 
thymocytes, compared to F5LckWT mice (0.8% ± 0.2), were noted in F5LckVA 
and F5Lckind mice (5.8%±1.5 and 7.6%) (Fig.3.10A). This translated into 
increased numbers of DN3 and DN4 thymocytes (Fig.3.10D). Despite this the 
thymus size was significantly reduced in F5LckVA (p=0.0002) and F5Lckind mice 
(72.1±11.2x106 and 119.6x106) compared to F5LckWT mice (198.8±12.2x106).  
In order to compare the sensitivity of the thymocytes in the different strains 
of mice, we cultured thymocytes with different concentrations of NP68 or 
NP34 overnight and measured CD69 upregulation in DP thymocytes 
(Fig.3.11). We gated on CD4+ live cells, because this would isolate the DP 
population in F5TCR transgenic mice. The cells were further gated as 
CD5+CD24lo to remove contaminating mature CD8+ T cells. In the media only 
samples there was <1% CD69 upregulation in all mouse strains, confirming 
that this acted as a negative control and the CD69 upregulation in the other 
samples was peptide specific (Fig.3.11A and B). In response to peptide 
stimulation the percentage upregulation of CD69 was dose-dependent in all 
mouse strains (Fig.3.11A and B). The upregulation of CD69 was significantly 
higher in F5Lckind mice in response to both NP68 and NP34 than in F5LckVA 
and F5LckWT mice (Fig.3.11A and B), suggesting that Lckind thymocytes were 
more sensitive, potentially explained by the high Lck expression at this stage 
of development (Fig.3.3). CD69 upregulation in response to both NP68 and 
NP34 tended to be lowest in F5LckVA mice at all concentrations, however it 
was not significantly different from F5LckWT thymocytes (except at 1x10-3 &M 
NP68) (Fig.3.11A and B).   
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Fig. 3.10!Thymic development in F5 TCR transgenic LckWT, LckVA, and Lckind mice. 
Thymi from age matched 6-8 week old F5LckVA (n=3), F5LckWT (n=3) and F5Lckind mice (n=2; no 
SD) were harvested and thymocyte development was analysed ex vivo by flow cytometry. 
(A) Representative dot plots show frequency of DN, DP and SP T cells with average 
proportions ± SD. Representative histograms show TCR and CD5 expression in CD8+ SP 
thymocytes. Numbers on histograms show average proportions ± SD. (B) Representative 
contour plots show CD44 versus CD25 staining in the DN population and the numbers show 
average proportions ± SD of cells in quadrants DN3 and DN4. (C) Bar chart shows average 
numbers ± SD of total thymocytes and cells in each of DN, DP, CD8+ SP compartments. (D) 
Bar chart shows average numbers ± SD of cells in indicated populations. Statistical analysis 
on LckWT and LckVA samples in parts C and D was done using Prism as follows: parametric, 
student’s t-test, unpaired, two-tailed, *P<0.05, **P<0.01, ***P<0.001.  Data are representative 
of 3 independent experiments. 
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Fig. 3.11 Lck abundance influenced sensitivity of thymocytes to NP68 and NP34 
stimulation. 
Thymocytes from F5LckWT, F5LckVA and F5Lckind mice were stimulated overnight in the 
presence of 2 &g mL-1 doxycycline, with peptide. Media alone was used as a negative control.  
Cells were first gated as thymocytes using FSC and SSC, then CD4+ Live/Dead Aqua and 
finally CD69 upregulation was measured in CD24loCD5+ cells to exclude mature SP cells. 
Average upregulation of CD69 ± SD is shown in bar charts for (A) NP68 and (B) NP34 
stimulation. Data are representative of 2 independent experiments with n=3 individual 
animals analysed in each group. Statistical significance was calculated using Prism as 
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Although we could not conclude effects on negative versus positive selection 
of cells in this experiment, the data certainly correlate with the prediction 
that Lckhi cells in Lckind mice are negatively selected, because F5Lckind DP 
thymocytes were most sensitive to peptide stimulation (Fig.3.11), yet 
expressed the lowest levels of CD5 in CD8+ SP cells (Fig.3.10A), suggesting 
that the highly sensitive cells were eliminated. 
It would be interesting to increase the concentration of NP34, as in published 
reports 2 µM was used (Smyth et al., 1998) and to measure apoptosis. This 
could indicate whether the cells expressing high levels of CD69 are likely to 
die. It would also be interesting to assess whether the increased CD69 
expression in response to NP68 stimulation in F5Lckind mice was due to the 
Lckhi cells. The data in Fig3.11 showed that F5LckVA thymocytes were just as 
sensitive to NP68 and NP34 stimulation as F5LckWT thymocytes despite 
reduced Lck expression. 
3.3 Results: Peripheral Phenotype of LckVA and Lckind 
mice 
3.3.1 The proportions of CD44hi T cells are increased in naïve 
mice with reduced Lck abundance  
The above sections studied the thymic development in LckVA and Lckind mice. 
We next assessed what the consequences of thymic development with low 
Lck expression were for the peripheral T cell phenotype on the polyclonal 
background.  
We confirmed low Lck expression in peripheral T cells from LckVA and Lckind 
mice by WB analysis (Fig.3.12A). The results showed that the relative 
expression of Lck in LckVA was 9% as compared to 100% in LckWT.  In Lckind mice 
it was similarly low: 7% (Fig.3.12A). As one would predict from decreased 
cell numbers of CD4+ SP and CD8+ SP thymocytes (Fig 3.2), the peripheral 
CD4+ and CD8+ T cell numbers were significantly reduced in LckVA and Lckind 
mice compared to LckWT mice. (Fig.3.12B). Reduced T cell numbers can lead to 
a lymphopenic environment (Salmond et al., 2009a), therefore we assessed 
the expression of the memory-phenotype and activation marker CD44  
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Fig. 3.12 Low Lck expression in peripheral lymphocytes led to increased proportions 
of memory phenotype cells. 
(A) Cell lysates from LN cells from polyclonal LckWT, Lckind, and LckVA mice were analysed by 
WB (pre-cast gel). The blot was first probed with anti-Lck (Upstate) and anti-Tubulin 
antibodies overnight at 4°C, and then with anti-mouse (for Lck) and anti-rabbit (for Tubulin) 
fluorescent secondary antibodies for 1 hour. The blot was subsequently scanned using the 
Li-Cor system. Data were quantified using the ratio of Lck/Tubulin for each sample and 
then normalised to LckWT levels. Full blot is shown in Appendix 7.2. (B) Cell counts on 
lymphocytes were done using the CASY counter. Data are an average of 3 independent 
experiments with total n=9 individually analysed mice in each group ± SD. Statistical 
analysis was done on Prism as follows: One-way ANOVA with post-ANOVA Tukey’s 
multiple comparisons test, p=0.05. (C) CD44 expression was measured for all genotypes, in 
both CD4+ and CD8+ T cells, as indicated. Percentages on histograms represent averages of a 
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(Goldrath et al., 2000) in the three strains (Fig.3.12C). The data showed that in 
the CD4+ T cell compartment in LckVA and Lckind mice (13.3%±3.2 and 20.4%±8.0 
respecively) there were increased proportions of CD44hi cells as compared to 
LckWT CD4+ T cells (10.4%±4.9). In the CD8+ T cell compartment both LckVA and 
Lckind mice had approximately 2-fold more CD44hi cells than LckWT mice 
(11.2%±2.6) (Fig.3.12C). Overall these data correlated with the reduced 
thymic output in LckVA and Lckind mice. A high ex vivo CD44 expression can 
hinder studies of activation as the CD44hi memory phenotype cells are 
different from naïve cells and may contribute to immune responses (Sprent 
and Surh, 2011; Su et al., 2013). 
3.3.2 Generating LckWT and LckVA bone marrow chimaeras. 
In order to assess whether the CD44 upregulation in LckVA mice, seen ex vivo 
(Fig.3.12C), was intrinsic to low Lck expression, or was indeed the result of 
extrinsic factors such as the lymphopenic environment, we made bone 
marrow chimeras (Fig3.13). This enabled the study of LckVA versus LckWT T 
cells whilst subjected to the same environmental conditions in the same host. 
If the degree of CD44 upregulation were more in LckVA cells compared to 
LckWT cells, it would indicate an Lck dependent intrinsic mechanism. If, 
however, the upregulation of CD44 were the same as seen in LckWT it would 
indicate an environment driven lymphopenic response.  
Bone marrows of LckVA and LckWT donors were depleted of mature T cells by 
anti-CD4 and CD8 staining and complement lysis (Fig.3.13A). Host Rag1KO 
mice were reconstituted with mixtures of CD45.2 LckVA and CD45.1 LckWT in a 
9:1 ratio (Fig.3.13B). This ratio was chosen because previous work with Lckind 
chimeras has suggested that the numbers of Lck low cells recovered from 
chimeras was lower than that of LckWT cells and our lab has found 9:1 to be 
the optimal ratio (Caserta et al., 2010). At 4 weeks (Fig.3.13C) and 9 weeks 
(Fig.3.13D) post-transplantation the chimeras were characterised by flow 
cytometry. At 4 weeks it was noted that the three animals analysed, had 
slightly increased proportions of LckWT lymphocytes (CD45.1+) as compared to 
LckVA lymphocytes despite the 9:1 ratio initially favouring the LckVA cells 
(Fig.3.13C top panel). This was also reflected in  
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Fig. 3.13 LckVA and LckWT cells expressed similar proportions of CD44 in the same 
lymphopenic environment. 
(A) Congenically marked LckVA (45.2) and LckWT (45.1) bone marrow cells were pooled in a 9:1 
ratio. Mature T cells were depleted with complement lysis and histograms showed decrease 
in TCR expressing cells after complement treatment. (B) Pooled BM from LckWT and LckVA was 
transplanted into irradiated Rag1KO hosts. At week 4 (C) and week 9 (D) proportions of CD44+ 
expression in CD4+ and CD8+ T cells in 3 individual mice was assessed by histogram analysis. 
LckWT were CD45.1+ (red) and LckVA were CD45.1- (blue). At week 4 (E) and week 9 (F) 
lymphocyte numbers in the LN of LckWT cells (red) and LckVA cells (blue) are shown in bar 
charts. Data are representative of 2 independent experiments. 
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total cell numbers (Fig.3.13E). Interestingly the results obtained on week 9 
showed that in 2 of the 3 mice analysed LckVA lymphocytes represented a 
majority compared to LckWT lymphocytes (Fig.3.13D and F). However, at both 
time points histogram analysis of CD44 expression showed that there were 
no consistent differences between the LckVA and LckWT peripheral T cells in 
CD44 upregulation (Fig.3.13C and D). Suggesting that both LckWT and LckVA 
lymphocytes respond similarly to a lymphopenic environment and that the 
CD44 upregulation was not an intrinsic feature of the reduced Lck 
expression in LckVA mice, but rather a biproduct of the lymphopenic 
environment caused by the reduced thymic output of cells (this issue is 
addressed further in chapter 5). 
Despite the initial 9:1 ratio of bone marrow cells at transplantation, LckVA 
versus LckWT, this ratio was not reflected in the cell numbers recovered 
(Fig.3.13E and F). This indicated that LckVA were less able to compete during 
thymic development, perhaps due to the partial DN block that led to reduced 
DP thymocyte numbers (Fig.3.2).  To investigate the inability of LckVA cells to 
compete with LckWT cells further, we assessed the proportions of LckWT and 
LckVA cells during different stages of thymic development in the chimaeras by 
flow cytometry (Fig.3.14).  
The data in Fig.3.14 showed that at the DN stage LckVA cells were in a 
majority ~72-78% compared to LckWT cells, which only represented ~3-5%. 
(The rest of the events, ~20% on the dot plots, were unstained and that was 
why the proportions did not add to a 100%). At the DP stage, in two of the 
three mice (no. 1 and 2), LckWT cells represented ~26 – 35% of the events and a 
further increase in their predominance was seen in the CD8+ SP population. 
In contrast, in mouse no.3 the LckWT cell population remained low (3-6%) at all 
stages of development.  
Overall, these data suggested that reduced Lck expression made T cells less 
able to compete with LckWT cells in the DN!DP transition during thymic 
development in bone marrow chimaeras (Fig.3.14). However, the transition 
from DP to SP was shown to be comparable between individual LckWT and  
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Fig. 3.14 LckVA cells unable to compete in thymic differentiation in bone marrow 
chimaeras with LckWT cells. 
Sub-lethally irradiated Rag1KO mice were reconstituted with a 9:1 mixture of congenitally 
marked LckVA (CD45.2) and LckWT (CD45.1) bone marrow cells. At 9 weeks after reconstitution, 
thymi were analysed by flow cytometry. (A) Representative dot plots show CD4 against 
CD8 staining for the 4 developmental populations (DN, DP, CD4+ SP, and CD8+ SP) for three 
individual mice. Each of DN, DP, CD4+ SP, and CD8+ SP populations were gated for relative 
proportions of LckWT (CD45.1) and LckVA (CD45.2) cells. CD4+ and CD8+ SP thymocytes were 
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LckVA mice (Fig.3.3) and this was also the case in bone marrow chimaeras 
(Fig.3.14). Transplanting LckVA cells in a 9:1 ratio with LckWT cells allowed for 
some compensation in cell numbers recovered, however, the peripheral 
pools varied a lot in composition between individual animals.  
3.3.3 Lck abundance did not affect peripheral numbers of TReg 
cells 
Downstream of TCR signalling one of the main targets of Lck is Zap-70. It 
has been shown that when Zap-70 expression and function are compromised 
the TCR signaling threshold is changed, which consequentially influences the 
thymocyte selection threshold such that normally negatively selected clones 
are positively selected (Tanaka et al., 2010). The negative selection escapees 
are perpetrators of an autoreactive phenotype in periphery. Importantly, this 
phenotype is accompanied by an increase in TReg proportions. Additionally, 
studies have suggested that natural TRegs are selected in the thymus in 
response to strong TCR signals (Anderson and Takahama, 2012). Our data 
indicated that there may be changes in the thymocyte selection thresholds 
due to changes in Lck abundance (Fig.3.7 and 3.11) and therefore we asked 
whether this might have led to changes TReg proportions in the peripheries of 
LckVA and Lckind mice .  
Our results of ex vivo T cell phenotyping for CD4+Foxp3+ T cells showed that 
although Lckind mice had significantly higher proportions of TRegs than LckWT or 
LckVA mice (Fig.3.15A), the numbers of TRegs were not significantly different 
(Fig.3.15B) between LckWT, LckVA or Lckind T cells, suggesting that even if there 
was a change to selection thresholds when Lck abundance was changed, this 
did not influence TReg selection. 
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Fig. 3.15 Proportions and numbers of TRegs were comparable to LckWT in LckVA and 
Lckind mice.  
Peripheral lymphocytes from LckWT (black), Lckind (purple) and LckVA (red) mice were analysed 
by ex vivo intracellular staining for TRegs (CD4+Foxp3+). The average proportions ± SD (A) and 
average numbers ± SD (B) of CD4+Foxp3+ TRegs are shown in bar charts. Data are representative 
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3.4 Summary 
· Lckind thymocytes expressed a broad range of Lck in the thymus 
(Fig.3.3D) while LckVA mice expressed constitutively low levels of Lck 
(Fig.3.1 and Fig.3.3D). 
· In both Lckind and LckVA mice, thymic development was restored as 
compared to LckKO mice, although thymocyte numbers were 
significantly lower than in LckWT mice (Fig.3.2). 
· Neither Lckind nor LckVA mice had impediments in thymocyte 
progression through positive selection (Fig.3.3 and 3.4). 
· In LckVA mice CD4+ and CD8+ SP thymocytes developed without the 
formation of the intermediate CD4loCD8- population (Fig.3.5), although 
the CD8+ SP thymocytes are less mature compared to LckWT mice. 
· Lckind mice had more immature CD4+ and CD8+ SP thymocytes than 
LckWT SP thymocytes despite the ability to form an intermediate 
CD4loCD8- population (Fig.3.5). 
· LckWT DP thymocytes were as sensitive as LckVA thymocytes, but less 
sensitive than Lckind thymocytes, to peptide stimulation (Fig.3.11). 
· Any changes to selection thresholds that may have occurred in LckVA 
and Lckind mice, did not affect peripheral TReg cell numbers (Fig.3.15). 
· Reduced Lck expression led to increased proportions of lymphopenia-
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3.5 Discussion 
The aim of the work presented in this chapter was to determine the impact 
Lck abundance has on thymocyte development. To this end we compared the 
Lckind mice, which expressed a range of Lck abundance in the thymus 
(Fig.3.3D) and LckVA mice, which expressed constitutively low levels of Lck 
(Fig.3.1. and Fig.3.3D) to LckWT mice, and where appropriate, LckKO controls. A 
number of observations were made, that highlighted Lck dependent 
differences in thymic development between Lckind and LckVA mice, allowing us 
to better understand the roles of Lck. 
The data presented in this chapter confirmed, as reported previously 
(Legname et al., 2000; Salmond et al., 2011), that both Lckind and LckVA mice 
overcame to some extent, the DN3 block seen in LckKO mice (Fig.3.1). Despite 
this reduced DP and SP thymocytes were recovered in Lckind and LckVA mice 
(Fig.3.2). The partial DN3 block found in some cells in the Lckind thymi, might 
have been because not all cells expressed the transgene at this stage in 
development, due to variegated transgene expression previously reported to 
be a factor in the rtTA x dox genetic system. 
Lck has been shown to play a critical role at the first DN checkpoint in 
thymic development (Molina et al., 1992), as signaling via the TCR is critical 
for regulating β chain selection. We did not find any striking differences in 
the TCR Vβ repertoire in Lckind and LckVA mice (Fig.3.8). Additionally, TCR 
signals are critical for α-chain allelic exclusion (Hogquist et al., 2005) yet, 
interestingly, we showed, that even 5% of WT levels of Lck, in LckVA mice, 
were sufficient for allelic exclusion of the TCRα-chains Vα2 and 8 (Fig.3.9). 
Although, this does not exclude the option that there might be defects in 
allelic exclusion of other α-chains, we would predict, based on the similar 
TCR sensitivity in DP thymocytes between LckVA and LckWT mice, that this is 
unlikely, as they appear to signal to the same extent as LckWT cells (Fig.3.11). 
In keeping with previously published data, we showed that at the DP stage 
of development Lckind thymocytes expressed variable levels of Lck (Legname 
et al., 2000), and after the positive selection step they expressed low levels of 
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Lck (Fig.3.3). Legname et al. predicted that very high Lck expression in DP 
thymocytes might be unfavourable for thymocyte development (Legname et 
al., 2000).  Indeed, it has been shown that overexpression of WT Lck is 
detrimental to thymic development as it can lead to development of thymic 
tumours, therefore there may be selection against high Lck expression 
(Abraham et al., 1991). When we assessed positive selection using the 
expression patterns of CD69 and TCR in Lckind, LckVA and LckWT thymocytes 
(Fig.3.3) we found that in LckWT mice the TCR expression levels increased 
during development from DN to DP to SP stages, as would be expected 
(Azzam et al., 1998). Despite a higher TCR expression in LckVA and Lckind DP 
thymocytes compared to LckWT thymocytes positive selection proceeded 
unhindered, as measured by relative proportions of cells at each of the 
selection stages distinguished by CD69 and TCR expression. The results 
revealed, however, a change in Lck expression levels in Lckind mice during 
positive selection from bimodal to low (Fig.3.3).  
Reduced abundance of Lck has been shown to lead to weaker TCR signals 
(Hernandez-Hoyos et al., 2000), which is also the premise of the signal-
strength model of CD4/CD8 lineage development. Therefore, we assessed 
lineage development in further detail by analysing CD5 versus TCR 
expression (Fig.3.5). We found that both Lckind and LckVA thymocytes, despite 
reduced Lck expression developed CD4+ and CD8+ SP in approximately the 
appropriate 4:1 ratio (Sinclair et al., 2013), although in reduced numbers 
(Fig.3.2).  
Interestingly, in contrast to LckWT and Lckind thymocytes, LckVA thymocytes did 
not develop an intermediate CD4loCD8- population (Fig.3.5) (Brugnera et al., 
2000) as is considered necessary in the kinetic-signalling model of lineage 
determination. These data suggested that perhaps the high levels of Lck 
expression in Lckind mice at the DP stage of development allow them to 
behave like LckWT thymocytes, however, the intermediate CD4loCD8- 
population was not absolutely required for the development of CD4+ and 
CD8+ SP thymocytes. The reduction in Lck expression in Lckind mice at the SP 
stage (Fig.3.3) compromised both CD4+ and CD8+ thymocyte maturation, 
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whereas in LckVA mice only CD8+ thymocyte maturation was altered (Fig.3.5). 
Therefore our data challenge the necessity of an intermediate CD4loCD8- 
population in thymocyte development and perhaps suggest that Lck 
abundance is more important for thymocyte maturation. 
Signals via the TCR are also critical for determining positive versus negative 
selection at the DP stage of development, particularly important is the 
affinity of the TCR for the selecting signal which may be predicted from CD5 
expression levels (Gascoigne and Palmer, 2011; Mandl et al., 2013).  
Reduced CD5 expression in Lckind SP thymocytes both on the polyclonal and 
F5TCR transgenic backgrounds, therefore, suggested that despite the high 
Lck expression at the DP stage, which potentially explains the increased 
sensitivity to peptide stimulation (Fig.3.11), the activation threshold is 
adjusted or the cells expressing high levels of Lck are negatively selected by 
the SP stage. These predictions are supported by the observation that mature 
CD4+ SP Lckind thymocytes had lower CD5 expression and peripheral CD4+ SP 
Lckind T cells have been shown to have an increased activation threshold 
(Lovatt et al., 2006). However, care must be taken when drawing parallels 
between transgenic and polyclonal mice. Despite these caveats, these data 
are in agreement with the notion that Lck expression levels above that found 
in WT mice, are damaging to the T cell repertoire, which would be in line 
with published data (Abraham et al., 1991), and that is why after positive 
selection only cells with low Lck expression in Lckind mice remain. 
Additionally, we did not find increased numbers of natural TRegs in the 
periphery in Lckind, which might be expected from studies in SKG Zap-70 
mutants, further suggesting that the high Lck expression probably leads to 
death (Tanaka et al., 2010). 
These data, however, did not rule out that the change in Lck expression in 
Lckind mice could be the result of active downregulation. Indeed, since we 
found no differences in efficiency of DP to SP conversion in LckVA and Lckind 
mice (Fig.3.4), suggesting that there was no increase in apoptosis in Lckind 
mice at the DP stage. Future work dissecting positive and negative selection 
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in more detail, particularly assessing apoptosis, would be one step towards 
settling this issue.  
Interestingly, we found that CD5 expression was similar in mature LckVA and 
LckWT thymocytes (Fig.3.7), suggesting similar signaling thresholds, which 
were supported by the observation that there were no significant differences 
between F5LckVA and F5LckWT thymocyte sensitivities to peptide stimulation 
(Fig.3.11). Unfortunately, it also appeared that the cells respond weakly 
below the 1 µM concentration to NP34 and it would have been interesting to 
repeat the experiment with higher concentrations of NP34.  
Finally, it is important to bear in mind that the TCR sensitivity to positively 
and negatively selecting signals were assessed very crudely here, and the 
results cannot be used to interpret survival or apoptosis after NP68 or NP34 
stimulation. The selection window for thymocytes is very narrow and the 
TCR is highly sensitive and discriminating when responding to p:MHC 
ligation (Daniels et al., 2006; Naeher et al., 2007). It would be interesting to 
extend these studies and study the LckVA mice on an OT-1 transgenic 
background, to take advantage of the wide range of different affinity 
peptides, which could elucidate the effect of Lck abundance on signaling 
thresholds. Furthermore, we could use fetal thymic organ cultures (FTOCs), 
where culturing a very young thymus, with less than 1% mature SP cells, 
with a known peptide of a known concentration allows one to calculate the 
resulting numbers of SP cells to measure efficiency of positive or negative 
selection (Smyth et al., 1998). Although we are confident that using CD4 
staining to mark DP cells was accurate as CD4+ SP proportions in F5 
transgenic mice are <2% (Fig.3.10A). As an extension of the flow cytometry 
assay we could also sort for CD4+ T cells prior to culturing thymocytes 
overnight, however this would still not directly indicate selection differences. 
How different TCR signals indicate positive versus negative selection or CD4 
and CD8 lineage choice is still poorly characterised. The combined 
contributions of strength and duration of TCR signals, unique patterns of 
gene expression controlled by transcription factors, the expression and 
Chapter 3 
  105 
function of which is in turn dependent on spatial and temporal regulation by 
cytokines and growth factors, can all influence the development of 
thymocytes (Gascoigne and Palmer, 2011; Mingueneau et al., 2013). Up until 
the DP stage of development the CD4+ SP cells and CD8+ SP cells develop in 
unison. At the DP stage a process of selection occurs where the cells with the 
correct TCR avidity for self-peptides presented on the appropriate MHC 
molecule class I or II, would differentiate into CD8+ or CD4+ SP, respectively.  
If the developmental expression patterns of TCR and CD5 are so 
determinative in response to TCR signals, why then with <5% Lck expression 
do we not see more significant disturbances in thymocyte development? 
Perhaps this is explained by the relative involvement of downstream 
signaling pathways. For example TCR signaling thresholds have been shown 
to influence positive versus negative selection via its effects on Ca2+ 
(Freedman et al., 1999; Kane and Hedrick, 1996) and ERK signals 
(Mariathasan et al., 2001). Strong and transient ERK activation led to negative 
selection, and sustained low level of activation led to positive selection 
(Mariathasan et al., 2001). Mechanistically, it has been shown that this is 
because small changes in signaling strength alters the localization of Ras and 
MAPK signaling intermediates within the cell: strong signals activate 
Ras/Raf-1/ERK at the plasma membrane causing negative selection, and 
weak signals induce their activation at the Golgi, leading to positive selection 
(Daniels et al., 2006). Similarly sustained Ca2+ mobilization in response to 
strong TCR signals was shown to lead to negative selection (Kane and 
Hedrick, 1996). Interestingly, however, Salmond et al. did not find any 
differences in the efficiency of Ca2+ flux in LckWT and LckVA thymocytes 
(Salmond et al., 2011), perhaps suggesting that there are no overt differences 
in the ultimate sensitivity of the TCR with reduced Lck expression levels and 
therefore we do not see more severe consequences, which is also what our 
data indicated (Fig.3.11). It would be interesting to assess whether the same 
is true for ERK signaling in LckVA mice. Alternatively, assessing Ca2+ in 
response to crosslinking with anti-TCR/CD4 antibodies may be too crude an 
analysis. In studies with polyclonal ThemisKO mice Fu et al. were unable to see 
differences in Ca2+ flux in positively selecting thymocytes in response to anti-
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CD3/CD4 crosslinking, yet when using the OTI system, with distinct 
positively and negatively selecting antigen-variant peptides, they showed 
that Themis deficient thymocytes elicited increased and sustained Ca2+ flux 
with weak agonists, only seen with strong agonists in WT cells (Fu et al., 
2013).  
Overall, this chapter has highlighted that differences in Lck abundance can 
influence thymic development on many levels. Interestingly, however, only 
5% of WT levels of Lck can rescue thymic development, and appears to be 
less consequential for development than changes in Lck expression levels 
during development, as was shown to be the case for Lckind mice. Perhaps the 
latter is because Lck is not normally developmentally regulated in the 
thymus and artificial changes in levels are more difficult to cope with for a 
cell, whilst setting up thresholds, than constitutively low levels of Lck 
(Olszowy et al., 1995).  
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Chapter 4:  The Impact of Constitutively Low 
Lck Expression on Peripheral T cell Signalling  
4.1 Introduction 
Upon exposure to antigen, peripheral T cells, as key mediators of the 
adaptive immune response, differentiate, acquire effector function, 
proliferate, and finally form memory cells. T cells selected in the thymus 
have the potential to be self-reactive, thus the threshold of activation must be 
fantigens, whilst enforcing central tolerance to self-antigens. The TCR 
signalosome can be thought of as consisting of three regulatory units (Acuto 
et al., 2008). The first is the SFK regulation module, including Lck and the 
associated positive and negative regulators of Lck activity. The second is the 
signal triggering module consisting of ITAMs in the dimeric CD3 chains of 
the TCR complex, and Zap-70. The third and final module is the signal 
diversification and regulation module (Acuto et al., 2008).  The intricate 
connectivity, inter-regulation and abundance of the molecules in the different 
modules gives the TCR its unique fine-tuning ability to discriminate between 
signals. Dysregulation at any stage of this response propagation can result in 
immune disorders, including autoimmune diseases, and therefore T cells 
activation is regulated on many levels. 
The TCR is devoid of kinase activity itself, and thus it requires Lck to initiate 
the signaling cascade. Lck phosphorylates TCR-associated ζ-chain and CD3 
ITAMs, which allow for recruitment of Zap-70. Zap-70 continues the cascade 
of phosphorylation events and induces the recruitment of the signal 
diversification and regulation module (Smith-Garvin et al., 2009). The first 
direct targets of Zap-70 are the transmembrane adapter protein LAT and 
SLP-76. The absence of the adapter proteins results in a loss of T-cell 
signalling, as they are critical for the spatiotemporal arrangements of 
subsequent effector molecules (Smith-Garvin et al., 2009). Ultimately the 
downstream signalling cascades lead to gene regulation by activating 
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transcription factors such AP1, NFκB, and NFAT (Oh-hora and Rao, 2008; 
Smith-Garvin et al., 2009).  
Studies in Lckind mice, in which lower than WT levels of Lck are expressed in 
response to doxycycline administration, showed that Lckind CD4 T cells had 
an increased activation threshold to anti-TCR stimulation (Lovatt et al., 2006), 
meaning that higher concentrations of stimulus were required for equal to 
WT levels of ERK phosphorylation. This suggests that the local abundance of 
Lck molecules is critical in regulating TCR signalling thresholds.  Differences 
in TCR signal quality and strength can affect which downstream signalling 
pathways are activated, and thereby determine the biological outcomes for T 
cells (Daniels et al., 2006; Guy et al., 2013; Inder et al., 2008). 
Within the SFK regulation module, Lck activity is tightly regulated, 
independently of TCR engagement, by the phosphorylation states of its 
inhibitory residue LckY505 and activatory LckY394 in the kinase domain (Brownlie 
and Zamoyska, 2013; Salmond et al., 2009b).  
The TCR signalosome is regulated by negative regulation pathways acting at 
different stages of TCR signaling, that are triggered by TCR stimulation, 
assuring that TCR signalling is controlled appropriately, in terms of the 
strength and duration of the signal. Deficiencies in early negative regulators 
like CTLA4, PD1, or SHP1 lead to immune disorders (Lorenz et al., 1994; 
Nishimura et al., 2001; Waterhouse et al., 1995). In the absence of more 
proximal negative regulation by Dok1 and Dok2 there is increased TCR-
induced IL-2 production, and proliferation (Yasuda et al., 2007). Finally, 
deficiency of the HPK1-SLP-76-14-3-3 negative regulation pathway, which is 
also activated in response to TCR stimulation by Lck phosphorylating HPK1 
can result in increased TCR-dependent tyrosine phosphorylation of SLP-76, 
PLCγ1, LAT, Vav1, and ZAP-70 (Shui et al., 2007).  
Chapter 4: Aims 
In chapter 3 our results indicated that changes in Lck abundance has variable 
effects on thymocyte development. Of particular interest, in light of the 
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above discussion of Lck being critical in setting up the TCR-signalosome and 
the consequent negative regulation pathways, is our observation that the 
activation threshold was similar between F5LckWT and F5LckVA thymocytes 
(Fig.3.11). It has been shown that in F5Lckind mice the activation threshold of 
peripheral T cells is increased due to reduced Lck expression, and this effect 
was shown to proceed linearly down the TCR signalling pathway (Lovatt et 
al., 2006). Additionally, F5Lckind thymocytes had a lower activation threshold 
than F5LckVA thymocytes (Fig.3.11). Consequently, we hypothesised that 
F5LckVA peripheral T cells would behave similarly to F5Lckind peripheral T 
cells.   
In this chapter, we examined the activation threshold of F5LckVA CD8+ T cells 
by analysing surface marker expression in response to overnight peptide 
stimulation. Surprisingly, we found that peripheral T cells in F5LckVA mice 
had similar activation to F5LckWT T cells in terms of the dose of peptide 
required in vitro, to upregulate activation markers. 
When assessing activation of downstream pathways such as Ca2+ 
mobilization, ERK phosphorylation, and proliferation, there were variable 
effects; some pathways were upregulated, some downregulated. 
Furthermore, cytokine production as a read out of the effector function in 
F5LckVA mice was studied and showed that F5LckVA T cells may have an 
impaired ability to differentiate into effector cells. Our results therefore are in 
keeping with published data suggesting that TCR-signals travel via different 
signalling branches, but not equally (Daniels et al., 2006; Inder et al., 2008).  
4.2 Results 
4.2.1 F5LckVA mice had reduced numbers of peripheral T cells 
We showed in chapter 3 that naïve polyclonal LckVA mice had upregulated 
levels of CD44 expression ex vivo due to lymphopenia (Fig.3.12). Studies of 
peripheral T cell activation using LckVA mice may be confused by the CD44hi 
memory-phenotype cells, as these may contribute differently to naïve T cells 
to the immune response (Sprent and Surh, 2011). In order to study the impact 
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of reduced levels of Lck on CD8+ T cells, we used F5 TCR transgenic mice. 
The thymic development of F5LckVA mice was characterised in chapter 3 
(Fig.3.10), and showed a decrease in CD8+ SP thymocyte numbers in F5LckVA 
mice as compared to F5LckWT mice.  
Here, we analysed the frequency of peripheral LN F5 CD8+ T cells, and also 
confirmed their naïve state by measuring expression of activation markers. 
The results in Fig.4.1A showed that the frequency of the F5LckVA CD8+ T cell 
population (96.6% ± 0.1) was equivalent to that in F5LckWT mice (95.7% ± 1.1). 
Lck is non-covalently associated with both the CD4 and CD8 co-receptors in 
T cells (Rudd et al. 1989; Veillette et al 1988). Reduced Lck expression in 
polyclonal Lckind mice led to a 3-fold decrease in CD4 expression levels 
(Lovatt et al., 2006). Therefore, expression levels of CD8 and Lck were 
assessed (Fig.4.1B). CD8 expression was similar in F5LckVA (MFI 9.1 ± 0.4) and 
F5LckWT mice (MFI 10.0 ± 1.9). As in the thymus, Lck expression was 
significantly reduced in peripheral F5LckVA T cells (MFI 11.3 ± 0.9) compared 
to F5LckWT T cells (MFI 21.4 ± 0.8). Both F5LckVA and F5LckWT T cells expressed 
higher levels of Lck than F5LckKO mice (MFI 7.6 ± 0.2). These data, however, 
did not accurately reflect the expression levels of Lck, as they suggested that 
Lck expression was only 2-fold lower in F5LckVA mice compared to F5LckWT, 
yet in chapter 3 (Fig.3.1) we confirmed the previously published finding 
(Salmond et al., 2011), that Lck expression driven by the VA-transgene leads 
to <5% expression of Lck compared to WT levels. This discrepancy may 
reflect a lack of sensitivity in detecting Lck by flow cytometry compared to 
WB. 
F5LckVA mice were potentially lymphopenic as the absolute numbers of CD8+ 
T cells in F5LckVA mice (7.76±3.4 x 106) were almost 3-fold lower than in 
F5LckWT mice (22.62±11.7 x 106) (Table.4.1). However, the peripheral CD8+ T 
cells in both F5LckWT and F5LckVA mice were naïve, as ex vivo CD44 expression 
was low and, importantly, similar between mice (Fig.4.1C). Neither F5LckWT 
nor F5LckVA CD8+ T cells were activated, as they did not express activation 
markers CD69 and CD25 (Fig.4.1C). We also used expression of CD5 as a 
surrogate marker for measuring TCR sensitivity (Azzam et al., 1998), and  
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Fig. 4.1 F5LckVA T cells were of naïve phenotype ex vivo. 
Peripheral LN cells from F5LckWT (black), and F5LckVA (blue) mice were evaluated ex vivo for 
activation markers by flow cytometry. (A) Representative dot plots show the average 
proportions ± SD of total TCR+CD8+ cells. The values shown are an average of 3 individual 
mice ± SD. (B) CD8 expression (left histogram) with the average MFI ± SD, and Lck 
expression (right histogram) were assessed in CD8+TCR+ T cells. The bar chart shows average 
MFI ± SD for Lck expression where LckKO (red) is shown as a control. (C) Histograms show 
the expression of indicated activation markers with average MFIs ± SD shown in the top 
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found that both F5LckWT and F5LckVA had equal CD5 surface expression 
(Fig.4.1C).  
Table 4.1 T cell numbers in LN of F5LckWT and F5LckVA mice. 
Mouse Model Total LN cell number (x10-6) Total CD8+ TCR+ cell number (x10-6) 
F5LckWT (n=6) 24.95 ± 12.7 22.62 ± 11.7 
F5LckVA (n=6) 9.29 ± 4.7 7.76 ± 3.4 
 
4.2.2 F5LckVA T cells were activated as efficiently as F5LckWT 
T cells  
Reduced Lck expression has been shown to decrease TCR avidity and 
thereby increase the activation threshold of peripheral CD4+ and CD8+ T cells 
(Caserta et al., 2010; Lovatt et al., 2006). We hypothesised that F5LckVA would 
behave similarly to F5Lckind mice, and would have an increased activation 
threshold compared to F5LckWT mice.   
T cells from LN of F5LckVA, F5Lckind, and LckWT mice were stimulated 
overnight, in vitro, with titrations of the cognate peptide NP68. We measured 
CD25 upregulation as a read out of activation status. CD25 is the α subunit of 
the IL-2R, and forms a high affinity complex with the β (CD122) and γ 
(CD132) subunits, allowing cells to respond to IL-2 (Leonard et al., 1990).  
Figure 4.2A showed that, as expected, cells expressing homozygous levels of 
F5 (F5HomLckWT) had 2-fold higher TCR expression (MFI = 978) as compared to 
TCR expression in heterozygous F5 (F5HetLckWT) mice (MFI = 487.3). F5HomLckWT T 
cells upregulated CD25 at lower peptide concentrations than F5HetLckWT T cells, 
therefore increased TCR expression made them more sensitive to peptide 
stimulation than F5HetLckWT cells (i.e. they had a lower activation threshold).  
TCR expression levels and activation thresholds were compared between 
F5HomLckVA, F5HetLckVA, and F5HetLckWT cells (Fig.4.2B). Surprisingly, F5HetLckVA (TCR 
MFI = 578) T cells had 1.6 fold lower TCR expression than F5HetLckWT (TCR MFI 
= 942). This was also reflected in sensitivity to peptide as measured by CD25 
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upregulation at 24h, where F5HetLckVA T cells required higher concentrations of 
peptide to upregulate CD25 in 50% of cells than did F5HetLckWT (Fig.4.2B). On 
the other hand, F5HomLckVA T cells (TCR MFI = 1226) had similar TCR 
expression to F5HetLckWT (TCR MFI = 942 ± 44.44), as was seen from the 
overlapping histograms. The slight difference in TCR MFI’s between 
F5HomLckVA and F5HetLckWT T cells was reproducible (Fig.4.2 B and C), but never 
reached a two-fold difference as was seen between F5HomLckWT and F5HetLckWT. 
Whereas, F5HomLckVA T cells had two-fold higher TCR expression (TCR MFI = 
1226) than F5HetLckVA T cells (TCR MFI = 578). Surprisingly, induction of CD25 
expression by peptide was the same for F5HomLckVA and F5HetLckWT CD8+ T cells, 
indicating that the activation thresholds were equivalent. The reason for why 
homozygous TCR expression in F5HomLckVA mice, was the same as 
heterozygous surface expression in F5HetLckWT mice, is unclear.  
When we analysed TCR expression in F5HetLckind CD8+ T cells (TCR MFI = 6.1 ± 
0.2), it was equivalent to that in F5HetLckWT CD8+ T cells (TCR MFI = 6.5 ± 0.4), 
but the activation threshold in F5HetLckind CD8+ T cells was increased, which 
was in agreement with previously published data (Lovatt et al., 2006) 
(Fig.4.2C). Additionally, preliminary experiments in OT1VA mice did not show 
reduced TCR expression compared to OT1WT mice. One possible explanation 
is that by driving both the F5 and VA transgenes from the same promoter 
(hCD2 cassette) there is competition for transcription factors, such that 
transcription of the TCR is reduced. Since TCR surface expression was shown 
to have an effect on the activation threshold in wild type mice (Fig.4.2A), we 
continued our studies with F5HomLckVA mice (named for convenience F5LckVA 
throughout the thesis) and used the F5HetLckWT mice as controls (named F5LckWT 
throughout the thesis), in order to normalise for TCR expression. In 
conclusion, contrary to our hypothesis and despite having very low 
expression of Lck, F5LckVA mice responded as efficiently as F5LckWT mice after 
overnight stimulation with NP68.  
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Fig. 4.2 F5LckVA T cells activated as efficiently as F5LckWT T cells. 
LN cells from F5HomLckWT, F5HetLckWT, F5HetLckind, F5HomLckVA and F5HetLckVA were activated with a 
titration of NP68 overnight. CD25 expression was assessed by flow cytometry, and plotted 
as percentage of positive cells of total. TCR expression was assessed by histogram analysis as 
the MFI of expression in ex vivo samples. Comparisons were made between (A) F5HomLckWT and 
F5HetLckWT, (B) F5HetLckWT and F5HomLckVA and F5HetLckVA, (C) F5HetLckWT, F5HetLckind, and F5HomLckVA. Data 
are representative of: 3 experiments in part A, of 2 experiments in part B and of 2 
experiments in part C. Importantly, F5HomLckVA versus F5HetLckWT comparisons have been done in 
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4.2.3 F5LckVA T cells had reduced phosphorylation of Lck 
targets upon TCR signaling 
The data in Fig.4.2 raises the question: how can reduced amount of Lck lead 
to an equal signalling threshold in F5LckVA mice and not F5Lckind mice? In 
order to tackle this issue, we looked at signalling events downstream of Lck 
upon TCR stimulation, that have been shown to be affected by reduced Lck 
expression in F5Lckind mice (Lovatt et al., 2006). 
Upon TCR engagement with p:MHC, Lck is recruited to the complex by its 
association with CD4 and CD8 co-receptors (in the F5 system only CD8). It 
then undergoes transphosphorylation of its activation loop tyrosine Y394 
upon clustering (Palacios and Weiss, 2004). Via this process, Lck becomes 
proximally positioned to phosphorylate the intracellular ITAMs within the 
CD3 and TCRζ signalling chains of the TCR receptor, and starts the 
signalling cascade. The Syk-family kinase Zap-70 is the first to be recruited to 
the phosphorylated ITAMs via its tandem SH2 domain. Lck phosphorylates 
and activates Zap-70 on its tyrosine Y319, and for full activation Zap-70 
autophosphorylates on residue Y493 (Wang et al., 2010). Zap-70 
subsequently phosphorylates T-cell-specific adapter proteins LAT, and SLP-
76, that recruit a huge number of different molecules, mediating various 
signalling pathways with different biological outcomes (Brownlie and 
Zamoyska, 2013; Palacios and Weiss, 2004; Walk et al., 1998; Wang et al., 
2010). 
We assessed the extent of phosphorylation of Lck targets in F5LckVA mice. We 
labelled naïve LN T cells from F5LckVA and F5LckWT mice with different 
concentrations of CFSE (Fig.4.3A). This enabled them to be identified when 
pooled in one well to reduce error during stimulation and fixing in the 
experiment. Cells were stimulated for 2.5, 5, 10 and 20 minutes with 1 &M 
NP68, and the stimulation was stopped with the addition of 2% PFA. Cells 
were stained intracellularly for: pZap-70Y493, pSrcY416 (which measures both 416 
on Fyn and Lck), pShc and pLck505. The results were acquired by flow 
cytometry and are shown in Fig.4.3.   
Chapter 4 
  116 
Fig. 4.3 Phosphorylation of Lck targets was decreased in F5LckVA compared to 
F5LckWT T cells.  
LN from F5LckWT and 5 F5LckVA mice (n=4) were harvested and pooled for each genotype 
before making single cell suspensions. (A) F5LckWT cells were labelled with 0.01 &M CFSE. 
The two genotypes were subsequently pooled and plated in 96-well cell culture plates and 
cells were stimulated for the indicated times with 1 &M NP68. Phosphorylation of indicated 
proteins (B-E) was controlled for by comparing to an unstimulated (filled grey), 15min of 1 
&M PP2 treatment prior to stimulation with 1 &M NP68 (blue line), or a pervanadate control 
treated for 10 minutes (red line). The black line on all histograms shows a sample stimulated 
for 10 minutes. The bar charts on the right show standardised means of MFIs ± SD. These 
were calculated individually for each of three technical repeats from the formula: (exp – 
PP2)/(total – PP2) x 100%, where exp is the MFI of the peptide-stimulated sample, PP2 is the 
MFI of the PP2-treateded sample and total is the MFI of the pervanadate-treated sample. 
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Histogram analysis was used to study the phosphorylation of indicated 
molecules (Fig.4.3B-E).  Phosphorylation upon pervanadate treatment (red 
line) and its inhibition when treated with PP2, the SFK inhibitor (blue line), 
were used as positive and negative controls, respectively. PP2 treatment did 
not completely inhibit phosphorylation of targets, indicated by its staining at 
a higher level than the unstimulated control in all cases (Fig.4.3B-E). It is 
possible that a higher concentration than 1 &M or longer than 15min pre-
incubation would be required. Bar charts to the right of each figure show 
standardised MFIs for each of the different time points for indicated 
molecules (Fig.4.3B-E). For all targets tested, F5LckVA showed 2-fold or more 
reduced phosphorylation at all time points, in keeping with reduced 
abundance of Lck.  
These results suggested that at early time points, reduced Lck expression 
compromised proximal phosphorylation efficiency, as has been previously 
shown (Lovatt et al., 2006). There was decreased phosphorylation of pLckY505, 
but whether this was a result of changes in the activity of negative regulators 
of Lck, for example, Csk or CD45, or simply a reflection of the reduced total 
amount of Lck in not clear. Potentially, reduced pLckY505 expression could 
explain why F5LckVA T cells upregulated activation markers as efficiently as 
F5LckWT cells (Fig.4.2), as reduced Lck expression could mean reduced 
induction of negative regulation and consequently a more active Lck 
molecule. 
4.2.4 ERK phosphorylation was reduced in F5LckVA T cells 
Further downstream in the TCR signalling pathway is the MAPK/ERK 
pathway. The ERK cascade is important for cellular proliferation, 
differentiation, and survival. Several studies have shown that the ERK 
pathway can be differentially regulated, depending on the strength of the 
signal, and this can lead to biologically divergent outcomes (Daniels et al., 
2006; Inder et al., 2008). Given that the immediate proximal signalling 
downstream of Lck was reduced in F5LckVA T cells (Fig.4.3), yet activation 
marker upregulation was equivalent to F5LckWT cells (Fig.4.2), we asked 
whether F5LckVA and F5LckWT mice differed in their activation of ERK.   
Chapter 4 
  118 
 
 
Fig. 4.4 Low levels of Lck expression reduced ERK activation in F5 T cells in response 
to peptide stimulation. 
LN cells from F5LckVA and F5WT mice were stimulated for indicated times with 1x10-7M NP68. 
Media only, PdBU, and UO126 treated samples were analysed as controls. (A) 
Representative histograms show intracellular pERK staining in F5LckWT (top panel) and 
F5LckVA (bottom panel) CD8+ T cells. (B) Representative histograms show overlays of 
intracellular pERK staining in F5 T cells on indicated backgrounds following stimulation for 
120 min with media (green) and 1x10-7 M NP68 (black line). The controls were treated for 15 
min with UO126 and then stimulated for 15min with 1x10-7 M NP68 (dark fill), or treated 
with PdBU alone for 15 min (red dashed line). (C) Bar graph shows average proportions of 
CD8+pERK+ cells ± SD, over the indicated time-course. (D) Mean MFIs ± SD for pERK+ cells in 
response to peptide stimulation were calculated from the formula (exp – UO126)/(total – 
UO126) x 100%, where exp is the MFI of the pERK+ gate from the peptide-stimulated sample, 
UO126 is the MFI of the UO126-inhibited sample and total is the MFI of the pERK+ gate from 
the PdBU stimulated sample. Data are representative of two independent experiments with 
3 mice pooled per genotype. Significance was calculated on Prism: parametric, student’s t-
test, unpaired, two-tailed *P<0.05, **P<0.01, ***P<0.001.  
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To assess ERK phosphorylation (pERK) in F5LckWT and F5LckVA mice, cells 
were stimulated in vitro with 0.1 &M NP68 for different lengths of time, and 
pERK was quantified at a single-cell level by flow cytometry (Fig.4.4.). The 
specificity of the pERK antibody was controlled by using a specific MEK 
inhibitor UO126 to pre-treat control samples. In F5LckWT cells, there was some 
background pERK staining in the UO126 treated cells, as 9% fell into the 
positive gate which was set on the unstimulated control. This was slightly 
higher than background levels in untreated F5LckWT cells (1.8%), but was 
possibly due to the way the gate was set rather than genuine pERK 
upregulation, as the clear positive pERK peak present in stimulated samples 
was inhibited (Fig.4.4A and B). The results in Fig.4.4C showed that the 
availability of Lck had a direct and significant effect on the proportions of 
cells that phosphorylated ERK. ERK phosphorylation was always 2-fold 
higher in F5LckWT cells at all time points tested, compared to F5LckVA cells 
(Fig.4.4C). However, the proportions of cells responding increased with time 
for both genotypes. The defect in ERK phosphorylation, seen in F5LckVA cells, 
was shown to be TCR-signalling dependent as, in response to PdBU 
stimulation, similar proportions of cells phosphorylated ERK in the two 
genotypes (Fig.4.4A and B). The MFI of pERK was reduced by ~1.2-1.5 fold in 
F5LckVA cells compared to F5LckWT at all time points tested (Fig.4.4D). 
These data were in agreement with results in Fig.4.3, which suggested that 
reduced Lck abundance in F5LckVA cells reduced phosphorylation of 
immediate targets. One of these was adapter molecule Shc (Fig.4.3D), and 
Shc feeds into the ERK pathway via Grb/SOS (Lovatt et al., 2006; Walk et al., 
1998).  
These data are also in agreement with published results by Lovatt et al., who 
showed that despite a more than 95% reduction in the phosphorylation of 
Zap-70, PLCγ, and LAT in the absence of Lck expression, pERK was still in 
the order of 10-30% of WT levels (Lovatt et al., 2006). They also showed that 
Fyn contributes to activation of the ERK pathway via a PLC-γ1/RasGRP1 
independent pathway, and influences the magnitude of pERK expression, 
Chapter 4 
  120 
whereas Lck controls the threshold of triggering (Lovatt et al., 2006). We did 
not assess the contribution of Fyn in this experiment. 
4.2.5 S6(S235/236) phosphorylation was reduced in F5LckVA T 
cells  
Upon T cell activation, mRNA translation and protein synthesis are 
upregulated due to the increased demand in T cells for proteins, lipids, 
nucleic acids, and ATP for sustaining growth, proliferation, and the 
acquisition of effector function (Wang and Green, 2012). The mTOR 
signalling pathway integrates and relays environmental signals to the 
nucleus, in an effort to regulate growth, metabolism, and survival (Mills and 
Jameson, 2009). One of the main substrates of the rapamycin-sensitive 
complex with raptor (mTORC1) is the ribosomal protein S6 kinase (S6K) 
(Chung et al., 1992).  One of the substrates of S6K is the ribosomal protein S6 
(rpS6) that is involved in ribosomal biogenesis. It has been shown that TCR 
stimulation of S6-heterozygous T cells led to normal cell growth, but cell 
cycle progression was impaired, exemplifying the importance of ribosomal 
biogenesis in T cells (Sulic et al., 2005). Additionally, it has previously been 
shown in F5Lckind mice that phosphorylation of rpS6 is downstream of TCR 
signalling, and hence, Lck dependent (Salmond et al., 2009a). We measured 
phosphorylation of rpS6 at residues S235/236 (pS6S235/236) in F5LckVA cells at 
different times after in vitro NP68 stimulation. 
The results in Fig.4.5A-C showed that at each time point indicated, 
proportionally fewer F5LckVA cells had phosphorylated pS6S235/236 compared to 
F5LckWT cells. By two hours of peptide stimulation, 47.5% of F5LckWT CD8 T 
cells are positive for pS6S235/236, but only 29.3% of F5LckVA had phosphorylated 
S6S235/236. The amount of pS6S235/236 expressed per cell at all time points is similar in 
F5LckVA cells as compared to F5LckWT (Fig.4.5D). These data fell in line with a 
previous study that suggested reduced Lck expression leads to reduced S6 
phosphorylation (Salmond et al., 2009a). 
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Fig. 4.5 F5LckVA T cells had reduced S6(S235/236) phosphorylation in response to peptide 
stimulation compared to F5LckWT T cells. 
LN cells from age matched F5LckVA and F5LckWT mice were stimulated for the indicated times 
with 1x10-7 M NP68. Samples treated with media only, 15min PdBU, and UO126 inhibitor 
were analysed as controls. (A) Representative histograms show intracellular pS6S235/236 staining 
in CD8+ F5LckWT (top panel) and F5LckVA (bottom panel) cells. Numbers on the graphs are 
average proportions pS6S235/236 cells ± SD. (B) Representative histograms show overlays of 
intracellular pS6S235/236 staining in F5 T cells on indicated backgrounds following stimulation for 
120 min with media (green line) and peptide (black line). The controls were treated for 15 
min with UO126 and then stimulated for 15min with peptide (dark fill), or treated with 
PdBU for 15 min (red dashed line). (C) Bar graph shows average proportions of CD8+ pS6+ T 
cells for triplicate samples  ± SD, in F5LckWT and F5LckVA cells. (D) Mean MFIs ± SD for pS6+ 
cells were calculated from the formula (exp – UO126)/(total – UO126) x 100%, where exp is 
the MFI of the pS6+ gate from the peptide-stimulated sample, UO126 is the MFI of the UO126 
inhibited sample and total is the MFI of the pS6+ gate from the PdBU stimulated sample. 
Data are representative of two independent experiments with 3 mice pooled per genotype 
and treated in technical triplicates. Significance was calculated on Prism: parametric, 
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4.2.6 F5LckVA T cells phosphorylated LckSer-59 as efficiently as 
F5LckWT T cells 
It has been shown that ERK can phosphorylate Lck at serine residue 59 
(pLckSer-59) in the N terminus (Watts et al., 1993; Winkler et al., 1993). Initially, 
Ser-59 phosphorylation was thought to have a negative effect on T cell 
activation (Watts et al., 1993).  However, later research has found that Ser-59 
phosphorylation on Lck modified Lck SH2 domain affinity (Joung et al., 
1995) for tyrosine phosphorylated SHP1, and thus reduced the interaction of 
SHP1 with Lck (Stefanova et al., 2003). SHP1 has been identified as a 
negative regulator of TCR signalling (Pani et al., 1996). Stefanova et al. went 
on to show that ERK mediated phosphorylation of Lck at Ser-59 interfered 
with SHP1 binding, thereby allowing for continuation of the activation 
cascade (Stefanova et al., 2003). 
We therefore wished to know whether the reduced ERK activation in F5LckVA 
T cells was sufficient to initiate Ser-59 phosphorylation of Lck. Potentially, 
this would allow F5LckVA cells to overcome negative regulation by SHP1 and 
continue signalling. To this end, F5LckWT and F5LckVA T cells were stimulated 
for different times with 1 &M NP68, and the cell lysates were blotted with 
anti-Lck or anti-V5 tag, respectively. Ser-59 phosphorylation causes 
retardation of the protein mobility in SDS/PAGE (Winkler et al., 1993), and 
the specific band can be visualised above the unphosphorylated Lck band.  
The data in figure 4.6 showed that over time, the pLckSer-59 band appeared 
above the total Lck (56 kDa) band in both F5LckWT and F5LckVA T cells. The 
percentage of pLckSer-59 of total Lck was calculated, and both F5LckVA T cells 
(44.8%) and F5LckWT T cells (47.3%) were found to contain equivalent amounts 
of pLckSer-59 at 60 and 120 minutes, which appeared with indistinguishable 
kinetics. These results suggested that despite reduced ERK phosphorylation, 
the threshold for ERK to carry out its effector function and phosphorylate 
Ser-59 on Lck has been overcome in F5LckVA T cells by these later time points.   
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Fig. 4.6 F5LckVA cells have equal phosphorylation of Ser-59 of Lck to F5LckWT  
LN cells from F5LckWT and F5LckVA mice were stimulated with 1 &M NP68 for the indicated 
times. Lysates were resolved by SDS/PAGE on a big gel overnight (Methods 2.11.4). F5LckWT 
and F5LckVA were probed with anti-Lck and anti-V5 tag, respectively, followed by detection 
with goat anti-mouse AF680. Blots were analysed using the Li-Cor Odyssey machine. The 
percentage of Ser-59 phosphorylation of Lck was calculated using the following equation: 
(pLckSer-59 x 100) / (p56 Lck + pLckSer-59). Data are representative of three independent 
experiments. The full blot can be found in Appendix 7.3. 
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ERK phosphorylation is downstream of PLC-γ, which hydrolyzes PIP2 to 
produce IP3 and DAG. DAG recruits RasGRP1, which leads to the activation 
of the MAPK cascade. It has recently been shown that bifurcation of 
signalling into different branches can already occur at the level of ITAM 
phosphorylation (Guy et al., 2013).  Guy et al. modified the number of intact 
ITAM subunits, and identified that low multiplicity of ITAMs was sufficient 
for cytokine production, whereas high ITAM multiplicity was required for 
TCR-driven proliferation (Guy et al., 2013). Seeing that phosphorylation of 
ERK was reduced (Fig.4.4), but overnight activation of T cells was equal to 
F5LckWT cells in F5LckVA T cells (Fig.4.2), we wondered whether another 
branch of the TCR signalling cascade was behaving differently. For this 
reason, Ca2+ mobilization was assessed, although it is also downstream of 
PLC-γ1 it signals via IP3 as opposed to DAG (Winslow et al., 2003).  
4.2.7 Ca2+ flux was more efficient in F5LckVA than F5LckWT T 
cells 
The regulation of Ca2+ in response to TCR engagement and activation of 
adapter proteins is a critical part of T cell activation. The influx of Ca2+ is a 
mediator for several Ca2+ - dependent pathways that lead to differentiation, 
effector function and gene transcription (Nagaleekar et al., 2008; Oh-hora and 
Rao, 2008). Ca2+ flux has been shown to be defective in cells lacking Lck 
(Straus and Weiss, 1992; Trobridge and Levin, 2001), as well as in CD4+ T 
cells in Lckind mice (Lovatt et al., 2006). Therefore, we wanted to assess Ca2+ 
flux in peripheral T cells in F5LckVA mice, which have <5% of WT levels of 
Lck.  
F5LckWT and F5LckVA LN cells were labelled with different concentrations of 
CFSE (Fig.4.7A). Cells were subsequently pooled, loaded with Indo-1, and 
stimulated by crosslinking biotin labelled TCR and CD8 with streptavidin. 
Indo-1 allows for calcium flux measurement, as it is a ratiometric dye. It 
changes spectral properties whether it is bound to calcium (emits at 390nm 
Violet) or unbound (emits at 500nm Blue), and the ratio is used as a measure 
of calcium flux. Upon crosslinking TCR and CD8, it was seen that F5LckVA 
(blue line) responded faster to stimulation by fluxing Ca2+ slightly before 
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F5LckWT (black line). F5LckVA T cells also had increased Ca2+ compared to 
F5LckWT as indicated by the higher ratio of Indo-1 (Blue)/ Indo-1 (Violet), 
suggesting that there was more unbound Ca2+ in F5LckVA mice (Fig.4.7B). 
Additional control experiments with crosslinking of TCR or CD3 alone 
showed similarly faster Ca2+ flux in F5LckVA T cells compared to F5LckWT T 
cells, although the results were not as obvious as with crosslinking CD8 and 
TCR, which would be predicted from Lck being co-receptor associated 
(Fig.4.7C). Crosslinking with anti-CD8 alone or stimulating with NP68 did 
not induce Ca2+ flux (Fig.4.7C).  
The above result of F5LckVA triggering Ca2+ flux more efficiently than F5LckWT 
was surprising, because the F5LckVA cells were found to be less efficient in 
activation of upstream mediators of the TCR signaling cascade, e.g. 
phosphorylation of Zap-70Y394 and downstream molecules like ERK (Fig.4.4). 
The MAPK pathway and Ca2+ signalling pathways converge at the level of 
PIP2, downstream of TCR-signalling, from where IP3 mediates Ca2+ signalling, 
and DAG via RasGRP1 and Ras mediates the MAPK pathway (Brownlie and 
Zamoyska, 2013). It is hard to envision how pathways that converge so close 
to the TCR-trigger can be split in their regulation, but one conceivable 
explanation is that it occurs at the level of negative feedback loops. The 
activation of Ca2+ signaling is an early event – within 4 minutes of TCR 
stimulation, whereas ERK phosphorylation occurs later at around 15 min 
according to our data (Fig.4.4). Perhaps, reduced Lck expression is not 
sufficient to trigger early negative regulators like Dok1 and 2, adaptor 
proteins that have been suggested to antagonise Zap-70 binding to ITAMs 
(Dong et al., 2006; Yasuda et al., 2007), however, at later time points this may 
not be an issue, as F5LckVA activating equally efficiently to F5LckWT at 24h 
would suggest (Fig.4.2). It should be noted, however, that ERK 
phosphorylation was assessed in response to peptide stimulation, whereas 
Ca2+ flux was assessed by CD8 and TCR crosslinking and these two stimuli 
are not exactly equivalent. 
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Fig. 4.7 Ca2+ was induced faster in F5LckVA T cells compared to F5LckWT T cells. 
Naïve LN T cells from F5LckWT and F5LckVA mice were loaded with 2 &M Indo-1 and 
examined for Ca2+ flux by flow cytometry (A) F5LckWT and F5LckVA were labelled with different 
concentrations of CFSE: 0.1 &M and 0.01 &M respectively, and pooled into one FACS tube in 
a 1:1 ratio. (B) Arrows indicate induction of Ca2+ flux by addition of streptavidin after 45 
seconds to crosslink anti-TCR and CD8, and Ionomycin after 8 minutes as a positive control. 
(C) Additional indicated conditions for inducing Ca2+ flux were used as controls. Data are 
representative of 1-3 independent experiments. The CFSE staining concentrations for the cell 
types were alternated between each experiment.  
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4.2.8 IL-2 production was enhanced in F5LckVA T cells  
Ca2+ signalling has been shown to be important for IL-2 and IFNγ production 
in T cells (Nagaleekar et al., 2008), as well as cell metabolism and 
proliferation (Fracchia et al., 2013). Therefore, the next set of experiments was 
designed to establish what impact such branching of signalling may have 
had on downstream pathways such as cytokine production, proliferation and 
effector function, and how they compared between F5LckWT and F5LckVA T 
cells. 
IL-2 is a well-known and important cytokine. On the one hand it induces T-
cell expansion, effector differentiation, and memory cell survival.  On the 
other hand, it controls the contraction of inflammatory responses by 
promoting growth and survival of TRegs and stimulating AICD (Martins et al., 
2008).  
CD25 expression in response to TCR derived signals was equivalent between 
F5LckVA and F5LckWT T cells (Fig.4.2). IL-2 binds the high affinity receptor 
CD25, creating a positive feedback loop via STAT5 leading to further CD25 
expression (Kim 2001, Smith and Cantrell 1985). We assessed the capacity of 
F5LckVA T cells to produce IL-2. To this end, F5LckWT and F5LckVA T cells were 
simulated with a titration of NP68 for 24h and 48h, after which IL-2 
production was measured by ELISA. 
The results in Fig.4.8A showed that IL-2 production at 24h in F5LckWT cells 
reached a plateau after stimulation with 1.1x10-4&M NP68, whereas in F5LckVA 
there was a dose dependent increase until they produced significantly 
(p=0.0011) more than F5LckWT at the highest concentration of stimulation. 
Overall, at 48h the IL-2 production in both F5LckWT and F5LckVA cells was lower 
than at 24h, as can be seen from the smaller y-axis scale. Yet, at all 
concentrations of NP68 stimulation at 48h, F5LckVA cells produced 
significantly higher levels of IL-2 than F5LckWT cells, except at the lowest 
concentration. Care should be taken in the interpretation of these data as 
only one experiment has been done, and at 48h the data may reflect   
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Fig. 4.8 F5LckVA T cells activated with NP68 produced more IL-2 than F5LckWT T cells. 
LN cells from F5LckWT and F5LckVA mice (n=5-7) were activated in triplicate with indicated 
concentrations of NP68 for (A) 24h and (B) 48h. IL-2 production was assessed by ELISA and 
plotted as average pg mL-1 ± SD. Data are representative of one experiment. Significance was 
calculated on Prism: parametric, student’s t-test, unpaired, two-tailed *P<0.05, **P<0.01, 
***P<0.001.   
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differences in consumption as well as be hampered by the sensitivity of an 
ELISA at such low pg ml-1 levels. 
Intriguingly, however, Joanna Klezckowska (unpublished data) showed that 
the IL-2 mRNA expression in F5Lckind T cells peaked later than in F5LckWT T 
cells and remained up for a more prolonged period of time. However, on a 
protein level, Lovatt et al. showed that in polyclonal Lckind CD4+ T cells IL-2 
production was less than in LckWT cells after 24h in culture with anti-CD3 and 
anti-CD28 stimulation (Lovatt et al., 2006). These differences may also reflect 
differences between CD4+ and CD8+ T cells. 
The role of IL-2 in T cell function is multifaceted (Malek, 2008), including 
roles in sustaining cell division by increasing cell cycling or cell survival -
functions that led to its initial identification (Gillis and Smith, 1977; Morgan 
et al., 1976; Taniguchi et al., 1983). Therefore, in light of the results in Fig.4.8 
suggesting that F5LckVA T cells produce more IL-2, the next section looks at 
their proliferation and survival potential. 
4.2.9 F5LckVA T cells had enhanced proliferation 
Upon antigen recognition, T cells become activated and follow a very typical 
response pattern of expansion, differentiation, contraction, and memory 
formation. In order to address if the increased IL-2 production in F5LckVA T 
cells correlated with proliferative capacity, both F5LckVA and F5LckWT T cells 
were labelled with Cell Tracer Violet, and stimulated with different 
concentrations of NP68 for different times. Proliferation was measured as 
dilution of Cell Tracer and assessed by FACS. 
The results in Fig.4.9A showed that both F5LckWT and F5LckVA T cells had 
divided at 24h as seen from the dilution of Cell Trace. Qualitative analysis 
revealed that already on day 2 at a concentration of 1.2x10-10M peptide, 
F5LckVA (purple line) had diluted Cell Tracer more. This trend was also 
evident at lower concentrations of peptide on days 3 and 4. Quantitative 
analysis was done using the proliferation index parameter calculated by 
FlowJo software as shown in Fig.4.9B. The proliferation index is a measure of   
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Fig. 4.9 F5LckVA T cells proliferated more upon stimulation with NP68. 
LN cells were pooled from 10 F5LckWT and 12 F5LckVA mice and stained with Cell Violet and 
stimulated for 4 consecutive days in triplicate in 96-well plates with indicated concentrations 
of NP68. (A) Representative overlays of FACS histograms show Cell Violet staining on days 
2, 3 and 4 in CD8+ F5LckWT (grey) and F5LckVA (pink). T cells were cultured in either media 
alone or with IL-7 as controls. On day 4 a Cell Violet high peak has reappeared on most 
histograms, which is probably autofluoresence of dead cells as it is unlikely that 
unproliferated cells would reappear. (B) Shown is the gating strategy for calculating 
proliferation index on FlowJo. First cells were gated as live based on SSC and FSC then the 
doublets are excluded using FSC-A and FSC-H, finally only CD8+ cells were gated for Cell 
Violet histograms. FlowJo was used to calculate the proliferation index. (C) Bar charts show 
the average proliferation index calculated for days 2, 3 and 4 in F5LckWT (grey) and F5LckVA 
(pink) T cells at indicated concentrations of NP68 stimulation. Data are representative of 3 
independent experiments. Statistical significance was calculated on Prism: multiple t-tests 
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the total number of cell divisions divided by the number of cells that went 
into division. This measure only takes into account the cells that underwent 
at least one division. The results of the evaluation shown in Fig.4.9C 
confirmed what was seen qualitatively in Fig.4.9A, that F5LckVA proliferated 
significantly more rounds of division than F5LckWT on all days and at almost 
all concentrations of peptide stimulation. 
From the above result, that F5LckVA proliferated more (Fig.4.9), it was not 
possible to discern whether this was the result of increased IL-2 production – 
especially since CD8 T cells have been shown to proliferate also in the 
absence of IL-2 (Kramer et al., 1994). Our results suggested that F5LckVA T 
cells had more efficient Ca2+ flux (Fig.4.7) and increased Il-2 production 
(Fig.4.8), that in combination with the increased proliferative capacity 
(Fig.4.9) suggest a potential correlation between these pathways. In addition 
to its effects on proliferation, IL-2 has been shown to potentiate T cell 
survival by up-regulating the anti-apoptotic molecule Bcl-2 (Lord et al., 
1998). The next experiment was therefore designed to compare Bcl-2 
expression between F5LckWT and F5LckVA T cells. 
4.2.10 F5LckVA T cells had increased Bcl-2 expression 
The 12 core Bcl2 family proteins are characterised by homologous domains 
that allow for interactions between the family members, and can either 
promote or inhibit cell apoptosis (Youle and Strasser, 2008). Bcl-2 and Bcl-XL 
are pro-survival molecules and possess four domains, BH1, 2 and 4, which 
are defined by a hydrophobic groove within the molecule to allow the 
binding of the fourth BH3 domain. Others, such as Bax and Bak, are pro-
apoptotic members and possess the domains BH1-3, which can create large 
pores in membranes in the cell, e.g. the mitochondrial membrane to release 
cytochrome c (Wyllie, 2010). The pro-survival family members, such as Bcl-2 
and Bcl-XL, inhibit Bax and Bak, thereby preventing their pro-apoptotic 
actions (Youle and Strasser, 2008). 
Data by Joanna Klezckowska showed that F5Lckind cells express higher levels 
of Bcl-2 than WT cells after a 48 hour peptide NP68 stimulation (unpublished 
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data). In addition, although Caserta et al. did not find differences in Bcl-2 
expression in Lckind cells, they did find the expression of other exhaustion 
markers, such as KLRG1 and PD1 to be reduced in the TCM pool, suggesting 
that decreased Lck levels are beneficial for TCM population survival and 
expansion (Caserta et al., 2010).  
In order to assess whether Bcl-2 expression was upregulated in F5LckVA T 
cells, as may be predicted from increased IL-2 production (Fig.4.8) and 
increased proliferation (Fig.4.9), the MFI of Bcl-2 expression was measured ex 
vivo (Fig.4.10A) and upon activation (Fig.4.10B and C). 
The results indicated that ex vivo expression of Bcl-2 was significantly higher 
in F5LckVA T cells (MFI = 5.2±0.17) as compared to F5LckWT cells (MFI = 
3.9±0.02) (Fig.4.10A). In addition, Bcl-2 expression was also higher in F5LckVA 
cells throughout a 48-hour peptide stimulation, as was seen from the 
histogram overlays in Fig.4.10B at different concentrations of NP68. In both 
F5LckWT and F5LckVA T cells, the expression of Bcl-2 was maintained 
throughout cell division when plotted against Cell Trace in Fig.4.10C. 
However, at each dividing peak Bcl-2 expression was higher in F5LckVA cells 
(blue) than in F5LckWT (black) T cells. These results suggested that there was a 
correlation between the increased IL-2 production, increased proliferation, 
and increased Bcl-2 expression seen in F5LckVA T cells. 
4.2.11 Effector T cells in F5LckVA produced more IFNγ and 
TNFα than F5LckWT T cells  
As a naïve CD8+ T cell differentiates into an effector CD8+ T cell, it acquires a 
different gene expression pattern that allows it to carry out cytotoxic 
functions and to produce antiviral cytokines (Joshi and Kaech, 2008) – a 
process that is potentially linked to the proliferative programme (Oehen and 
Brduscha-Riem, 1998). Our results showed that reduced Lck expression 
increased the proliferative capacity of CD8+ T cells in F5LckVA mice, 
potentially by increased IL-2 production and Bcl-2 production. We wished to 
assess whether and how reduced Lck expression affected the generation of 
CTL function in vitro.  
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Fig. 4.10 Bcl-2 expression was enhanced in F5LckVA CD8+ T Cells 
LN cells were pooled from 10 F5LckWT and 12 F5LckVA mice, and stimulated for 4 consecutive 
days in a 96-well plate in triplicate with a titration of NP68. Bcl-2 expression was measured 
by intracellular staining. (A) Bar graph shows average MFI in CD8+ T cells of technical 
triplicates ± SD of Bcl-2 expression measured ex vivo. Significance was tested with an 
unpaired, two-tailed, students t-test, ***p=0.0002. (B) FACS histograms show Bcl-2 
expression on Day 2 in F5LckWT (black) and F5LckVA (blue) cells at different concentrations of 
NP68 stimulation. Bcl-2 expression was measured by intracellular staining after triplicate 
wells were pooled.  (C) Dot plots show Bcl-2 expression (Y-axis) versus Cell Violet staining 
(X-axis) on Day 2 in CD8+ F5LckWT (black) and F5LckVA  (blue) cells. Similar results were 
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Fig. 4.11 F5LckVA T cells produced more IFNγ and TNFα than F5LckWT T cells after 
activation. 
30x106 LN cells from F5LckWT and F5LckVA mice were cultured in cell culture medium with 100 
nM NP68 for 72 hours. Cells were restimulated in triplicate for 6 hours with different 
concentrations of NP68 in a 96-well plate with Brefeldin-A.  (A) Representative dot plots 
show TNFα and IFNγ production as measured by intracellular staining. Controls used were 
media only, PdBU/Ionomycin treatment, and IL-2 treatment. (B) The bar charts show the 
mean ± SD proportions of CD8+ T cells producing IFNγ or (C) TNFα. Data are representative 
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Since the activation of effector function is downstream of TCR engagement, 
we assessed the production of IFNγ and TNFα, two effector cytokines, in 
response to NP68 stimulation in F5LckWT and F5LckVA T cells. We cultured cells 
with 100 nM NP68 for 3 days and then restimulated them with different 
concentrations of NP68 for 6h in the presence of Brefeldin-A. Figure 4.11A 
showed that both F5LckWT and F5LckVA T cells had the potential to produce 
IFNγ and TNFα upon restimulation in a peptide specific manner, as the level 
of detected cytokine was above that of media only samples (negative 
control). In response to PdBU/Iono stimulation, approximately 60% of T cells 
in both F5LckWT and F5LckVA mice produced IFNγ and approximately 55% 
produced TNFα. The titrations of NP68 did not cover enough of a range to 
produce a dose response curve, but despite this it was noted that F5LckVA 
consistently produced more IFNγ and TNFα at each concentration of NP68 
stimulation than F5LckWT cells. 
4.2.12 F5LckVA T cells produced less cytokine upon 
restimulation after culture in IL-2  
The CD8+ T cell response has two goals, firstly, to quickly generate enough 
CTLs to clear the infection and, secondly, to retain a subset of memory cells 
that would act faster, should the same pathogen be encountered again. 
Antigen-experienced T cells are activated by 10 to 50-fold lower peptide 
concentration than naïve T cells (Pihlgren et al., 1996). One theory is that 
antigen-experienced CD8+T cells have an altered and more efficient signal 
transduction cascade, potentially due to the differential spatial 
reorganization of negative regulators of TCR signal mediators (Borger et al., 
2013).  
In an attempt to mimic an antigen re-encounter in vitro, antigen-experienced 
cells from F5LckWT and F5LckVA T cells were produced as shown in Fig.4.12A. 
Cells were cultured with 100 nM of NP68 for 2 days and then grown in 20 ng 
mL-1 of IL-2 for a further 2 days. On the 4th day, cells were recalled with 
different concentrations of NP68 over 6 hours (Fig.4.12A). The production of 
IFNγ and TNFα was determined using intracellular staining. Figure 4.12B 
showed that both F5LckWT and F5LckVA produced IFNγ and TNFα in a  
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Fig. 4.12 Antigen-experienced F5LckVA T cells had increased threshold for IFNγ and 
TNFα production. 
(A) F5LckWT (pool of n=3) and F5LckVA (pool of n=3) LN T cells were cultured for 2 days with 
100 nM NP68 followed by 2 days with 20 ng mL-1 of IL-2 to produce antigen-experienced 
cells. On day 4 cells were restimulated in triplicate with different concentrations of NP68 for 
6 hours in the presence of Brefeldin-A. Line graphs show (B) the average proportions ± SD 
and (C) the average MFIs ± SD of CD8+IFNγ+ F5LckWT and F5LckVA T cells at different 
concentrations of peptide. Similarly, line graphs show (D) the average proportions ± SD and 
(E) the MFIs ± SD of CD8+TNFα+ F5LckWT and F5LckVA T cells at different concentrations of 
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dose-dependent manner in response to NP68 restimulation. F5LckVA T cells 
had an increased threshold for IFNγ (Fig.4.12B) and TNFα (Fig.4.12D) 
production compared to F5LckWT T cells, meaning a higher peptide 
concentration was required to reach similar proportions of cytokine 
producing cells. This observation was in agreement with published data, that 
reduced Lck expression increased the activation threshold (Caserta et al., 
2010; Lovatt et al., 2006). We showed that in naïve F5LckVA T cells the 
activation threshold was the same as in F5LckWT T cells (Fig.4.2), and that 
cytokine production upon naïve cell stimulation was increased in F5LckVA T 
cells as compared to F5LckWT T cells (Fig.4.11). Thus, the current result 
potentially suggested that the provision of IL-2 has changed the activation 
threshold in F5LckVA T cells.  At the highest concentration of NP68 stimulation 
tested (1x10-9M), proportions of F5LckVA (99.7%) and F5LckWT (99.6%) cells 
producing IFNγ (Fig.4.12B) were the same. For TNFα production, the 
proportions of cells were also very similar; F5LckVA (67%) and F5LckWT (77%) 
(Fig.4.12D).  
The MFI of IFNγ or TNFα expression can give an indication of the amount of 
cytokine produced per cell. Data in the line graph in figure 4.12C showed, 
that F5LckWT T cells produced more IFNγ per cell than F5LckVA T cells, up until 
the highest concentration of stimulation 1x10-9M. Contrastingly, figure 4.12E 
showed that in the case of TNFα, reduced Lck expression posed no limitation 
for the amount of cytokine produced per cell, despite the proportions of 
F5LckVA T cells being lower than F5LckWT (Fig.4.12D). The MFI of TNFα at 
lower concentrations of NP68 stimulation was the same, and at higher 
concentrations even higher, in F5LckVA than F5LckWT T cells (Fig.4.12E). Overall, 
the data showed that similar proportions of antigen-experienced F5LckVA T 
cells were able to produce similar amounts of cytokine as F5LckVA T cells, 
once the activation threshold was overcome.  
Two key molecules in effector and memory potential development are T-bet 
and Eomes (Kaech and Cui, 2012). T-bet and Eomes are transcription factors 
upregulated upon TCR engagement (Intlekofer et al., 2005; Sullivan et al., 
2003). They are partially redundant in their roles of inducing genes necessary 
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for CTLs such as IFNγ, granzyme B, perforin, CXCR3, and CXCR4 (Intlekofer 
et al., 2005; Kaech and Cui, 2012).   
The results in Fig.4.11 and 4.12 indicated differences between F5LckWT and 
F5LckVA cells in the initial production of IFNγ and TNFα. Therefore, we asked 
whether there were also differences in the expression patterns of T-bet and 
Eomes. Fig.4.13A showed that both F5LckWT and F5LckVA cells upregulated 
Tbet and Eomes in response to TCR stimulation by day 2. An overlay of 
F5LckWT and F5LckVA suggested that F5LckVA expressed slightly higher levels of 
both T-bet and Eomes on day 2. By day 4, T-bet expression was equal 
between F5LckWT and F5LckVA T cells, and F5LckWT seemed to express slightly 
more Eomes than F5LckVA.  
T-bet and Eomes are known to cooperate to sustain memory T cell 
homeostasis by expression of IL-2Rβ (CD122), which allows for IL-15-
mediated signalling and the homeostatic proliferation of memory cells 
(Kaech and Cui, 2012). Therefore, expression of CD122 was assessed as a 
further read out of the cooperative functions of T-bet and Eomes. In both 
F5LckWT and F5LckVA T cells, CD122 expression was upregulated after two 
days of activation (Fig.4.13B), and there was no difference between the two 
cell types as evidenced by overlayed histograms.  
As mentioned above, both T-bet and Eomes are important for controlling the 
expression of effector molecule genes such as granzyme B (Intlekofer et al., 
2005). Granzymes are serine endopeptidases expressed by CTLs, and are 
released to the intercellular space to eliminate infected cells (Odake et al., 
1991; Poe et al., 1991). Eomes has been shown to bind directly to the 
granzyme B promoter (Sullivan et al., 2003). Therefore, granzyme B 
expression was assessed as a further read out of the effector capacity on day 
2 of activation. Figure 4.13B showed that F5LckVA and F5LckWT T cells both 
upregulated granzyme B expression upon activation by day 2. However, 
F5LckVA T cells expressed higher levels of granzyme B, as determined by 
histogram analysis. On the 4th day, granzyme B expression was still slightly 
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Fig. 4.13 Expression patterns of T-bet and Eomes at different times of antigen-
experienced cell generation. 
F5LckWT (black line) and F5LckVA (blue line) LN T cells from 3 animals of each genotype were 
cultured for 2 days with 100 nM NP68 and a further 2 days with 20 ng mL-1 IL-2. The cells 
were stained and analysed by flow cytometry at indicated time points for the indicated 
molecules (A, B and C). Day 0 samples (filled grey) were fixed until day 2 samples were 
obtained and also fixed in order to stain and acquire them simultaneously. These data are 
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higher in F5LckVA T cells, but the difference between expression in F5LckWT 
and F5LckVA cells decreased. 
Naive T cells depend on IL-7 signals via CD127 for survival (Tan et al., 2001). 
It has been shown that CD127 expression is downregulated in T cell 
activation by in vivo infection, and is upregulated again in memory cells (Best 
et al., 2013). Indeed, memory cell generation and maintenance have been 
shown to be IL-7 dependent, potentially by upregulating Bcl-2 (Schluns et al., 
2000). Interestingly, our results showed that CD127 expression was low on 
day 0 and upregulated on day 2 of in vitro stimulation in both F5LckWT and 
F5LckVA T cells (Fig.4.13C). CD127 expression was modestly higher in F5LckVA 
T cells, which was in correlation with our findings in Fig.4.10, showing 
increased Bcl-2 expression in F5LckVA T cells. 
These results suggested that although initially F5LckVA T cells had an 
increased activation threshold in upregulating IFNγ and TNFα as antigen-
experienced cells (Fig.4.12), they reached proportionally the same levels of 
expression as F5LckWT T cells at higher concentrations. This suggested that 
reduced Lck expression increased the threshold of activation required for 
cytokine production in the presence of IL-2. There appeared to be no defects 
in the transcriptional regulation of cytokine production as a result of 
increased threshold of cytokine production in F5LckVA T cells, since T-bet and 
Eomes expression were similar to F5LckWT T cells (Fig.4.13A).  Finally, 
granzyme B expression was enhanced in F5LckVA T cells as compared to 
F5LckWT T cells after 2 days of activation, perhaps a reflection of their more 
proliferative state (Fig.4.9), and increased cytokine production upon 
stimulation of naïve cells also seen after 2 days of activation (Fig.4.11).  
4.2.13 Phosphorylation of p38 was enhanced in F5LckVA T 
cells 
The data in this chapter have so far been highly indicative of differential 
branching of signalling pathways post-TCR stimulation, as some of the read-
outs of functional consequences were upregulated when compared to F5LckWT 
(proliferation, Ca2+ flux) and others were downregulated (pERK, cytokine 
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production in the presence of IL-2), when Lck expression was reduced. In an 
effort to identify which upstream pathway could be responsible for the 
increased proliferation, we assessed the phosphorylation of the MAPK p38.   
TCR ligation has been shown to lead to p38 mediated proliferation and 
cytokine production by its role in phosphorylating adenylate/uridylate-rich 
element (ARE)-binding proteins (Ashwell, 2006).  ARE-binding proteins 
stabilise and increase translation of mRNAs containing 3’ UTR AREs. 
Additionally, pharmacological inhibition of p38 in humans reduces pro-
inflammatory cytokine secretion from ex vivo LPS-stimulated peripheral 
blood mononuclear cells (PBMCs) (Parasrampuria et al., 2003), suggesting 
that this pathway plays an important role in immune function. 
Upon TCR activation by p:MHC, Lck phosphorylates Zap-70, which in turn 
phosphorylates LAT. LAT activates the GTP exchange factor Vav1, which 
activates Rac1, a MAPKKK, thus leading to the activation of MKK3 and 
MKK6. MKK3 and 6 directly phosphorylate p38 on residues Thr-180 and 
Tyr-182 – the canonical pathway. The activation of p38 and ERK activation 
are both Lck dependent, however, only p38 activation was shown to be LAT 
independent (Mittelstadt et al., 2005). Interestingly, it has been found that 
Zap-70 directly activates p38 on an alternative Tyr-323 residue (Mittelstadt et 
al., 2005). The proposed reason for MAPK independent activation of p38 is 
that it may be involved in anergy, as it is active in the absence of co-
stimulation by CD28 (Mittelstadt et al., 2005). In addition, the importance of 
the alternative p38 pathways in T cells was established when mice deficient 
for the growth-arrest gene Gadd45a, that inhibits p38 phosphorylation, were 
found to harbour hyperproliferative T cells and suffer from autoimmunity 
(Salvador et al., 2005). 
Perhaps F5LckVA T cells ‘preferentially’ signalled via the p38 pathway as 
opposed to the ERK pathway. We did not have access to the antibody 
specific for the Tyr-323 residue of p38. Therefore, the phosphorylation on 
residues Thr-180 and Tyr-182, which are part of the canonical p38 activation  
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Fig. 4.14 F5LckVA T cells had enhanced p38 phosphorylation. 
F5 LckWT and F5LckVA LN T cells (n=2/genotype) were stimulated with 1 &M NP68 for the 
indicated time points. Specificity of p38 phospho-Thr180/Tyr182 antibody was controlled by 
inhibitor SB203580 treatment for 30 minutes at 37°C prior to stimulation for 6h. Since 
inhibitor and unstimulated sample (grey fill) histograms overlapped, the inhibitor sample 
(black dotted line) was used to overlay with experimental samples (blue line).  The numbers 
on the graphs represent average MFIs of technical replicates ± SD. This experiment has only 
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pathway, were assessed instead in an experiment where naïve F5 LckWT and 
F5LckVA LN T cells were stimulated for different times with 1 &M NP68. 
The results in Fig.4.14 showed that p38 phosphorylation at Thr-180/Tyr-182 
(pp38) was comparable at 6h and 12h time points between F5LckWT and 
F5LckVA T cells. At 24h, the F5LckVA pp38 MFI was already higher (239 ± 21.8) 
than in F5LckWT (219.3 ± 7.1). At 48h, in F5LckVA T cells pp38 MFI was 
upregulated by 2 fold from 24h (507.6 ± 11.7), whereas in F5LckWT T cells it 
was only upregulated slightly (229.7 ± 18.2). This result suggested that 
indeed F5LckVA T cells ‘preferentially’ signalled via p38 as opposed to ERK. 
However, it has to be noted the time courses for measuring the two MAPK 
were very different: ERK was measured for up to 2h, pp38 measurements, 
however, start from 6h, as there was no p38 phosphorylation at early times in 
preliminary experiments.  
4.2.14 Foxo1 phosphorylation was similar between F5LckVA 
and F5LckWT T cells 
Another level of regulation of cellular responses is provided by Foxo 
transcription factors, which regulate many facets of lymphocyte homeostasis, 
including differentiation, turnover, and homing (Hedrick et al., 2012). 
Phosphorylation of Foxo1 at residues T24, S256, S319, S329 (Burgering and 
Kops, 2002) by Akt, downstream of PI3K, leads to its translocation from the 
nucleus and therefore degradation and consequent repression of its 
transcriptional activity (Hedrick, 2009). PI3K activation, and subsequent Akt 
activation, can occur via TCR ligation or IL-7 mediated signalling. The latter 
of these can lead to increased expression of Bcl-2 and decreased expression of 
p27Kip1 (a cell cycle inhibitor) (Hedrick, 2009). In the case of Foxo1 deficiency, 
CD127 expression is hindered because an Il7r enhancer is no longer bound 
(Fabre et al., 2008; Kerdiles et al., 2009). Furthermore, Rao et al. made use of 
the reductionist and in vivo approach to identify Foxo1 as a critical regulator 
of T-bet and Eomes activity in CD8+ T cells (Rao et al., 2012). This further 
emphasises the role of Foxo1 in homeostasis and life span of naïve T cells as a 
means of sensing growth factor availability and fate decisions. 
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We showed that after 24h of activation, T cells with reduced Lck expression 
activated as efficiently as F5LckWT T cells (Fig.4.2). Additionally, at 48 and 72h, 
F5LckVA T cells had enhanced proliferation (Fig.4.9), Bcl-2 expression 
(Fig.4.10), and after 48 hours of activation CD127 expression was also 
enhanced (Fig.4.13C). 
In light of these results, we assessed Foxo1 phosphorylation upon activation 
of naïve LN T cells from F5LckWT and F5LckVA mice for different times with 1 
&M NP68. Foxo1 activation was measured by flow cytometry using a 
phospho-Foxo1 antibody (pFoxo1Ser-256), and its specificity was confirmed by 
using an Akt inhibitor - Ly29004. The results in figure 4.15 showed that until 
24h there was no marked increase in pFoxo1Ser-256, in either F5LckWT or F5LckVA T 
cells, as measured by MFI of expression, in comparison to the inhibitor 
treated sample. However, by 48h there was a distinct increase in pFoxo1Ser-256 
expression in both genotypes, and dividing the MFI at 48h by the MFI for the 
inhibited sample per each genotype, suggested that in F5LckWT there was a 9-
fold increase and in F5LckVA there was a 7.5 fold increase in pFoxo1Ser-256. The 
proportions of pFoxo1+ cells at the 48h time point were 45%±2.8 in F5LckWT 
and 54%±1.3 in F5LckVA T cells. These results implied that there was a modest 
increase in Foxo1 phosphorylation in F5LckVA T cells compared to F5LckWT 
cells. It must, however, be noted that this experiment has only been done 
once and the results are therefore preliminary. 
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Fig. 4.15 Foxo1 phosphorylation was similar between F5LckWT and F5LckVA T cells  
F5 LckWT and F5LckVA LN T cells (n=2/genotype) were stimulated with 1&M NP68 for the 
indicated time points. Specificity of the pFoxo1Ser-256antibody was controlled by treatment with 
1 &M Ly29004 (Akt inhibitor) for 30 minutes at 37°C prior to stimulation with 1 &M NP68 for 
6h. Since inhibitor (dotted black line) and unstimulated sample (grey fill) histograms 
overlapped, the inhibitor sample was used to overlay with experimental samples (blue line). 
The numbers on the graphs represent average MFI of technical replicates ± SD. This 
experiment has only been done once. 
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4.3 Summary 
· Phosphorylation of immediate targets of Lck: Zap-70 and Shc was 
reduced in F5LckVA mice (Fig.4.3), as was ERK phosphorylation 
(Fig.4.4). 
· T cell activation after 24h of stimulation was equivalent between 
F5LckWT T cells and F5LckVA T cells (Fig.4.2). 
· F5LckVA T cells also had enhanced Ca2+ flux (Fig.4.7), produced elevated 
levels of IL-2 after 24 and 48h of stimulation (Fig.4.8) and had a higher 
proliferative capacity (Fig.4.9) correlating with higher Bcl-2 expression 
(Fig.4.10). 
· F5LckVA T cells produced more IFNγ and TNFα than F5LckWT T cells 
after 72h of activation and subsequent recall (Fig.4.11) but when 
cultured in IL-2, prior to recall, F5LckVA T cells produced proportionally 
less IFNγ and TNFα (Fig.4.12). 
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4.4 Discussion 
The aim of the work presented in this chapter was to establish the role of 
reduced Lck expression in the activation of peripheral CD8+ T cells. Data 
presented in this chapter showed that pathways downstream of TCR-
stimulation were differentially regulated when Lck abundance was reduced, 
meaning that some downstream pathways were downregulated, as might be 
expected from previously published data (Lovatt et al., 2006), however, 
others were upregulated. 
The data showed that despite reduced Lck expression, T cell activation 
efficiency, as measured by upregulation of an early activation marker such as 
CD25 after 24h of stimulation, was equivalent between F5LckWT T cells and 
F5LckVA T cells (Fig.4.2). This was in striking contrast to previously published 
data that showed F5Lckind T cells, expressing 20% of WT levels of Lck, had an 
increased activation threshold compared to WT controls (Lovatt et al., 2006), 
which we also confirmed in this chapter (Fig.4.2). We investigated several 
TCR-mediated Lck dependent signalling pathways and their biological 
outcomes. In correlation with previously published findings, our data 
showed that phosphorylation of immediate targets of Lck, for example Zap-
70 and Shc (Fig.4.3), and a later target ERK (Fig.4.4) were reduced in T cells 
with reduced Lck expression (Lovatt et al., 2006). On the other hand, we also 
showed that F5LckVA T cells had enhanced Ca2+ flux (Fig.4.7), produced 
elevated levels of IL-2 after 24 and 48h of stimulation (Fig.4.8), and had a 
higher proliferative capacity (Fig.4.9) than F5LckWT T cells. When we looked at 
cytokine production upon stimulation of naïve cells (Fig.4.11), we found that 
F5LckVA produced increased levels of IFNγ and TNFα. In contrast, when we 
looked at cytokine production in antigen-experienced cells, we found that 
growing them in IL-2 had affected the responsiveness of F5LckVA T cells, and 
they produced proportionally less IFNγ and TNFα (Fig.4.12). Finally, we 
showed that F5LckVA T cells expressed increased levels of p38 (Fig.4.14) and 
modestly increased levels of pFoxo1 (Fig.4.15).  
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The following discussion will look at potential explanations for these 
observations from the perspective of regulation of Lck, its role in T cell 
signalling, as well as in negative regulation. 
Lck is crucial for TCR signalling and its activity is dynamically regulated, 
negatively by Csk, which phosphorylates its inhibitory tyrosine Y505, and by 
PTPN22, which dephosphorylates the activatory tyrosine Y394. Lck is both 
positively and negatively regulated by CD45 that dephosphorylates Y505 as 
well as phosphorylates Y394. The latter is also phosphorylated by trans-
autophosphorylation by Lck. Nika et al. showed that in naïve cells, 40% of 
Lck was constitutively doubly phosphorylated on Y394 and Y505, potentially 
keeping T cells poised for activation (Nika et al., 2010). Upon TCR ligation, 
one potential adapter molecule PAG, which keeps Csk in close proximity to 
Lck in the plasma membrane, is dephosphorylated and Csk is released. This 
tips the equilibrium towards CD45 dephosphorylation of Y505 on Lck, and 
leads to activation and phosphorylation of ITAMs by Lck.  The absence 
negative regulation of Lck leads to sustained TCR signalling even without a 
peptide ligation (Schoenborn et al., 2011). To show this, Schoenborn et al. 
modified Csk such that it did not inhibit Lck. They found that inactivating 
Csk even without TCR ligation, activated the TCR signaling cascade, with 
Zap-70 phoshorylated on Y319 and also on Y493 (which is a site for both Lck 
and Zap-70 itself). They found that the signaling cascade was sustained, 
including the initiation of Ca2+ flux and the phosphorylation of ERK 
(Schoenborn et al., 2011). We showed that reduced Lck abundance led to 
increased Ca2+ flux, and since Schoenborn et al. suggest that more active Lck 
could lead to a similar result (Schoenborn et al., 2011), it would be interesting 
to assess whether the reduced Lck levels also led to a more active Lck. The 
pool of pre-existing Lck may be slightly more activated in F5LckVA to carry 
out equivalent functions to wild type Lck – although, extrapolating from our 
data, this may be unlikely, as immediate phosphorylation events 
downstream of Lck were reduced (Fig.4.3). Additionally, increased Lck 
activation without TCR ligation would also lead to increased 
phosphorylation of ERK (Schoenborn et al., 2011). A helpful determinant of 
Lck activity is the onset of CD3ζ phosphorylation in response to TCR 
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ligation, as with a 90% reduction of activated Lck, CD3ζ phosphorylation 
was strongly delayed (Nika et al., 2010). Thus analysing CD3ζ 
phosphorylation might be a more accurate reflection of Lck activity. 
An interesting study showed that by changing the number of CD3 ITAMs 
that were phosphorylated (multiplicity) and able to mediate downstream 
signalling, one could change the biological outcome for the cell (Guy et al., 
2013).  Low ITAM multiplicity was able to facilitate Zap-70 and ERK 
phosphorylation equally to wild type controls, as well as to direct secretion 
of IL-2, IFNγ and TNFα, but it did not lead to proliferation, because of 
defects in c-Myc activation. High ITAM multiplicity was required for 
efficient proliferation (Guy et al., 2013). Guy et al.  used AND TCR transgenic 
mice and showed that strong and weak agonist stimulation, correlated with 
high and low ITAM multiplicity, respectively (Guy et al., 2013). Overall, this 
study showed that by altering the TCR signalling pathway from one of the 
most proximal locations, downstream signalling outcomes are changed. The 
observations that Ca2+ signalling and expression of CD25 were intact with 
low multiplicity ITAMs are in keeping with our data (Guy et al., 2013), the 
lack of proliferation with low ITAM multiplicity, however, is in significant 
contrast to our results, as we showed that decreased Lck abundance led to 
increased proliferation (Fig.4.9). The results presented in this chapter, 
supported by published data (Guy et al., 2013), suggested that there are 
differential effects on downstream signalling thresholds when components of 
the TCR signalling cascade are changed. 
This may be a situation where spatiotemporal patterning is relevant and is 
mediating such contrasting differences as suggested by Singleton and 
colleagues (Singleton et al., 2009). They propose that the level of intricate 
control and adaptability of the pathways involved in TCR signalling is 
dependent on the spatiotemporal patterning of signalling molecules during T 
cell activation (Singleton et al., 2009). Marking receptor-ligand pairs with 
sensors such as green fluorescent protein (GFP) allowed them to study the 
distribution of the entire receptor population and its ligand. They described 
T cell activation having highly diverse spatiotemporal patterning of 
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signalling molecules, which is influenced by the strength and context of TCR 
signalling with physiologically distinct outcomes. The diversity in 
spatiotemporal patterning would affect the probabilities at which signalling 
molecules would interact with each other. They went on to suggest, however, 
that changes to patterning of proximal signalling molecules may be of little 
consequence to distal signalling events. This was evidenced by their studies 
comparing T cells from two different transgenic systems with distinct 
spatiotemporal signalling patterns in proximal signalling molecules. They 
proposed that if TCR signalling is above a certain threshold, then proximal 
spatiotemporal patterning is inconsequential (Singleton et al., 2009).  
Guy and colleagues proposed that high ITAM multiplicity was required for 
recruitment of Vav1 and subsequent cytoskeletal remodelling (Guy et al., 
2013). Although they did not study the spatiotemporal aspect of TCR 
signalling, changes in Vav1 expression could correlate with the 
spatiotemporal patterning of signalling molecules (Schoenborn et al., 2011). It 
would be interesting to assess the expression of Vav1 and the organization of 
molecules in the immune synapse by confocal microscopy in F5LckVA mice to 
see whether there are any differences compared to F5LckWT mice. 
Ca2+ flux and IL-2 production are two critical pathways in T cell signalling. 
The influx of Ca2+ is a mediator for several Ca2+ - dependent pathways 
including differentiation, effector function and gene transcription 
(Nagaleekar et al., 2008; Oh-hora and Rao, 2008). Engagement of the TCR 
mediates two independent mechanisms that increase the calcium ion 
concentration in the cell: IP3 binding to IP3 receptors depletes Ca2+ stores from 
the ER, and facilitates ‘store operated’ entry of Ca2+ through Ca2+ channels in 
the plasma membrane (Oh-hora and Rao, 2008). The first effect of increased 
Ca2+ in lymphocytes is to stop their movement, allowing them to form stable 
interactions with APCs. It has been shown that differences in affinities of 
antigenic peptides can influence the abundance of calcium fluxed and the 
frequency of Ca2+ spikes, with high-affinity TCR engagement mediating more 
substantial Ca2+ flux and leading to prolonged engagement with APCs (Wei 
et al., 2007). Ca2+ flux has been shown to be defective in cells lacking Lck 
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(Straus and Weiss, 1992; Trobridge and Levin, 2001), as well as in CD4+ T 
cells in Lckind mice (Lovatt et al., 2006). However, in the case of the LckVA mice, 
Ca2+ flux was shown to be comparable to LckWT mice upon TCR and CD4 cross 
linking in DP thymocytes (Salmond et al., 2011). It is therefore interesting 
that we found faster and increased Ca2+ flux in peripheral F5LckVA T cells 
(Fig.4.7) upon CD8 and TCR crosslinking. Additionally, we stimulated the T 
cells in different ways to measure Ca2+ flux: CD3 crosslinking and TCR 
crosslinking seperately, and observed the same results, confirming that it is a 
TCR-mediated Lck dependent difference (Fig.4.7). Increased Ca2+ flux may 
explain the increased proliferation we see in F5LckVA T cells, but it is difficult 
to explain why this particular pathway is upregulated as opposed to ERK, 
for example. However, the two results cannot be directly compared as Ca2+ 
flux was not measured with peptide stimulation and perhaps ERK 
phosphorylation in F5LckVA T cell had not peaked yet and we should do a 
longer time course. Thus, the ideal control experiment here would be to 
measure ERK phosphorylation in response to CD8 and TCR crosslinking 
over a longer time course. 
TCR-signal dependent increase of AP1, NFAT, and NFκB, and the 
translocation of these transcription factors to the nucleus, mediates the 
binding of the Il2 promoter (Malek, 2008). In concert with Ca2+ signals, the 
increased IL-2 production may also support the increased proliferative 
capacity in F5LckVA T cells (Fig.4.9). IL-2 signalling also induces expression of 
B lymphocyte maturation protein 1 (Blimp-1) after 2-3 days of stimulation, a 
key repressor of IL-2 production (Martins and Calame, 2008). Given more 
time, it would have been interesting to study whether the increased 
proliferative capacity was truly due to IL-2 expression, by doing IL-2 
blocking experiments. It would also be interesting to address Blimp-1 
expression in F5LckVA T cells. Perhaps it is not induced as efficiently as in 
F5LckWT T cells, explaining the increased IL-2 production at 48h in F5LckVA T 
cells. Additionally, it is possible that F5LckVA T cells would succumb to AICD 
more than F5LckWT T cells, due to sustained IL-2 signalling (Malek, 2008). To 
assess this, we could analyse the surface expression of PD1 - a molecule 
associated with T cell exhaustion (Francisco et al., 2010). Therefore, it may be 
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possible that increasing Ca2+ signals and IL-2 production ensures a successful 
development of effector functions in the cells, to counterbalance the weaker 
TCR-mediated signalling caused by reduced Lck abundance. 
From our study, it also appeared that IL-2 had a significant impact on the 
behaviour of F5LckVA cells when it came to effector cytokine production. 
When studying cytokine production following stimulation of naïve cells 
(Fig.4.11), we found that F5LckVA T cells produced increased levels of IFNγ 
and TNFα, an observation that is potentially in line with increased Ca2+ flux 
and IL-2 production. In contrast, when we looked at cytokine production 
after growing the cells in IL-2, we found the activation threshold of F5LckVA T 
cells was increased and they produced proportionally less IFNγ and TNFα 
(Fig.4.12). To distinguish whether this effect was really due to the exogenous 
IL-2, or perhaps differentiation differences between F5LckWT and F5LckVA T 
cells, or indeed the TCR sensitivity, it would be interesting to repeat the 
experiments by initially activating T cells with a titration of peptide, growing 
them in IL-2, and recalling them with the same titration of peptide. This 
would allow us to see whether it is an activation threshold difference. 
Alternatively, we could activate T cells with a titration of peptide, then grow 
them in IL-2, and then recall them with an optimal concentration of peptide. 
This would hopefully indicate whether there is a differentiation difference. 
Signalling via the TCR activates intracellular phosphorylation dependent 
cascades that lead to the appropriate fate decisions. It is yet to be determined 
how stimulation of the TCR can direct discrete subsets of signalling 
pathways in order to achieve particular outcomes. Explanations for this 
‘decision making’ range from signal strength to scaffold protein mediated 
signalosomes (Round et al., 2007). Furthermore, signal strength and duration 
during the initial immune response have been found to distinguish between 
full activation and tolerance of responding CD8+ T cells (Williams and Bevan, 
2007). Negative regulation is an important mechanism in assuring TCR 
signalling is controlled appropriately, in terms of the strength and duration 
of the signal. For example, a mutation in the negative regulator PTPN22 
leads to increased TCR signalling and a predisposition to autoimmune 
Chapter 4 
  153 
disease, as it interrupts the interaction between PTPN22 and Csk (Brownlie 
et al., 2012). PTPN22 normally binds Csk and dephosphorylates activating 
residue Tyr394 on Lck, particularly in effector and memory T cells. It would be 
interesting to assess the expression of PTPN22 in F5LckVA T cells, as it is 
possible that their enhanced proliferation is indicative of increased TCR 
signalling due to reduced PTPN22 expression.  
Another TCR-dependent proximal negative feedback mechanism activated 
by Lck in response to TCR signalling is the cytoplasmic PTP SHP1 (Acuto et 
al., 2008). SHP1KO mice develop autoimmune disease due to increased positive 
and negative thymocyte selection and T-cell activation (Charest et al., 1997). 
When SHP1 is phosprylated by Lck at Y564 it also interacts with Lck (Lorenz 
et al., 1994). Phosphorylation of Ser-59 on Lck by ERK disrupts the 
interaction between Lck and SHP1, preventing activation of SHP1 (Acuto et 
al., 2008; Stefanova et al., 2003). The data in this chapter suggest that Ser-59 
phosphorylation of Lck is equal in F5LckWT and F5LckVA T cells (Fig.4.6). Such a 
mechanism of preventing negative regulation is another potential 
explanation as to why F5LckVA CD8 T cells activate with equal efficiency to 
F5LckWT T cells (Fig.4.2). 
A potential interaction between Dok1 and Csk, which may contribute to 
negative regulation of Lck activity in response to TCR ligation, has been 
described (Schoenborn et al., 2011). The Dok1-/-Dok2-/- phenotype with 
increased TCR-induced IL2 production, and proliferation correlating with 
increased phosphorylation of Zap-70, LAT and ERK, is somewhat similar to 
what we describe in this chapter, suggesting the reduced Lck expression 
seems to mimic a negative feedback deficiency. Our data in figure 4.6 
suggested Ser-59 phosphorylation is intact in F5LckVA mice, indicating that 
reduced Lck abundance is enough to prevent negative regulation. The 
question is whether it is also sufficient for activating it. It would be 
interesting to study the expression and activation of Dok1 and Dok2 proteins 
in F5LckVA mice to see whether reduced Lck expression is sufficient to 
overcome their activation threshold. 
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In response to TCR stimulation, Lck phosphorylates HPK1 of the HPK1-SLP-
76-14-3-3 negative regulation pathway, and HPK1 deficiency can result in 
increased TCR-dependent tyrosine phosphorylation of SLP-76, PLCγ1, LAT, 
Vav1, and ZAP-70 (Acuto et al., 2008). It is important to note that ERK 
activation is increased, and not JNK or p38, in HPK1 deficiency. This axis is 
an example of an additional level of TCR-signalosome control that acts later, 
potentially regulating the duration of TCR signals and the subsequent 
biological outcome (Acuto et al., 2008). In this chapter, we show, however, 
that F5LckVA mice have increased p38 phosphorylation (Fig.4.14). This and the 
decreased Zap-70 phosphorylation shown (Fig.4.2), may indicate that there is 
no HPK deficiency in F5LckVA cells, but it would be interesting to study the 
HPK-SLP-76-14-3-3 pathway in F5LckVA cells to assess whether it is 
differentially regulated.  
Several studies in the past have suggested that the absence of Lck or its 
reduced expression, compromise TCR signalling. The current study showed 
that with reduced Lck expression, some signalling pathways were 
downregulated while others were enhanced. It is possible that differential 
signalling occurs because regulation of TCR signalling has been altered on 
multiple levels, such as in the forward signal, but also in different negatively 
regulating signals that would normally be triggered at different times in the 
cascade during T cell development with constitutively low Lck expression. In 
the future it would thus be interesting to assess the gene expression patterns 
in F5LckVA T cells compared to F5LckWT T cells to determine what fundamental 
changes might be mediating the observations made in this study. 
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Chapter 5:  The Role of Lck in the Formation 
and Maintenance of Memory T Cells During 
Listeria monocytogenes Infection in vivo  
5.1 Introduction 
In order to successfully eradicate intracellular pathogens, CD8+ T cells must 
develop potent effector functions as CTLs, such as secretion of IFNγ and 
target cell lysis through production of granzymes. Upon resolution of the 
effector response, a memory population remains, that can mount a rapid 
response should exposure to the pathogen recur. 
Our understanding of the factors that determine fate decisions of effector 
cells and their differentiation into memory cells is still incomplete. CTL 
formation and subsequent memory development are affected by the strength 
and duration of the initial trigger between naïve T cells and p:MHC 
complexes (signal 1), co-stimulation (signal 2) and inflammatory stimuli 
(signal 3) (Williams and Bevan, 2007). The stages of CD8+ T cell 
differentiation to generate mature CTLs involve clonal expansion, 
proliferation and differentiation of effector functions (Williams and Bevan, 
2007). In the previous chapter we described the role Lck abundance plays in 
effector function development in vitro. We found that cells with reduced Lck 
expression had a higher proliferative capacity (Fig.4.9) as well as increased 
Bcl-2 expression (Fig.4.10) and they are capable of producing effector 
cytokines, albeit with an increased activation threshold in the presence of IL-
2 (Fig.4.12). Consequently, we wished to address the impact of altered signal 
strength on effector to memory T cell differentiation in vivo. 
Reduced Lck expression has previously been shown to reduce the functional 
avidity of TCR interactions and to increase the activation threshold of T cells 
(Caserta et al., 2010; Lovatt et al., 2006). Therefore, changing Lck expression 
affects the initial trigger between naïve T cells and p:MHC complexes and 
this has also been shown to impact on CTL formation and subsequent 
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memory function (Caserta et al., 2010). Caserta et al. showed that CD4+ T cells 
with reduced Lck expression had increased effector-effector memory 
responses and an improved generation of memory populations (Caserta et 
al., 2010).  Additionally, reduced Lck expression prolonged IL-2 expression, 
increased pro-survival marker expression and reduced exhaustion marker 
expression (Caserta et al., 2010). Zehn et al. have shown, that the extent of 
initial proliferation is directly proportional to the affinity of peptide, but very 
low affinity peptides (low functional avidity interactions) are sufficient for 
promoting T cell effector and memory T cell development (Zehn et al., 2009).  
Studies have shown that both CD4+ (Farber et al., 1997) and CD8+ (Borger et 
al., 2013) memory T cells demonstrate increased responsiveness to antigen 
recall associated with changes in proximal TCR signaling. In addition to 
negative regulators of TCR signaling being redistributed away from the site 
of TCR engagement in CD8+ memory T cells, Lck was more efficiently 
recruited to the site of TCR engagement (Borger et al., 2013), possibly 
because of the reported increased localization with the CD8 co-receptor 
(Bachmann et al., 1999). Additionally, Tewari et al. have reported that 
memory CD8+ T cells were Lck-independent with less stringent requirements 
for antigen-specific TCR signaling to activate them (Tewari et al., 2006).  
Collectively, these studies led us to hypothesise that LckVA T cells, due to 
reduced effector cytokine production but increased Bcl2 expression and high 
proliferative capacity, may have compromised primary responses but 
develop normal memory T cell populations. To determine the effects of 
reduced Lck expression in the LckVA mice on the initial response to pathogen 
and the subsequent formation of memory in vivo we employed a L. 
monocytogenes infection model. 
L. monocytogenes infection is a useful tool to study the cellular immune 
responses in mice (Foulds et al., 2002). Intravenous injection induces systemic 
infection and triggers the innate responses critical for host survival. 
Macrophages that ingest the bacteria from the bloodstream migrate to the 
splenic T cell zone, the spleen therefore being the major site of immune 
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defence, thereby triggering the adaptive immune response that is responsible 
for the clearance of L. monocytogenes (Pamer, 2004). The infection is 
characterised by rapid expansion of activated CD8+ T cells (Foulds et al., 
2002). This initial phase of proliferation peaks around day 5-7 and is followed 
by a contraction of pathogen specific cells once the bacteria are eliminated 
(Mannering et al., 2002; Pamer, 2004). Only approximately 5-10% of bacteria 
specific cells remain and account for the memory pool (Kaech and Cui, 2012; 
Pamer, 2004). Rechallenging mice with L. monocytogenes enables the study of 
the memory response (Pamer, 2004). We used an attenuated and OVA-
recombinant strain of L. monocytogens (LmOVA), which is actin-assembly 
inducing protein (Act-A) deficient. Act-A is required for nucleating actin and 
allowing the bacteria to create actin polymers, which enable it to move 
within the cytosols of cells as well as move into neighbouring cells (Pamer, 
2004). Act-A deficiency thus highly attenuates L.monocytogenes virulence but 
still initiates innate immune responses and induces protective T-cell 
responses (Pamer, 2004). The beneficial feature of LmOVA is that the 
pathogen expresses OVA and OVA-specific CD8+ T cells can be followed 
with H2-Kb dimers or dextramers loaded with the immunodominant N4 
peptide (Pamer, 2004; Zehn et al., 2009).  
It has been shown that in L. monocytogenes infection, following T cell priming, 
the amount of antigen and the duration of its presentation are irrelevant in 
determining the magnitude of the response (Mercado et al., 2000). Thus, the 
T cell response is programmed within the first 24h of antigen encounter 
leading to T cell fate decisions and thus the heterogeneity among the effector 
and memory pools of CD8+ T cells (Kaech and Cui, 2012; Mercado et al., 2000; 
Williams and Bevan, 2007).  
In order to be able to label T cells that responded to LmOVA in the primary 
infection thereby allowing their detection at later time points, we used 5-
bromo-2’-deoxyuridine (BrdU). BrdU is a thymidine analog and is 
incorporated into the DNA of proliferating cells. The cells that have 
incorporated BrdU can be tracked up to 70 days later with a specific 
monoclonal antibody (Mannering et al., 2002).  Approximately 90-95% of 
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effector cells generated during a primary immune response die and only the 
remaining small percentage go on to become memory cells. Thus the initial 
effector pool is very heterogenous and recent years have seen a great increase 
in research defining phenotypic markers to differentiate cells into terminal 
effectors and memory precursor cells (Kaech and Cui, 2012). Conventionally, 
CD44 and CD62L surface expression are used to identify TCM and TEM 
populations, CD44hiCD62Lhi and CD44hiCD62Llo respectively (Sallusto et al., 
1999). Additionally, subsets of effector cells that develop into memory cells, 
MPECs can be characterised as CD127+KLRG-1- and terminally differentiated 
SLECs are typically CD127-KLRG-1hi (Joshi et al., 2007; Sarkar et al., 2008). 
Chapter 5: Aims 
Combining the staining strategies for the characterisation of memory cells by 
labelling for several key markers with BrdU labelling, allowed us to compare 
effector to memory cell differentiation in LckWT and LckVA T cells during 
LmOVA infection. In this chapter we distinguished between the Ova-specific, 
immunodominant response, and the total response to Listeria. We showed, 
that LckVA mice produced fewer Ova-specific CD8+ T cells during primary and 
secondary infections, and in agreement with in vitro data from chapter 4, 
LckVA T cells produced less effector cytokines and expressed increased levels 
of Bcl-2. However, we also showed that LckVA T cells survived better through 
the contraction phase of the effector response and developed a distinct 
Listeria – specific memory population compared to LckWT mice.  
5.2 Results 
5.2.1 LckVA mice make fewer OVA-specific T cells  
In order to assess whether reduced abundance of Lck compromises the 
primary or secondary responses to infection, LckVA and LckWT mice were 
infected with LmOVA using the protocol described in Fig.5.1A. Listeria 
infection leads to an increase in overall splenic cellularity and CD8+ and CD4+ 
T cell populations, which are thus a relevant measure of the overall response 
to infection (Foulds et al., 2002).  Therefore, the cell proportions and numbers 
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were determined in LckVA and LckWT mice (Fig.5.1). Henceforth, the terms 
naïve and uninfected mice are used interchangeably. As shown in Fig.5.1B it 
was evident that LckVA mice and LckWT responded similarly to LmOVA 
infection. LckWT spleen cell numbers increased significantly (p=0.0047) from 
156.5x106±21.5 in naïve mice to 219.4x106±4.9 in infected mice on day 7. 
Similarly in LckVA mice, a significant (p=0.0040) increase in spleen cell 
numbers from 116.5x106±19.5 in naïve mice to 217.3x106±22.0 in infected mice 
was seen on day 7. There was no significant difference between LckWT or LckVA 
cell numbers on either day 0 or day 7. A contraction at day 42 was seen in 
both genotypes, cell numbers in LckWT mice returned to naïve levels 
(157x106±32.1) and were also reduced in LckVA mice (141.5x106±40.7). The 
secondary response was measured on day 46, 4 days after re-infection. A 
significant increase over day 42 cell numbers was seen in LckWT 
(516.8x106±98.6, p=0.0004) and LckVA mice (362.3x106±81.6, p=0.0018). There 
was a significant difference (p=0.037) between LckWT and LckVA cell numbers on 
day 46. The expansion on day 46 over day 42 was 3.3-fold in LckWT and 2.6-
fold in LckVA mice. 
Fig.5.1C showed that the proportions of CD8+ T cells were reduced in LckVA 
compared to LckWT mice at all time points. This translated to significant 
decreases in CD8+ cell numbers in naïve (p=0.0016), day 42 (p=0.0068), and 
day 46 (p= 0.0095) groups as shown in Fig.5.1D.  
The CD4+ compartment was considerably smaller in LckVA mice as compared 
to LckWT mice as illustrated in Fig.5.1 (E and F). This is in line with published 
data showing that reduced Lck expression limits CD4+ T cell positive selection 
more than that of CD8+ T cells (Molina et al., 1992). It is likely that neutrophils 
and macrophages, the principal mediators of the killing of L.monocytogenes 
(Pamer, 2004), made up for the cell numbers seen in Fig.5.1B.  
In chapter 3 we showed that LckVA had increased proportions of CD44hi cells 
ex vivo potentially partly due to lymphopenic expansion (Fig.3.12), but CD44 
is also upregulated in response to infection (Sprent and Surh, 2011). 
Henceforth, for simplicity we will refer to CD44hi cells found in naïve mice as   
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Fig. 5.1 Mice with reduced Lck expression had fewer CD8+ and CD4+ T cells in LmOVA 
infection. 
(A) LckVA and LckWT mice were infected with LmOVA as shown. (B) The absolute number of 
splenocytes was recorded using the CASY counter throughout the course of LmOVA 
infection. Proportions (C) and absolute numbers (D) of CD8+ T cells and proportions (E) and 
absolute numbers (F) of CD4+ T cells are shown. Each symbol represents an individual 
mouse, together with means ± SD of a minimum of 3 mice per group. Significance was 
calculated on Prism: parametric, unpaired, two-tailed, student’s t-test *P<0.05, **P<0.01, 
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memory-phenotype cells. Fig.5.2A shows the proportions of CD44hi cells were 
always higher in naïve LckVA mice compared to LckWT mice due to the memory-
phenotype cells. The advantage of the LmOVA infection model is that specific 
p:MHC tetramer or dextramer staining can be used to trace responses to the 
immunodominant OVA epitope, therefore the extent of OVA-specific 
responses in LckVA and LckWT mice were assessed (Fig.5.2). Dot plots showed 
CD44+Dex+ proportions were reduced in LckVA mice at all time points 
recorded. Although, there was slightly higher background staining in LckVA 
mice in naïve cells (1.7%±0.6 CD44+Dex+) compared to LckWT (0.9%±0.2 
CD44+Dex+), the proportions of CD8+CD44+Dex+ T cells in LckVA mice were 
reduced as compared to LckWT on day 7 and day 46 (Fig.5.2B), and this 
translated to significant decreases in cell numbers as shown in Fig.5.2C. 
Overall, our results showed that OVA-specific primary and secondary T cell 
responses were significantly reduced in LckVA mice, despite high CD44 
expression at all time points (Fig.5.2).  
5.2.2 Total proliferative response to Listeria is comparable in 
LckVA and LckWT mice 
Listeria infection causes T cell activation, proliferation and significant 
expansion (Fig.5.1B) (Foulds et al., 2002; Mannering et al., 2002). We showed 
in chapter 4 that F5LckVA CD8+ T cells proliferated more in response to 
challenge with cognate peptide in vitro (Fig.4.9). Therefore it was of interest 
to determine the total extent of proliferation in vivo during Listeria infection, 
despite lower proportions of OVA-specific cells in LckVA mice. 
One way of measuring extent of proliferation is by staining for the nuclear 
protein Ki-67 by FACS without distinguishing OVA-specific cells with 
dextramer. Ki-67 was first identified by Gerdes et al. in a Hodgkins 
Lymphoma-derived cell line (Gerdes et al., 1983). Ki-67 is specific for cells in 
all stages of cell cycle except G0, quiescent cells, or those undergoing DNA 
repair (Soares et al., 2010). As shown in Fig.5.3A and B, proportions of 
CD8+Ki-67+CD44+ T cells were low in both LckVA (14.2±1.1%) and LckWT 
(9.9±1.4%) mice, although significantly higher in LckVA mice (p=0.0062).   
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Fig. 5.2 LckVA mice generated fewer OVA-specific T cells in both the primary and the 
secondary responses. 
CD8+ splenocytes in naïve (uninfected) and infected LckWT and LckVA mice were analysed at 
indicated time points for CD44 and Dex expression. (A) Representative histograms show 
average percentages ± SD of CD44+ cells (top row). Representative dot plots show CD44 
versus Dex staining with proportions of LmOVA specific CD44+Dex+ indicated in top right as 
averages ± SD (bottom row). The average proportions (B) and numbers (C) of 
CD8+CD44+Dex+ cells are shown in bar charts. All values are plotted as means of 3-5 mice per 
group ± SD. Data are representative of 2 experiments per time point. Significance was 
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Conceivably, this reflects the increased proportions of memory-phenotype 
cells in LckVA mice (Fig.5.2A) that are known to have a continuous slow 
turnover (Benigni et al., 2005). On day 7 of infection a clear proliferative 
response to Listeria was recorded in both LckVA (60.4±6.2%) and LckWT  
(40.6±2.6%) T cells, again, this was significantly higher in LckVA mice 
(p=0.0071). By day 42 the pathogen is long cleared, and a contraction of the 
effector response has occurred (Mannering et al., 2002). The T cells were 
largely in a resting state, as reflected in the reduced CD8+Ki-67+CD44+ T cell 
proportions in both LckVA (8.3±1.1%) and LckWT mice (5.2±0.2%). Once again, 
however, the proportions of CD8+Ki-67+CD44+ T cells were significantly higher 
in LckVA mice (p=0.0012). Upon secondary infection, on day 46, an enhanced 
recall response was measured with CD8+Ki-67+CD44+ T cell proportions in 
both LckVA (75±2.5%) and LckWT mice (79.3±2.4%), above that seen on day 7. 
This was significantly higher in LckWT mice (p=0.04).  
The CD8+Ki-67+CD44+ T cell numbers were also calculated for each time point 
(Fig.5.3C). In naïve LckVA mice, although the proportions of CD8+Ki-67+CD44+ 
T cells were significantly higher, the actual cell number was significantly 
lower (p=0.025), reflecting the lower total CD8+ T cell numbers calculated in 
Fig.5.1D. On days 7 and 42, there was no significant difference between LckVA 
and LckWT mice in terms of CD8+Ki-67+CD44+ T cell numbers. On day 46, the 
CD8+Ki-67+CD44+ T cell numbers were significantly lower in LckVA mice 
(p=0.0083) compared to LckWT mice.  
Overall, the data here showed that the total proliferation to Listeria during 
the primary response in LckVA mice was similar to LckWT mice when comparing 
CD8+Ki-67+CD44+ T cell numbers, which was in agreement with the equal 
CD8+ T cell numbers on day 7 (Fig.5.1D). The overall proliferative response in 
secondary Listeria infection, as measured by cell number, was significantly 
reduced in LckVA mice as compared to LckWT mice on day 46, which is also in 
agreement with the significantly decreased CD8+ T cell numbers on day 46 
(Fig.5.1D). However, the observation that both LckWT and LckVA T cells had 
similar proportions of CD8+Ki-67+CD44+ cells, but fewer cells in total, may   
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Fig. 5.3 The proliferative response to Listeria infection was characterised by Ki-67 
expression in LckVA and LckWT CD8+ T cells. 
Ki-67 expression was measured by intracellular staining in LckWT and LckVA mice at indicated 
time points. (A) Representative dot plots show CD44 versus Ki-67 staining. Quadrants show 
average percentages of a group of 3-5 animals. Bar charts show average percentages (B) and 
numbers (C) of CD8+CD44+Ki-67+ cells. The error bars show SD. The average MFI ± SD is 
shown for CD8+CD44+Ki-67+ gates in naïve and day 7 infected mice (D) and day 46 mice (E). 
Results are representative of 2 independent experiments. Note that the data for proportions 
of Ki-67+ cells was pooled between experiments, but for MFI’s this was not possible and so 
no significance test was done on MFI of naïve CD8+CD44+Ki-67+ samples due to n=2. 
Significance was calculated on Prism: parametric, unpaired, two-tailed, student’s t-test 
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indicate that LckVA cells were undergoing more cell death. Both LckWT and 
LckVA T cells had reduced Ki-67 expression on day 42, which indicated that 
both had undergone a contraction in the immune response and T cells were 
largely quiescent. 
L. monocytogenes infection induces a similar clonal expansion in CD4+ T cells 
to that seen in CD8+ T cells (Pamer, 2004). CD4+ T cells have also been shown 
to be important for inducing the long-term memory potential of CD8+ T cells 
(Sun et al., 2004). Therefore, we also measured Ki-67 expression in CD4+ T 
cells (Fig.5.4). Basal proliferation in naïve CD4+ cells was proportionally 
slightly higher than in CD8+ T cells, but there was no significant difference 
between LckVA (17.3±3.7%) and LckWT  (12.4±2.3%) CD4+Ki-67+CD44+ T cells. On 
day 7 CD4+Ki-67+CD44+ increased proportionally in both LckVA and LckWT mice. 
However, there was again no significant difference between LckVA (30.1±1.6%) 
and LckWT mice (25±3.0%). As with CD8+ T cells, an improved recall response 
was identified in CD4+Ki-67+CD44+ T cells on day 46 in both LckVA and LckWT 
mice, and it was significantly higher (p=0.0175) in LckVA (54.7±4.2%) than LckWT 
(44.5±2.7%) mice. 
The CD4+Ki-67+CD44+ T cell numbers, shown in Fig.5.4C, were calculated for 
each time point. The proportions of CD4+Ki-67+CD44+ T cells in naïve LckVA 
mice were not significantly different from LckWT, and neither were the actual 
cell numbers, but there was a trend for them to be lower in LckVA mice. During 
the primary response on day 7, CD4+Ki-67+CD44+ T cell numbers were 
significantly lower (p=0.017) in LckVA mice compared to LckWT mice. On day 46 
LckVA had significantly higher proportions of CD4+Ki-67+CD44+ T cells, but the 
CD4+Ki-67+CD44+ T cell numbers were significantly reduced (p=0.0064) in 
LckVA compared to LckWT mice. These results reflected the lower CD4+ T cell 
proportions and numbers calculated in Fig.5.1E and F. Overall, the data 
regarding proliferation in CD4+ T cells, suggested two things. Firstly, that the 
CD4+ T cell primary and secondary proliferative responses were similar in 
LckVA and LckWT mice as measured by the proportions of cells in the cell cycle 
expressing Ki-67. Secondly, the reduced overall numbers of CD4+Ki-67+CD44+   
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Fig. 5.4 The numbers of CD4+ proliferating cells in Listeria infection were reduced in 
LckVA mice. 
Ki-67 expression was measured by intracellular staining in LckWT and LckVA mice at indicated 
time points. (A) Representative dot plots show CD44 versus Ki-67 expression in CD4+ T cells. 
Quadrants show average percentages of a group of 3-5 animals. Bar charts of average of 
proportions (B) and numbers (C) of CD4+CD44+Ki-67+ cells are shown. Error bars denote the 
SD. The MFI was calculated for CD4+CD44+Ki-67+ cells and the averages ± SD from indicated 
days are represented in bar charts (D and E). Results are representative of 2 independent 
experiments. Note that the data on proportions was pooled between experiments but for 
MFI’s this was not possible and so no significance test was done on naïve CD4+CD44+Ki-67+ 
cell MFIs due to n=2. Error bars represent standard deviations. Significance was calculated 
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T cells in LckVA mice, although reflecting the lower CD4+ T cell numbers 
(Fig.5.1E and F), suggested that they too may be undergoing more cell death. 
There is some evidence that the MFI of Ki-67 staining indicates different cell-
cycle stages and differential localization of the Ki-67 protein within cells 
(Danova et al., 1988; Starborg et al., 1996). Although we did not study the 
cell-cycle progression in these experiments, we found that on all days, except 
day 7, there were no differences in MFI of Ki-67 expression in CD8+Ki-
67+CD44+ T cells between LckWT and LckVA mice (Fig.5.3D and E). On day 7, 
however in LckVA mice Ki-67 MFI was significantly lower (p=0.0003) than in 
LckWT T cells (Fig.5.3D). This may suggest an accumulation of cells in the final, 
M phase (Mitosis - cell is ready to split into two daughter cells) in LckVA cells, 
perhaps indicating that they went faster through the cell cycle or that they 
had delayed mitosis. If they went faster through the cell cycle, we would 
expect to see increased proliferation in CD8+ T cells on day 7, but this was not 
the case (Fig.5.1D and Fig.5.3C). Thus it was more likely that LckVA mice have 
delayed mitosis or that they went through the cell cycle faster and also died 
faster. More detailed experiments addressing the cell cycle would need to be 
done to confirm such conclusions, especially since Ki-67 MFI was not 
significantly different on day 46 in CD8+ T cells.  
There were no differences in Ki-67 MFIs in CD4+Ki-67+CD44+ T cells between 
LckWT and LckVA mice (Fig.5.4D and E). 
5.2.3 Effector cytokine production from Ova-specific cells 
was reduced in LckVA mice in LmOVA infection 
Production of IFNγ and TNFα by multiple cell types, is a critical component 
of both innate and adaptive immunity to L.monocytogenes infection (Pamer, 
2004). Inflammatory cytokine production early in infection is important for 
naïve cell differentiation into IFNγ producing effector cells (Pape et al., 1997). 
Furthermore, IFNγ-gene knockout mice readily succumb to L.monocytogenes 
infection (Harty and Bevan, 1995). In chapter 4 we showed differential effects 
on effector cytokine production in response to in vitro stimulation of F5LckVA 
T cells. When F5LckVA T cells cultured with IL-2 and cognate peptide the 
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cytokine production was reduced, however, culturing them without the IL-2 
step the cytokine production was enhanced, as compared to F5LckWT T cells.  
We first assessed the cytokine production in LckVA and LckWT mice during 
Listeria infection. To this end splenocytes were harvested from both naïve 
and infected animals on days 7 and 46 of LmOVA infection - the primary and 
secondary responses, respectively. The cells were cultured overnight with a 
titration of HKL, made from the same batch of LmOVA used in the initial i.v. 
injections, in an effort to stimulate IFNγ and TNFα cytokine production that 
we could measure by ELISA.  
Although we could not distinguish which cells produced cytokine by this 
assay, they were specific for prior infection with Listeria as no IFNγ was 
produced in response to HKL by cells from naïve LckVA or LckWT cells in vitro 
(Fig.5.5A and B). The amount of IFNγ produced in both LckVA and LckWT cell 
cultures increased in an HKL concentration dependent manner on both days 
7 and 46 (Fig.5.5A and B). There was a trend for less IFNγ to be produced by 
LckVA cells than by LckWT cells at all concentrations of HKL stimulation on both 
days 7 and 46, however, no statistical significance was found (Fig.5.5 A and 
B). On day 46, IFNγ production was seen already at the lowest 0.1x106 HKL 
concentration in both LckVA and LckWT mice (Fig.5.5B), which is in agreement 
with the notion that a recall response is stronger than the primary response. 
There was a large variation between biological replicates, probably 
highlighting the variability of infection between mice. 
TNFα production was only measured on day 7 (Fig.5.5C).  The amount of 
TNFα produced in both LckVA and LckWT cultures increased in an HKL 
concentration dependent manner (Fig.5.5C). Some TNFα production was 
induced even in naïve mice, indicating that the bacteria could induce some 
production of TNFα directly in vitro. This may be due to other cells, such as 
macrophages, producing TNFα during an innate immune response to HKL 
in vitro (Pamer, 2004). Furthermore, at the highest concentration of HKL 
(10x106) naïve LckWT mice produced the same amount of TNFα as infected 
LckWT mice in vitro (Fig.5.5C). At all concentrations of HKL stimulation LckVA   
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Fig. 5.5 IFNγ and TNFα production upon recall with HKL was similar between LckWT 
and LckVA mice. 
Splenocytes from 3 individual LckWT and LckVA mice culled at indicated times were cultured 
overnight with the indicated titrations of HKL. Production of IFNγ on day 7 (A) and day 46 
(B), and TNFα on day 7 (B) were measured by ELISA. Data in bar charts represent means ± 
SD. Significance was calculated on Prism: parametric, unpaired, two-tailed, student’s t-test 
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cells produced same amounts of TNFα as LckWT cells, except at the highest 
concentration of HKL, where both naïve and infected LckVA cells produced 
less TNFα than LckWT cells (Fig.5.5 C).  
A caveat with these data is that HKL stimulation has only been done once for 
each time point of LmOVA infection. Overall, the data indicated that there 
were no differences in TNFα and IFNγ production in response to HKL 
stimulation in LckVA and LckWT cells.  
LmOVA infection induces a CD8+ T cell response specific for the H-2Kb-
restricted SIINFEKL (N4) peptide. IFNγ and TNFα production in response to 
N4 can thus be used as a measure of TCR sensitivity to antigen stimulation 
(Joshi et al., 2007). Therefore, we asked whether there was a difference in the 
production of IFNγ or TNFα from antigen-experienced cells between LckVA 
and LckWT mice infected with LmOVA by re-stimulating splenocytes with the 
N4 peptide in vitro 7 days post-infection (Fig.5.6A). When cells from naïve 
mice were cultured in media only a very small proportion of cells made IFNγ 
in both LckVA (0.4±0.05%) and LckWT mice (0.3±0.12%). The same was true for 
cells from LckVA (0.6±0.4%) and LckWT infected mice (0.4±0.3%) after being 
cultured in media alone and there were no significant differences between 
these populations (Fig.5.6A). The low proportions of IFNγ producing cells, 
found in naïve LckVA (light blue fill) and LckWT (grey fill) mice, stayed constant 
at all concentrations of N4 tested. Overall this confirmed that the increase in 
proportions of cells producing IFNγ, seen in cells from infected animals, was 
N4-peptide specific (Fig.5.6A). A concentration dependent increase in the 
proportions of IFNγ producing cells, in both LckWT (black line) and LckVA (dark 
blue line) infected mice was seen (Fig.5.6A). There were significantly reduced 
proportions of IFNγ producing LckVA CD8+ T cells, as compared to LckWT, at all 
concentrations of N4-peptide stimulation (Fig.5.6A), which was in line with 
our data in Fig.5.2B and C that showed LckVA mice had significantly lower 
numbers of CD8+Dex+CD44+ Ova-specific cells.  
In C57BL/6 mice, in addition to a strong CD8+ mediated OVA-antigen 
specific T cell responses, LmOVA also stimulates a strong CD4+ T cell   
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Fig. 5.6 LckVA mice had reduced proportions of Ova-specific CD8+ IFNγ+ T Cells upon 
in vitro re-stimulation 7 days post-infection. 
LckWT and LckVA mice were challenged with LmOVA for 7 days. Thereafter splenocytes were 
restimulated for 4h in the presence of Brefeldin-A with a titration of N4-peptide (A) or LLO190-
201 peptide (B) for IFNγ producing CD8+ or CD4+ T cells, respectively. Intracellular staining for 
cytokines was performed and the results were acquired by flow cytomtery. This experiment 
was done once with n=3 mice per group. Data represent the mean ± SD. Significance was 
calculated on Prism: parametric, unpaired, two-tailed, student’s t-test *P<0.05, **P<0.01, 







































































  172 
response to LLO190-201 (Geginat et al., 2001; Haring and Harty, 2006). We, 
therefore re-stimulated splenocytes 7 days post-infection with a titration of 
LLO190-201 and measured the proportions of IFNγ producing CD4+ T cells 
(Fig.5.6B). Very low proportions, <1% of IFNγ producing cells were found in 
naïve LckVA (light blue fill) and LckWT (grey fill) mice and this stayed constant at 
all concentrations of LLO190-201 stimulation. A concentration dependent increase 
in the proportions of IFNγ producing cells, from LckWT (black fill) but not LckVA 
(dark blue fill) infected mice was seen (Fig.5.6B). Cells from infected LckVA 
mice had significantly higher (p=0.02) proportions of IFNγ producing CD4+ T 
cells cultured in media alone. The proportions IFNγ producing CD4+ T cells 
were similar in LckVA mice compared to LckWT mice at all concentrations of 
LLO190-201 tested (Fig.5.6B). Unfortunately, this experiment has only been done 
once on day 7 and would require repeating to confirm the conclusions. 
However, because the total IFNγ production in response to HKL was similar 
in LckVA mice on day 7 but the OVA-specific IFNγ production was 
significantly reduced (Fig.5.5A and Fig.5.6A) it is possible that LckVA would 
have more IFNγ producing CD4+ T cells than LckWT mice.  
We next measured the proportions of peptide specific CD8+ and CD4+ IFNγ 
and TNFα-producing T cells after a secondary infection on day 46 (Fig.5.7). 
Very low proportions, <2% of TNFα or IFNγ producing cells were found in 
naïve LckVA (light blue fill) and LckWT (grey fill) mice and this stayed constant at 
all concentrations of N4 and LLO190-201 stimulations (Fig.5.7A-D). A 
concentration dependent increase in the proportions of IFNγ and TNFα 
producing CD8+ and CD4+ T cells, in both LckWT (black fill) and LckVA (dark blue 
fill) infected mice, was seen (Fig.5.7A-D). In agreement with data acquired on 
day 7 (Fig.5.6A), LckVA mice had significantly reduced proportions of IFNγ 
producing CD8+ T cells as compared to LckWT at all concentrations of N4-
peptide stimulation (Fig.5.7A) as well as significantly reduced proportions of 
TNFα producing CD8+ T cells (Fig.5.7B).  These data correlate with the results 
in Fig.5.2 that showed the total numbers of Ova-specific cells were 
significantly lower in LckVA mice on day 46.  It should be noted that although 
we saw 80% of CD8+ cells in LckWT mice were producing IFNγ on day 46 
(Fig.5.7A) yet we only recorded 42.1% of CD8+ T cells as being Ova-specific at   
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Fig. 5.7 LckVA mice had reduced proportions of antigen-specific IFNγ and TNFα 
producing cells after secondary infection. 
LckVA and LckWT mice were challenged with a secondary LmOVA infection on day 42 and 
results were acquired on day 46. Splenocytes were restimulated for 4h in the presence of 
Brefeldin-A with indicated concentrations of N4-peptide for proportions of IFNγ (A) and 
TNFα (B) producing CD8+ T cells, or LLO190-201 for proportions of IFNγ (C) and TNFα (D) 
producing CD4+ T cells. The cytokines were stained for intracellularly and the results were 
acquired by flow cytometry. Data are representative of 2 independent experiments with n=2 
in naïve groups (does not allow for statistical analysis) and n=5 in infected groups. Data 
represent the mean ± SD. Significance was calculated on Prism: parametric, unpaired, two-
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the same time point (Fig.5.2). Dextramer binding might therefore be 
underestimating the proportions of antigen-specific T cells. The data also 
showed that LckVA mice had significantly reduced proportions of IFNγ 
producing CD4+ T cells, at all concentrations of LLO190-201 stimulation after 
secondary infection (Fig.5.7 C), as well as significantly reduced proportions 
of TNFα producing CD4+ T cells at all concentrations of LLO190-201 stimulation, 
as compared to LckWT cells (Fig.5.7D).  
Collectively, these data suggested that LckVA have similar effector cytokine 
production in response to primary and secondary Listeria infections when 
measured by HKL recall, however, the antigen-specific effector responses in 
CD8+ and CD4+ T cells were reduced.  
5.2.4 Maintenance of Listeria specific T cells through the 
contraction phase of the immune response was 
enhanced in LckVA mice 
Although, LckVA mice had decreased proportions and numbers of Listeria 
specific cells (Fig.5.2) and they made a reduced Ova-specific effector 
response (Fig.5.6 and 5.7), the data in Chapter 4 indicated that LckVA T cells 
expressed increased levels of Bcl-2 (Fig.4.10), an important anti-apoptotic 
molecule and marker of long-term memory cells (Kaech and Cui, 2012). The 
questions we wished to address were, whether the survival of LckVA T cells 
was altered through the contraction phase following infection, and how this 
would impact upon the generation of memory cells.  
Similarly to Ki-67 staining, BrdU staining can be used as a measure of cell 
proliferation. BrdU is a thymidine analogue and thus is incorporated into the 
DNA of proliferating cells (Tough and Sprent, 1994). The advantage of BrdU 
staining over Ki-67 is that once a cell has proliferated and incorporated BrdU 
it will remain BrdU+, even when it later becomes quiescent. 
We injected mice with BrdU on day 4 after primary LmOVA infection and 
BrdU was also given in drinking water during the peak of the infection days 
4 – 10, thereby ensuring that all cells proliferating to Listeria could 
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incorporate BrdU. The BrdU incorporation was measured by analysis of 
intracellular staining on flow cytometry on days 7, 42 and 46. 
Staining for BrdU requires a harsh DNase treatment of the cells. This caused 
an artefact of staining, the appearance of a very bright Dex+ population of 
cells, which was excluded as shown in Fig.5.8A. This population is clearly 
visible on CD44 versus Dex dot plots in the double positive quadrant 
(Fig.5.8A top row). The population consistently represented 1-3% of Dex+ 
cells, even in naïve mice, where we know the frequency is generally <1% in 
samples not subject to the BrdU staining protocol, and we therefore gated it 
out using histogram analysis (Fig.5.8A middle row). The removal of this 
artefact did not interfere with the real Dex staining (Fig.5.8A bottom row). 
We continued all further flow cytometry analysis on the gated populations. 
We used several controls to confirm real BrdU staining (Fig.5.8B). We 
compared cells without DNAse treatment and without BrdU staining to cells 
that were DNAse treated, but without BrdU staining. It was clear that the 
treatment severely affected cell morphology and the live gate on forward and 
side scatter had to be adjusted. The treatment itself did not create false 
positive events in the BrdU gate. When we stained DNase treated cells for 
BrdU we saw a clear population appear in the BrdU gate (Fig.5.8B). 
Our results showed that, like Ki-67 staining, BrdU staining reliably measured 
cell proliferation as there was little BrdU incorporation in CD8+ T cells in 
naïve LckWT mice (2.8±1%), but this increased significantly (p=0.0093) with 
infection (17±6.3%) on day 7.  The background staining for BrdU was higher 
in naïve LckVA mice (11.4±0.9%) but the proportions of CD8+BrdU+ T cells still 
increased significantly (p=0.0079) with infection on day 7 (18±2.8%) 
(Fig.5.9A). The proportion of BrdU+ cells was significantly higher (p=0.0003) 
in naïve LckVA mice than LckWT mice but there was no significant difference 
between them on day 7. The higher background staining in LckVA mice may 
have been due to the high proportions of CD44+ cells present in naïve mice as 
shown in Fig.5.2A.  
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Fig. 5.8 Exclusion of artefacts and the gating strategy for BrdU staining. 
LckVA and LckWT mice were injected BrdU i.p on day 4 post-infection with LmOVA. BrdU was 
also fed in drinking water on days 4-10 post-infection. (A) Top row shows zebra plots of 
CD44 vs Dex staining. The middle row shows on a histogram the gating for excluding the 
CD44+Dexhi artefact. The third row shows new zebra plots of CD44 vs Dex gating without the 
artefact. Numbers on dot plots show average proportions ± SD. (B) Representative plots of 
BrdU staining controls with representative values. BrdU was gated for as shown by FSC vs 
SSC, and doublets were excluded by gating for FSC-H vs FSC-A. 
  
Chapter 5 
  177 
By day 42, the infection has been cleared and the majority of effector cells 
have died in the contraction of infection, as can be seen in the reduction of 
cell numbers in Fig.5.1B. The cells that remain represent the memory pool. 
The proportions of CD8+BrdU+ cells decreased in infected mice on day 42 in 
both LckWT (2.1±0.4%) and LckVA (8.6±2.2%) mice (Fig.5.9A). Yet, the proportion 
of CD8+BrdU+ memory T cells was significantly higher (p=0.0018) in LckVA 
mice as compared to LckWT mice on day 42. The background staining for naïve 
mice culled on day 42 as controls, was low in both LckWT (1.1%) and LckVA 
(2.4%) mice (Fig.5.9A). These results indicated several things, firstly that LckVA 
mice maintain increased proportions of cells during the contraction phase 
that initially proliferated in the primary response, compared to LckWT mice, 
suggesting these were true Listeria specific memory cells. Secondly, the 
reduced proportions of CD8+BrdU+ T cells in naïve mice on day 42 as 
compared to day 7 suggested that the increased CD44+ pool of cells in LckVA 
mice turns over enough to dilute out BrdU incorporation. Finally, not all 
BrdU incorporation was Dex specific on day 7 (Fig. 5.9B), which suggested 
the response to Listeria involved a broad T cell repertoire.  
Ideally, one would also expect to see some Dex+BrdU+ cells on day 42, 
representing the Ova-specific memory response. However, this typically 
occurs in less than 10% of cells thus the sensitivities of Dex and BrdU may 
not be sufficient (Pamer, 2004).  
To estimate the incorporation of BrdU+ above background levels we 
subtracted the background BrdU incorporation in Dex+ and Dex- cells, as seen 
in uninfected mice on each day, from the incorporation seen in infected mice 
(Fig.5.9B). The results of this calculation, shown in Fig.5.9C, indicated that 
LckVA mice (5.5%) had 6.8-fold higher proportions of Dex-BrdU+ cells on day 42 
than LckWT (0.8%) mice.  
On day 46 the proportions of CD8+BrdU+ T cells were very low in both LckWT 
(0.7±0.1%) and LckVA mice (2.3±1.2%), which suggested that vigorous 
proliferation in secondary response led to the dilution of BrdU to 
undetectable levels, confirming that the labelled cells at day 42 from infected  
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Fig. 5.9 Maintenance of Listeria specific CD8+BrdU+ T cells was enhanced in LckVA 
mice. 
LckVA and LckWT mice (n=2-5) were injected with BrdU i.p on day 4 post-infection with 
LmOVA. BrdU was also fed in drinking water on days 4-10 post-infection. (A) 
Representative histogram overlays show isotype control antibody (grey filled histogram) 
and BrdU staining in LckWT (black) and LckVA (blue) mice, gated on CD8+ T cells. (B) 
Representative dot plots show Dex vs BrdU staining in CD8+ T cells. All numbers in part A 
and B show average proportions ± SD. (For n=2 the SD was not calculated). (C) The table 
shows the results of the calculation: Dex+BrdU+% or Dex-BrdU+% in naïve mice minus the 
result in infected mice on indicated days. Values used are those in part B. Data are 
representative of 2 independent experiments for Naïve and day 42, and 1 experiment for day 
7 and day 46. Significance was calculated on Prism: parametric, unpaired, two-tailed, 
student’s t-test *P<0.05, **P<0.01, ***P<0.001.   
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94.1 3.7 
Subtraction of naïve  
background 
Day 7 Day 42 Day 46 
LckWT LckVA LckWT LckVA LckWT LckVA 
Dex+BrdU+ 5.2 1.1 0.1 0.2 0 0 
Dex-BrdU+ 9.9 4.8 0.8 5.5 0.2 0 
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mice were indeed Listeria specific. This was supported by the observation 
that Dex and BrdU staining were mutually exclusive on day 46 (Fig.5.9B). 
We also assessed BrdU incorporation in CD4+ T cells. The data were similar 
to that in CD8+ T cells in that naïve LckWT CD4+CD44+ T cells had small 
proportions (3.7±1.3%) of BrdU incorporation initially and this increased on 
day 7 (11.5±3.1%).  However, the background was again higher in naïve LckVA 
CD4+CD44+ T cells (15.6±1.7%) but still increased on day 7 (35.4±3.2%) 
(Fig.5.10A).  
The proportions of CD4+BrdU+CD44+ cells were low on day 42 in infected 
LckWT (0.8%±0.2) and LckVA mice (2.1%±0.6), respectively, but not much higher 
than the proportions of cells in naïve mice on day 42 in LckWT  (0.5%) and LckVA 
mice (1.4%). Unfortunately, we could not test for significant differences in 
naïve mice on day 42 because only 2 mice were culled per group.  These 
results, however, indicated that in contrast to CD8+ T cells there is limited 
maintenance of CD4+ T cell memory in either mouse strain. On day 46 the 
proportions of CD4+BrdU+CD44+ T cells stayed very low in both LckWT 
(0.5±0.1%) and LckVA (0.7±0.2%) mice.  
Collectively, these data suggested that both LckVA and LckWT CD8+ T cells 
maintained a pool of Listeria specific BrdU+ memory T cells on day 42 but not 
CD4+ T cells. The proportions of Listeria specific memory CD8+ T cells 
maintained was significantly greater in LckVA mice (Fig.5.9).  
Expression of the anti-apoptotic molecule Bcl-2 has been implicated in T cell 
memory formation, particularly in T cell survival during the contraction 
phase post-primary response (Dunkle et al., 2013). We showed in chapter 4 
that F5LckVA express more Bcl-2 ex vivo as well as upon in vitro activation 
(Fig.4.10). Therefore, we next investigated whether LckVA T cells also express 
more Bcl-2 during in vivo infection, particularly on day 42. To this end we 
measured Bcl-2 expression in CD8+ T cells from naïve LckWT and LckVA mice on 
days 7, 42 and 46 post-LmOVA infection.  
  
Chapter 5 
  180 
Fig. 5.10 CD4+ T cells did not maintain a Listeria specific BrdU+ T cell pool. 
LckVA and LckWT mice (n=2-5) were injected with BrdU i.p on day 4 post-infection with 
LmOVA. BrdU was also fed in drinking water on days 4-10 post-infection. At indicated time 
points during the course of LmOVA infection splenocytes from LckWT and LckVA were 
intracellularly stained for BrdU. (A) Representative dot plots of CD44 vs BrdU staining are 
shown for CD4+ T cells, numbers show averages of a minimum of 2 mice in each naïve group 
and a minimum of 3 in each infected group. Data are representative of 2 independent 
experiments for naïve and day 42, and 1 experiment for day 7 and day 46. 
  



















































  181 
The data in Fig.5.11 showed that in naïve and infected day 7 cells, stained 
with the Bcl-2 isotype antibody as a negative control, non-specific staining 
was minimal in either LckWT or LckVA CD8+ T cells. At all time points Bcl-2 and 
Dex staining were mutually exclusive. The proportions of CD8+Dex-Bcl-2+ T 
cells were similar at all time points between LckVA and LckWT mice. Only on day 
46, LckVA mice had significantly higher proportions (5.5±0.5%, p=0.0028) of 
CD8+Dex-Bcl-2+ T cells compared to LckWT mice (3.9±0.4%). On day 42, the 
proportions of CD8+Dex-Bcl-2+ T cells were ~2-fold higher in LckVA (8.5±6.8%) 
mice than in LckWT mice (3.6±0.9%), however the large SD in LckVA mice 
suggests this was not consistent between animals.  
We also measured the MFI of Bcl-2 expression in the Dex-Bcl2+ gate, which 
indicated the relative abundance of Bcl-2 expressed per cell (Fig.5.11B-C). A 
significant decrease in Bcl-2+ MFI was seen in LckVA T cells upon infection on 
day 7 but not in LckWT T cells (Fig.5.11B) At all time points, except day 46, Bcl-
2+ MFI was higher in LckVA T cells than in LckWT T cells and in most cases this 
was significant (Fig.5.11B and C).  
Overall, these data showed that LckVA CD8+ T cells had a significantly higher 
MFI of Bcl-2 expression in naïve mice than LckWT, at the peak of the primary 
infection on day 7, as well as on day 42 (Fig.5.11B and C). On day 46 the 
trend for increased Bcl-2 MFI in LckVA mice was not significant compared to 
LckWT mice (Fig.5.11C). Significance could not be tested naïve mice on day 42 
because only two animals for each genotype were used, but the trend is the 
same as in day 7 mice with LckVA T cells having higher Bcl-2 MFI. The data in 
Fig.5.11 are thus in agreement with data presented in chapter 4, suggesting 
that proportionally more LckVA CD8+ T cells express higher levels of Bcl-2, 
which might contribute to the enhanced maintenance of CD8+BrdU+ T cells on 
day 42. 
5.2.5 Role of Lck in the development of distinct memory T cell 
populations  
The effector population of CD8+ T cells that arises in an infection is a very 
heterogenous pool of cells that can be subdivided into groups with distinct   
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Fig. 5.11 LckVA CD8+ T cells expressed more Bcl-2 than LckWT CD8+ T cells. 
Splenocytes from naïve and infected LckWT and LckVA mice were stained for expression of Dex, 
CD8+ and Bcl-2 on indicated days. (A) Representative dot plots show Dex versus Bcl-2 
staining in CD8+ splenocytes. Values shown on the dot plots are means of 2-5 mice per 
group. Bcl-2 staining was controlled for by isotype staining done on a pool of all samples in 
each group on indicated days. Graphs of average Dex-Bcl-2+ MFI ± SD in CD8+ T cells on day 
7 (B) and days 42 and 46 (C) are shown. Data are from one experiment. Significance was 
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functional properties. Only a small proportion (~5-10%) of responding T cells 
survives to form a memory population. The expression patterns of CD44, 
CD62L and CCR7 can be used to broadly characterise TEM and TCM populations 
(Sallusto et al., 1999). TEM cells typically produce cytotoxic proteins, home to 
inflamed peripheral tissues. TCM cells typically home to secondary lymphoid 
organs and mount robust recall responses. CD127 and KLRG1 can be used to 
subdivide the effector phenotypes into MPECs (CD127hiKLRG1lo), and SLECs 
(CD127loKLRG1hi) (Joshi et al., 2007). Although both MPEC and SLEC 
populations arise from the effector pool, these populations are functionally 
distinct. MPECs are destined to survive and become long-lived memory 
CD8+ T cells, whereas SLECs are short-lived. SLECs have enhanced CTL 
functions, such as enhanced migration, expression of IFNγ and granzyme B 
(Kaech and Cui, 2012). MPECs on the other hand express increased Bcl-6, 
which enhances their survival (Kaech and Cui, 2012). However, not all 
CD127hi cells become memory cells and some KLRG-1hiCD127lo cells can persist 
for some time after infection, thus other markers are needed (such as CD27) 
to further discriminate these populations (Joshi et al., 2007; Kaech et al., 
2003).  
Additionally, it has been shown that Bcl-2 expressing T cell populations have 
higher memory potential than Bcl-2lo cells (Dunkle et al., 2013). Dunkle et al. 
performed cell transfer experiments, where they transferred cells with 
different Bcl-2 expression levels and challenged the recipient mice with 
LmOVA (Dunkle et al., 2013). They found that cells expressing the highest 
Bcl-2 levels yielded the highest numbers of memory cells defined as KLRG1lo 
CD127hi (Dunkle et al., 2013).  KLRG1 versus CD127 staining and CD44 versus 
CD62L are therefore not exclusive criteria for distinguishing memory cell 
populations after a primary response, however, in our study we used these 
markers to broadly characterise the memory potential of LckVA and LckWT mice. 
We first looked at the proportions of cells in TEM and TCM compartments as 
characterised by CD44 and CD62L expression in CD8+ and CD4+ T cells in 
both LckVA and LckWT mice post-LmOVA infection (Fig.5.12). In our 
experiments, unfortunately, CCR7 staining did not work. 
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Fig. 5.12 Distribution of TEM and TCM CD8+ T cells in LckWT and LckVA mice. 
Splenocytes from naïve and LmOVA infected LckWT and LckVA mice were stained for expression 
of CD44, CD62L, and Dex on indicated days. (A) Representative dot plots with percentages 
show distribution of TEM (CD44+CD62L-) and TCM (CD44+CD62L+) populations in CD8+ T cells. 
Gating was adjusted as necessary on individual days. (B) Representative dot plots with 
percentages show distribution of TEM and TCM populations in CD8+Dex+ T cells. Bar charts show 
average proportions (n=2-5) of CD8+ TEM ± SD (C) and CD8+ TCM ± SD. Significance was only 
calculated for groups where n≥3. Significance was calculated on Prism: parametric, 
unpaired, two-tailed, student’s t-test *P<0.05, **P<0.01, ***P<0.001.  
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LckVA naïve mice were found to harbour increased proportions of TEM (14.9 %) 
cells as compared to LckWT mice (8.0%), however because n=2 in this group we 
could not test for significance (Fig.5.12C). The increase in TEM populations was 
probably due to increased CD44 expression ex vivo in LckVA mice (Fig.5.2).  At 
the peak of primary LmOVA infection on day 7 TEM cell proportions increased 
in both LckWT (18.8±4.6%) and LckVA mice (20.1±3.3%) above naïve levels, 
however, there was no significant difference between the two genotypes 
(Fig.5.12C). On day 42, LckVA mice had 4-fold higher proportions of CD8+ TEM 
cells than LckWT mice. This reflected the increased proportions seen in naïve 
mice but also correlated with the increased proportions of Listeria specific 
CD8+BrdU+ T cells maintained in LckVA mice as shown in Fig.5.9.  On day 46, 
in both LckVA and LckWT mice ~40% of CD8+ T cells were of TEM phenotype, 
which correlated with the notion that a secondary immune response has a 
more efficient effector response than the primary.  
Significantly higher proportions of CD8+ TCM cells were found in LckVA mice on 
day 7 (p<0.0001). However, there were no significant differences between 
CD8+ TCM proportions on days 42 and 46 in LckVA and LckWT mice (Fig.5.12D). 
We also showed that Dex specific CD8+ T cells were ~62-67% of TEM phenotype 
in both LckVA and LckWT mice (Fig.5.12B).  
Naïve LckVA mice had more CD4+ TEM cells (45.1%) than LckWT mice (15.7%). 
Again, because n=2 in this group we could not test for significance 
(Fig.5.13B). On day 7, both LckVA (51.9%±5.2) and LckWT mice (25.4%±4.9) had 
an increase in CD4+ TEM cells in response to infection. On day 42 a contraction 
in the effector response was seen in both LckVA and LckWT CD4+ T cells, but LckVA 
maintained significantly (p=0.0018) more CD4+ TEM cells than LckWT mice 
(Fig.5.13B). Both mouse strains also had a similar increase in TCM populations 
on day 42, correlating with the formation of a memory pool, although this 
was smaller than in CD8+ T cells. This is in line with published data that have 
shown CD8+ T cells form the more prominent memory pool in Listeria 
infection (Ladel et al., 1994; Pamer, 2004). On day 46, proportions of   
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Fig. 5.13 Distribution of TEM and TCM CD4+ T cells in LckWT and LckVA mice. 
Splenocytes from naïve and LmOVA infected LckWT and LckVA mice were stained for expression 
of CD44 and CD62L on indicated days. (A) Representative dot plots with percentages show 
distribution of TEM (CD44+CD62L-) and TCM (CD44+CD62L+) populations in CD4+ T cells. Gates 
were adjusted on individual days. Bar charts show average proportions (n=3-5) of CD4+ TEM ± 
SD (B) and CD4+ TCM ± SD. Significance was calculated on Prism: parametric, unpaired, two-
tailed, student’s t-test *P<0.05, **P<0.01, ***P<0.001. Data are from one experiment. 
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TEM and TCM populations were similar in LckWT and LckVA CD4+ T cells (Fig.5.13C). 
Overall these data showed that there were increased proportions of Listeria 
specific CD8+ and CD4+ TEM populations in LckVA mice following the contraction 
phase of the immune response, as assessed on day 42. These cells were 
unlikely to be the CD44hi cells found in naïve mice because we showed in the 
BrdU incorporation experiments that CD8+CD44hiBrdU+ cells were no longer 
present in uninfected mice on day 42 (Fig.5.9).  
We also assessed the relative proportions of MPECs and SLECs in CD8+CD44+ 
T cells (Fig.5.14). Both LckWT and LckVA naïve (uninfected) mice had a 
population of CD8+ T cells that were CD44hi and approximately 70% of these 
were also CD127hi, most probably representing a pre-existing memory cell 
pool (Fig.5.15A and C). During the primary infection on day 7, equal 
proportions of KLRG-1+ SLECs appeared in both LckWT (11.8±4.4%) and LckVA 
(10.0±2.6%) mice in response to the primary infection, and a reciprocal 
decline in the proportions of MPECs was seen (Fig.5.15B and C). 
Interestingly, our data showed that in both LckWT and LckVA mice there was 
also a CD8+CD127+KLRG1+ CD44+ T cell population (DPECS) (Fig.5.14). On 
day 7 the size of this population was similar in LckWT (10.48±3.7%) and in LckVA 
mice (9.4±3.1%).  
The contraction of the effector response was assessed on day 42 and a decline 
in SLECs was noted in LckWT mice (2.6±0.4%) and LckVA mice (9.3±1.3%) 
compared to day 7 (Fig.5.15B), a pattern that is in agreement with previous 
reports (Joshi et al., 2007). In LckVA mice the proportions of SLECs on day 42 
were significantly higher (p=0.0002) compared to LckWT mice. Strikingly, on 
day 42 the proportions of DPECs were also significantly higher (p=0.0027) in 
LckVA (36.3±11.7%) than in LckWT mice (5.2±0.5%), a 7-fold difference. Such a 
double positive effector cell population (CD127+KLRG1+) emerging after 
LmOVA infection has previously been described (Obar et al., 2011). Obar and 
colleagues showed that in secondary responses this population had a greater 
ability than SLECs to undergo expansion but less than that of MPECs and  
Chapter 5 
  188 
 
 
Fig. 5.14 Impact of reduced Lck expression on MPEC and SLEC populations during 
LmOVA infection 
Splenocytes from naïve and infected LckWT and LckVA mice were stained for expression of 
CD127, KLRG1, CD44 and Dex on indicated days. (A) Samples were gated on total 
CD8+CD44+ T cells and subsequent CD127 versus KLRG1 staining shows distribution of 
MPEC, SLEC and DPEC populations. Values shown in the top right are means of 3-5 mice 
per group. Average proportions ± SD on indicated days are summarised in bar charts for 
SLECs (B) and MPECs (C). Data shown are representative of two independent experiments. 
Significance was calculated on Prism: parametric, unpaired, two-tailed, student’s t-test 
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they therefore suggested that the population can contribute to the effector 
responses but will not give rise to true MPECs (Obar et al., 2011).  
In LckWT mice we found a modest increase in MPECs from day 7 (57.8±4.6%) 
to day 42 (64.6±2.1%) but a decrease in LckVA mice from day 7 (58.2±6.5%) to 
day 42 (41.9±8.7%). The proportions of MPECs were significantly lower 
(p=0.0035) in LckVA mice than in LckWT mice on day 42, most likely because a 
large proportion of the cells in LckVA mice were DPECs. There were no 
significant differences between LckVA and LckWT mice in proportions of SLECs 
or MPECs on day 46 (Fig.5.14) but DPEC proportions remained significantly 
higher (p=0.0086) on day 46 in LckVA mice (35.3±3.2%) compared to LckWT mice 
(25.1±4.2%).  
We next asked whether the DPEC population maintained on day 42 in LckVA 
mice represented the CD8+BrdU+ T cell population described in LckVA mice on 
day 42 in Fig.5.9. To this end we gated for CD127 and KLRG-1 on the 
CD8+BrdU+ population. Indeed, the results shown in Fig.5.15 indicated that 
there were three-fold more DPECs in LckVA mice (39.9%) than there were in 
LckWT mice (13.1%).  
5.2.6 Analysis of SLECs and MPECs 
For a CD8+ T cell to make a commitment decision whether to become a SLEC 
or an MPEC, several cues have to be integrated, including strength and 
duration of antigenic stimulation, costimulation, CD4+ T cell help and 
amount of inflammation they are exposed to (e.g. cytokine IL-12 and its 
modulation of transcription factor T-bet) (Mescher et al., 2006). SLECs and 
MPECs also differ in functional, proliferative, trafficking and survival 
characteristics (Olson et al., 2013). One classical marker of localization is 
CD62L, TCM cells are CD62L+ and localise to lymphoid tissues and TEM cells are 
CD62L- and localise to peripheral sites (Sallusto et al., 1999). We showed in 
Fig.5.12 that LckVA mice had increased proportions of CD8+ TEM cells and also 
that they had increased proportions of SLECs during the contraction phase in 
Fig.5.14. Fully mature TCM CD8+ T cells are CD62Lhi, KLRG-1lo, CD127hi, CD27hi, 
CD44hi and their development is associated with low expression of Tbet   
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Fig. 5.15 The CD8+BrdU+CD44+ maintained in LckVA mice after the contraction phase in 
LmOVA infection were KLRG1+CD127+ effector cells. 
CD8+BrdU+CD44+ T cells in LckWT and LckVA mice were analysed for KLRG-1 and CD127 
staining on indicated days post LmOVA infection. Zebra plots are representative of n=3-5 
individual mice, and the numbers show average proportions in each quadrant. Data are 
representative of one experiment.  
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(Joshi et al., 2007; Olson et al., 2013). Expression of the transcription factor 
Eomes has been shown to induce effector gene expression in activated CD8+ 
T cells in cooperation with Tbet (Intlekofer et al., 2005). Additionally, a report 
by Hu et al. shows that the migratory pattern of activated T cells also impacts 
on the commitment of cell fate (Hu et al., 2011). Expression of CXCR3 in 
effector CD8+ T cells enables trafficking to virus-infected cells in the 
periphery. CXCR3 expression peaked with the peak of LCMV infection, 
however, it was downregulated on KLRG1hi SLECs, terminally differentiated 
effector cells, but not KLRG1lo MPECs (Hu et al., 2011).  
We therefore assessed the expression levels of CD62L and CXCR3, shown in 
Fig.5.16, as well as Tbet and Eomes, shown in Fig.5.17 in CD8+CD44+ SLEC 
and MPEC populations in LckWT and LckVA mice during different days of 
LmOVA infection. We wanted to investigate whether there were any Lck 
mediated differences in expression patterns of these markers that may 
explain the differences in relative proportions of effector and memory cells. 
In naïve LckWT and LckVA mice there were very few SLECs (Fig.5.14) and 
therefore the histograms were quite uneven (Fig.5.16A and B). In naïve mice 
the MPEC population that was present, represented pre-existing memory 
cells and there was no difference in proportions of CD8+CD62L+ T cells 
between LckWT and LckVA mice (Fig.5.16A). The proportions of CD8+CD62L+ T 
cells were higher in SLECs than in MPECs on the same day in both LckWT and 
LckVA mice. LckVA mice had slightly higher proportions, than LckWT mice, of 
CD8+CD62L+CD44+ T cells in SLECs on days 42 but the difference was not 
statistically significant.  Similarly, on 46, the difference between CD62L 
expression in SLECs in LckVA and LckWT mice was not statistically significant 
suggesting the two genotypes are similar in their capacity to migrate to 
secondary lymphoid organs (Sallusto et al., 1999).  
In MPECs, there was a bimodal expression of CXCR3 in both LckWT and LckVA 
mice (Fig.5.16B). The proportions of CD8+CXCR3+CD44+ T cells were similar 
in MPECs of LckVA and LckWT mice on day 7. On day 42, LckVA mice had 
significantly higher proportions (p<0.0001) of CD8+CXCR3+CD44+ T cells  
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Fig. 5.16 LckVA CD8+ T cells had similar expression of CD62L in SLECs and increased 
CXCR3 in MPECs, compared to LckWT mice.  
Splenocytes from LckWT (black line) and LckVA (blue mice) were stained for (A) CD62L and (B) 
CXCR3 expression in CD8+CD44+ SLEC and MPEC populations in on indicated days post 
LmOVA infection. Histograms are representative of n=3-5 individual mice, and the numbers 
show average proportions ± SD of either CD62L+ or CXCR3+ cells. Significance was only 
calculated for groups where n≥3. Significance was calculated on Prism: parametric, 
unpaired, two-tailed, student’s t-test *P<0.05, **P<0.01, ***P<0.001.  Data are representative 
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and the same was true on day 46 (p=0.0002) (Fig.5.16B). High CXCR3 
expression is a characteristic of MPECs (Kaech and Cui, 2012). 
Overall, these data showed that CD62L expression is not significantly 
affected by Lck abundance, however, CXCR3 expression is constitutively 
higher in MPECs in LckVA mice than in LckWT mice although this population 
was proportionally smaller in LckVA mice (Fig.5.14 and 5.16).  
To assess differences between Tbet and Eomes expression in SLECs and 
MPECs in LckVA and LckWT mice we analysed the MFI of the CD44- population 
and CD44+ populations in infected LckWT and LckVA mice at indicated 
timepoints (Fig.5.17). Tbet expression is crucial for effector cell formation and 
decreases as the cells form memory populations (Kaech and Cui, 2012). 
Indeed, in both LckVA and LckWT CD8+ T cells Tbet expression was higher in 
CD44+ population on day 7 SLECs than in the CD44- population and higher in 
SLECs than in MPECs in each strain (Fig.5.17A). T-bet expression was higher 
in CD44+ day 42 SLECs in both LckVA and LckWT mice compared to CD44- T 
cells, and the respective CD44+ MPECs (Fig.5.16A). 
On day 46, interestingly, LckVA SLECs, both CD44- and CD44+ populations had 
lower Tbet expression than LckWT cells. This may have indicated that the 
SLEC population was perhaps not the main effector population on day 46 in 
LckVA mice. The proportions of DPECs, were significantly higher in LckVA than 
in LckWT mice on day 46 and may have contributed more to the effector 
response. 
Eomes expression is reciprocal to that of Tbet and is higher in memory 
populations than in effector populations (Kaech and Cui, 2012). Our data 
showed that Eomes expression in CD8+ T cells, on day 7 in LckWT MPECs was 
not higher than in SLECs, but it increased ~2-fold in LckVA MPECs compared 
to LckVA SLECs. Similar patterns were observed on days 42 and 46. Eomes 
expression was consistently lower in LckVA SLECs as compared to LckWT SLECs 
but there were no consistent differences in Eomes expression between LckVA 
or LckWT MPECs. These data showed by qualitative analysis of histograms, 
that collectively there were no striking Lck mediated differences  
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Fig. 5.17 Expression of Tbet and Eomes was similar in LckWT and LckVA mice. 
Splenocytes from infected LckWT and LckVA mice were gated CD8+CD44+ LckWT (black line) and 
LckVA (blue line), and CD8+CD44- LckWT (filled grey histogram) and LckVA (dashed red line). 
Histograms show, the expression of (A) Tbet and (B) Eomes in SLEC and MPEC populations 
on indicated days of LmOVA infection. Histograms are representative of n=2-5 individual 
mice, and the numbers show average MFIs ± SD. SD and significance were only calculated 
for groups where n≥3. Significance were calculated on Prism: parametric, unpaired, two-
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in expression levels of Tbet and Eomes and therefore the expression patterns 
of these markers do not account for the observed differences in MPEC, SLEC 
and DPEC proportions during LmOVA infection. 
5.2.7 TCRβ chain usage during LmOVA infection 
The data presented in this chapter indicated that although LckVA T cells made 
a reduced CD8+ T cells response to the Ova-specific immunodominant 
peptide (Fig.5.2 and Fig.5.7), the overall response to Listeria measured by Ki-
67 expression (Fig.5.3) and cytokine production in response to HKL recall, 
(Fig.5.5) were relatively similar. This indicated that LckVA might recruit a 
broader T cell response to other Listeria peptides as compared to LckWT mice. 
Since T cells expressing TCR Vβ 5.1/5.2 chain are often the highest affinity 
clones for OVA-peptide we wanted to assess the TCR Vβ usage to identify 
any obvious differences between LckVA and LckWT mice. 
 Zehn et al. compared the LmOVA specific responses of OT-1 transgenic cells 
(monoclonal repertoire specific for OVA peptide) to endogenous Ova-
specific CD8+ T cells in polyclonal mice (Zehn et al., 2009).  Four days after 
LmOVA infection, both the transferred OT-1 T cells and the endogenous Ova-
specific CD8+ T cells were present in equal proportions, however by day 7 the 
OT-1 T cells outnumbered the endogenous Ova-specific CD8+ cells 30-fold 
(Zehn et al., 2009). Additionally they showed that in a C57BL/6 mouse early 
in the LmOVA response (day 4) several different TCR Vβ specificities can be 
identified, including TCR Vβ 4, 5.1/2, 6, 7, and 8.1/2, however by day 7 TCR 
Vβ 5.1/5.2 is the most dominant. They concluded that both low and high-
functional avidity T cells initially respond to LmOVA infection, but the high-
affinity T cells expand more and the T cell response undergoes a maturation 
where weak affinity clones present initially are replaced by high affinity 
clones (Zehn et al., 2009). However, they did not assess TCR Vβ expression at 
time points later than day 7. 
We showed in chapter 3, that Lck abundance may have some bearing on the 
TCR repertoire (Fig.3.8 and 3.9) and therefore we assessed the TCR Vβ usage 
during secondary LmOVA infection in LckVA and LckWT mice.  
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Fig.5.18A showed that in uninfected LckWT mice of the CD8+ CD44- T cells the 
expression of each of TCR Vβ 6, 7, 8.1/8.2, and 11 were similarly ~8-10%. The 
expression of TCR Vβ4 was <1%. The same pattern was observed in CD8+ 
CD44+ T cells in uninfected LckWT mice. The selection of TCR Vβs covered in 
this experiment added up to about 50% of the repertoire. There was no 
difference between LckWT and LckVA uninfected mice for TCR Vβ expression in 
CD8+CD44- T cells. However, in LckVA uninfected mice higher proportions of 
Vβ5.1/5.2 and lower proportions of Vβ 7 were found in CD8+CD44+ T cells 
compared to LckWT suggesting a slight bias in the starting LckVA TCR 
repertoire.  
In secondary infection, an increase in the proportions of Vβ5.1/2-expressing 
CD8+CD44+ T cells was seen in LckWT mice (compare proportions of CD44- 
(light grey) to CD44+ (black) cells in Figs 5.18A and B), as would be expected 
from published data (Zehn et al., 2009). A concomitant decrease in 
expression of TCR Vβ 6, 7, 8.1/8.2, and 11 was seen to <5% in LckWT mice. The 
expression patterns of all TCR Vβs tested in LckWT CD8+CD44- populations did 
not change with infection. In LckVA mice the expression of Vβ5.1/5.2 increased 
by ~5% in CD44- populations upon infection (compare light blue bars 
between Fig.5.18A and B) but the proportion of the other TCR Vβs changed 
little. In LckVA CD44+ populations the proportion of all TCR Vβs tested did not 
change upon infection. One explanation for these data is that because 
uninfected LckVA mice already have a bias towards Vb5.1/5.2+ cells in the 
CD44+ compared to the CD44- T cell populations, they may have fewer naïve 
Vb5.1/5.2+ T cells able to be activated in response to Listeria infection.  
Overall these data confirmed in both LckVA and LckWT polyclonal repertoires 
many different TCR Vβ clones are recruited to the response but the 
predominant TCR expressed was Vβ 5.1/2, as would be expected from a 
response to LmOVA infection (Zehn et al., 2009). There did not appear to be 
any significant differences between LckWT and LckVA mice in TCR Vβ use 
during secondary infection. These results indicated that the reduced Ova-
specific response in LckVA mice could not be due to absence of TCR Vβ5.1/2 
expression, however, we may have missed other differences due to testing a 
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limited range of Vβ chains that only covered about 50% of the repertoire. 
Secondly, we did not verify whether any of the individual T cells express 
more than one TCR Vβ chain. 
A caveat of this study is that we only looked at day 46 when the immune 
response is predicted to be relatively mature, meaning high affinity clones 
have replaced the low affinity clones, as Zehn et al. showed that the immune 
response matured already by day 7 (Zehn et al., 2009). Finally, the 
experiment shown in Fig.5.18 has only been performed once, although on 
several individual animals, despite this the experiment should be repeated 
before many firm conclusions are made.  
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Fig. 5.18 TCRβ chain usage during secondary response to LmOVA infection. 
CD8+ splenocytes from (A) naïve/uninfected LckWT (n=2), LckVA (n=2) and (B) infected LckWT 
(n=4), LckVA (n=3) mice were assessed for expression of the indicated Vβ chains 4 days after 
secondary infection. Shown are proportions of Vβ+ of all CD8+ CD44- or all CD44+ T cells. The 
bar charts show average proportions ± SD. SD was only calculated for groups where n≥3. 
Data are representative of one experiment.   
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5.3 Summary 
· LckVA mice made significantly reduced primary and secondary T cell 
responses to the immunodominant Ova-peptide as compared to LckWT 
mice, shown by reduced numbers of Ova-specific cells (Fig.5.2) and N4 
specific effector cytokine production (Fig.5.6 and 5.7). 
· Cytokine production by CD4+ T cells LLO190-201 was similar in primary 
response but reduced in secondary LmOVA infection in LckVA mice (Fig. 
5.6 and 5.7). 
· The overall proliferative response to Listeria was similar in primary 
infection in LckVA and LckWT mice as measured by CD8+ T cell numbers 
(Fig.5.1) and Ki-67 expression (Fig.5.3), however, the secondary 
response was reduced.  
· Total effector cytokine production, in both primary and secondary 
immune responses to Listeria when recalled with HKL, were similar 
between LckVA and LckWT mice (Fig.5.5). 
· LckVA mice had enhanced maintenance of Listeria specific CD8+CD127+ 
KLRG1+BrdU+ memory T cells (Fig.5.9 and Fig.5.14) during the 
contraction phase.  
· The TCR Vβ repertoire is similar between LckWT and LckVA mice during 
secondary infection (Fig.5.18). 
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5.4 Discussion 
This chapter has examined the consequences of reduced Lck expression on 
the response to in vivo LmOVA infection. The overall primary proliferative 
response to Listeria was similar in LckVA and LckWT mice, yet the secondary 
CD8+ T cell response was reduced (Fig.5.1 and 5.3), as were both primary and 
secondary responses to Ova (Fig.5.2). Yet, the Listeria specific effector 
cytokine production, in both primary and secondary immune responses 
when recalled with HKL, was similar between LckVA and LckWT mice (Fig.5.5). 
The following discussion will address these findings in the context of current 
literature with regards to the roles of Lck expression levels in effector and 
memory cell development during infection. 
It has previously been shown that low expression of Lck reduced TCR 
functional avidity (Caserta et al., 2010).  In the case of CD4+ T cells with 
reduced Lck expression responding to tumour antigens, the maintenance of 
TEM populations was increased and the generation of self-renewing, 
recirculating, tumour-antigen specific TCM CD4+ T cells was improved. Lckind 
CD4+ T cells were also shown to have 3-fold better survival than LckWT cells in 
the face of chronic antigen presentation (Caserta et al., 2010). In the present 
chapter there were no significant differences in proportions of TCM (Fig. 5.12) 
or MPEC (Fig.5.14) populations between LckWT and LckVA mice on day 42. 
Although in agreement with published reports MPECs did represent the 
majority of CD8 T cells at this time point with ~60% in LckWT and ~50%LckVA 
mice (Obar et al., 2011).  
Interestingly, we showed increased proportions of CD8+ and CD4+ TEM 
populations (Fig.5.12 and Fig.5.13, respectively) as well as CD8+KRLG1+ SLEC 
and DPEC populations (Fig.5.14 and 5.15) during the contraction phase of the 
immune response to Listeria in LckVA mice. At first sight the persistence of 
KLRG1+ cells, particularly KLRG1+CD127- appears striking because it is in 
contrast with their definition, as they are expected to be short-lived and not 
persist 6 weeks post-infection (Kaech and Cui, 2012). It is, however, 
important to note several things here. Firstly, fewer than 10% of cells in both 
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LckWT and LckVA mice were SLECs at the day 42 time point, and it has been 
shown that such low levels can appear later than 54 days post-infection 
(Obar et al., 2011). Additionally, Obar et al. showed that equal proportions of 
MPECs and DPECs could survive until day 54 of infection and DPECs may 
represent a memory population with an intermediate capacity for expansion 
in secondary infections (Obar et al., 2011). However, DPECs were not able to 
give rise to true memory cells in subsequent expansions (Obar et al., 2011). 
Considering that only LckVA mice developed a significant pool of DPECs, their 
generation may be related to the functional avidity of LckVA cells. LckVA CD8+ T 
cells had decreased TCR sensitivity in cytokine production, which indicated 
that they required more antigen to be activated to the same extent as LckWT 
cells during infection (Fig.5.6 and Fig.5.7). Secondly we used a rather crude 
method, only two markers, of categorizing these cells into MPECs and 
SLECs, which may not be the most definitive way of subsetting these cells, as 
many other markers have been shown to be important for their phenotyping 
(Kaech and Cui, 2012). Bcl-2 been shown to be important for both effector 
and memory population survival (Kurtulus et al., 2011). How much 
increased expression of Bcl-2 expression in LckVA mice contributed to survival 
of TEM and KLRG1+ effector cells is unclear (Fig.5.11). Despite Bcl-2 being 
critical for memory cell development (Dunkle et al., 2013), we did not see 
increased proportions of MPEC populations in LckVA mice (Fig.5.12).  
Interestingly, our data indicated that the Ova-specific response in LckVA mice 
was clearly reduced (Fig.5.2, Fig.5.6 and Fig.5.7), but there were no apparent 
differences in the overall recall response to Listeria as assessed by overnight 
culture with HKL (Fig.5.5). Although this experiment was only done once, it 
may be an indication of LckVA mice are responding to a broader range of 
Listeria peptides. Meaning that, although OVA-specific responses were 
reduced, other peptides from the pathogen may dominate the response when 
TCR sensitivity is reduced (Zehn et al., 2009). However, when we assessed 
the Vβ repertoire, although we found that in an uninfected LckVA mice the 
CD44hi cells already expressed high levels of TCR Vβ5.1/5.2 and this did not 
change during infection, the proportions of other TCR Vβ tested were similar 
to LckWT mice (Fig.5.18). In chapter 3, when we analysed the TCR Vβ 
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repertoire of mature thymocytes we did not notice an inherent bias toward 
TCR Vβ5.1/5.2 expression in LckVA mice. It is possible, therefore that such a 
bias is inherent to the antigens, which may be gut derived, driving expansion 
of the CD44hi population in uninfected LckVA mice. Yet, how much the CD44hi 
cells in uninfected LckVA mice contribute to the immune response to Listeria is 
unclear. It has been found, however, that 50% of CD4+ memory phenotype 
cells in humans are specific for viral antigens that the person has never 
encountered before (Su et al., 2013). This suggests memory-phenotype cells 
may have significant implications for immune responses due to high levels of 
cross-reactivity amongst T cell specificities (Su et al., 2013). Interestingly, we 
found a high background in Ki-67 expression in LckVA CD8+CD44+ T cells 
(Fig.5.3) and when we labelled cells with BrdU, we found that the CD44hi 
pool of memory-phenotype cells in naïve/uninfected mice diluted BrdU 
within 42 days of labelling (Fig.5.8). This suggested that the CD44hi memory 
phenotype pool of cells exhibited high turnover and potentially undergoes 
constant renewal. The CD44hi cells in LckVA may have thus been recruited to 
the Listeria response, however, they may also have been dying more. In 
support of the latter argument we showed that the proportions of CD8+Ki-
67+CD44+ cells were higher in LckVA mice on days 7 and 46, but the numbers of 
proliferating cells were either similar in primary or reduced in secondary 
responses compared to LckWT mice (Fig.5.3).  
The balance of SLECs and MPECs resulting from an infection is dictated by 
the sum of strength and duration of the initial trigger between naïve T cells 
and p:MHC complexes (signal 1), co-stimulation (signal 2) and inflammatory 
stimuli (signal 3) (Williams and Bevan, 2007). Changes to any of these three 
signals would change the biological outcome by ultimately affecting the 
expression of transcription factors. Low-functional avidity interactions can 
drive T cell proliferation, effector and memory cell development, however, 
high avidity interactions are required for more prolonged and substantial T 
cells expansion (Kaech and Ahmed, 2001; Zehn et al., 2009). Zehn et al. 
showed that there were very few phenotypic differences between cells 
responding to low-functional avidity or high-functional avidity interactions, 
but one the markers was CD25 (Zehn et al., 2009). CD25 is the high-affinity 
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IL-2 receptor α chain and it is upregulated in response to T cell activation. IL-
2 can exert both positive and negative effects on T cells (Malek, 2008), and 
Kalia et al. showed that in LCMV infection prolonged IL-2 signals promoted 
terminal-effect differentiation in vivo (Kalia et al., 2010). Cells with CD25hi 
expression underwent greater proliferation, apoptosis and had higher KLRG-
1 expression, features in line with a terminal effector phenotype (Kalia et al., 
2010). Kalia et al. proposed that the mechanism behind the distinct memory 
outcomes associated with CD25hi cells is enhanced STAT5 phosphorylation 
and enhanced Blimp-1 expression (Kalia et al., 2010), the latter of which is 
known to drive terminal-effector differentiation (Rutishauser et al., 2009). 
Our results in chapter 4 indicated that CD25 surface expression was 
comparable to F5LckWT, during in vitro peptide stimulation, in LckVA cells and 
they also had increased IL-2 production. One could speculate that this would 
also be the case in vivo and may be part of the mechanism driving the 
development of increased proportions of TEM, DPEC, and SLEC populations. 
Thus it would be interesting to assess CD25 expression and IL-2 production 
during LmOVA infection in LckVA cells. Perhaps we would also find enhanced 
Blimp-1 expression, which could be driving terminal-effector differentiation 
in LckVA T cells. 
The study by Kalia et al. highlights the role of the transcriptional profile that 
governs the effector and memory cell populations (Kalia et al., 2010). Indeed, 
Best et al. recently published an extensive profiling of gene-expression 
signatures throughout infection grouping different factors into clusters based 
on their kinetic patterns of expression and the biological processes associated 
with them (Best et al., 2013). For example, they showed that cells biased 
toward memory precursor potential had lower expression of genes of cell 
cycle and division cluster, and of short-lived effector memory cluster, than 
their short-lived effector memory counterparts (Best et al., 2013). T-bet 
regulates many genes encoding effector molecules and thus belongs to the 
effector cell specific cluster (Best et al., 2013). Eomes has cooperative and 
redundant functions to T-bet in regulating effector gene transcription 
(Intlekofer et al., 2005). Mice with mutations in both Eomes and T-bet 
expression (Eomes+/-Tbet-/-) were shown to have defects in memory CD8+ T 
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cells development and cytotoxic effector programming (Intlekofer et al., 
2005). Given these important roles of T-bet and Eomes in MPEC versus SLEC 
differentiation its perhaps surprising that we found no striking Lck-
dependent differences in T-bet or Eomes expression during LmOVA infection 
(Fig.5.16).  
The transcription factors Id2 and Id3 have also been implicated in memory 
CD8+ T cell subset formation (Yang et al., 2011). A deficiency in both Id2 and 
Id3 leads to a loss of CD8+ effector and memory populations (Yang et al., 
2011).  Id3 expression is regulated in response to TCR signals as well as 
environmental cues, perhaps there is an effect on Id3 expression in LckVA mice 
that leads to a deficiency in memory T cell development, as high Id3 
expression would be expected to drive CD127 upregulation and memory cell 
formation (Yang et al., 2011). Interestingly, Blimp-1 has been shown to 
antagonise Id3 expression (Savitsky et al., 2007). From our data we predict 
that LckVA might have enhanced IL-2 expression, which could, lead to 
enhanced Blimp-1 expression and subsequently diminished Id3 expression, 
such an axis could be the mechanism behind enhanced effector cell 
maintenance in LckVA mice.  
The heterogeneity among effector CD8+ T cells is also influenced by the 
composition of the cytokine milieu, for example IL-12 promotes SLEC 
formation (Cui et al., 2009). In different sites, blood versus secondary 
lymphoid organs, different patterns of cytokines are expressed, which 
differentially regulate expression of chemokine receptors and their ligands, 
to ensure appropriate CD8+ T cell migration (Hu et al., 2011; Plumlee et al., 
2013). For example CCR7 expression ensures naïve CD8+ T cells localise 
within the T-zone areas of spleen and lymph nodes. However, upon T cell 
activation by antigen and signals from type I IFNs, CCR7 is downregulated 
and inflammatory chemokine receptors such as CXCR3, CXCR6 and CCR5 
are upregulated, which direct the activated T cell to sites of inflammation 
(Hu et al., 2011). Whilst studying LCMV infection, Hu et al. showed that 
CXCR3 deficiency increased memory cell formation and better recall 
response, because there was less colocalization of effector T cells with 
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antigen in the spleen (Hu et al., 2011). Although, looking at a completely 
different infectious model, we showed that LckVA mice had constitutively 
enhanced CXCR3 expression in the MPEC population of CD8+ T cells 
(Fig.5.16) and reduced proportions of MPECs on day 42 (Fig.5.15). Indeed, 
Zehn et al. showed that OT-1 T cells stimulated by weak ligands could be 
detected in blood earlier than cells stimulated by stronger signals. They show 
that there is earlier downgregulation of CCR7, which leads to weakly 
stimulated cells leaving the splenic periarteriolar lymphocyte sheaths (PALS) 
sooner (Zehn et al., 2009). It would be interesting to assess CCR7 expression 
in LckVA T cells during LmOVA infection. Extrapolating from the above 
studies, it appears possible that we might find during a time course assay, 
that LckVA T cells downregulate CCR7 earlier than LckWT cells. 
Several models of memory development have been proposed and were 
discussed in the introduction to the thesis (Section 1.5.1)(Kaech and Cui, 
2012). Overall, this chapter has investigated the role of Lck abundance in 
effector and memory cell development during in vivo LmOVA infection. The 
data presented here are in line with the view that it is the strength of the TCR 
trigger that determines the relative memory potential of the effector 
populations and their proportional distribution. LckVA mice, potentially due to 
low-avidity interactions, made a reduced Ova-specific primary response, but 
had enhanced maintenance of KLRG1+ effector cells, particularly of 
CD127+KLRG1+ effectors, which may represent an intermediate quality 
memory cell population as LckVA did make an enhanced memory response, 
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Chapter 6:  Discussion 
The overall aims of this thesis were to determine the influence of Lck 
abundance on thymocyte development, peripheral T cell activation and 
memory formation. 
Our experiments, conducted in vitro showed that <5% of WT levels of Lck 
were sufficient to restore thymocyte development compared to LckKO mice, yet 
the prioritisation of signalling pathways in peripheral activation was altered 
as compared to F5LckWT mice. We are not the first to describe augmented 
signalling downstream of Lck. Methi et al. have shown that Lck knockdown 
(Lck-kd) with short interfering RNAs (siRNAs) leads to reduced 
phosphorylation of CD3ζ chains, Zap-70 kinase and Ca2+ signalling and a 
paradoxical prolonged hyperactivity of the ERK1/2 pathway, with enhanced 
IL-2 production (Methi et al., 2005). They proposed that enhanced activation 
of ERK1/2 was due to: 1) the decreased Lck-dependent phosphorylation and 
activation of SHP1, which therefore does not negatively regulate TCR 
activation; 2) the reduced phosphorylation of CD3ζ chains that can recruit 
Grb2-SOS and mediate Ras-MAPK signalling, whereas in WT cells total 
CD3ζ phosphorylation leads to recruitment of Zap-70, which potentially 
normally displaces Grb2 binding to CD3ζ chains (Methi et al., 2007); and 3) 
reduction in c-Cbl and Cbl-b activity, which failed to target TCR/CD3 
complexes for degradation upon activation induced internalisation, leading 
to prolonged TCR signalling (Methi et al., 2008).  
Although, in this thesis we found a slightly different phenotype upon 
signalling with reduced Lck expression than reported by Methi et al. (2005), 
with reduced ERK activation but enhanced Ca2+ flux, IL-2 production, and 
proliferation, it must be noted that they studied acute siRNA Lck-kd in 
Jurkat and mature human T cells whereas we were looking at constitutively 
low Lck expression in mouse cells, which may have adapted to the lower 
levels of Lck during differentiation in the thymus.  
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Our results for ERK activation and Ca2+ flux were obtained with different 
activation methods. For the ERK study we used NP68 stimulation, whereas 
for Ca2+ flux analysis we used CD8 and TCR crosslinking. It is plausible that 
some of the difference we see in LckVA mice between ERK activation and Ca2+ 
flux is explained by the relative proportions of active versus inactive Lck 
and/or co-receptor bound versus co-receptor free Lck. Conceivably, by 
crosslinking we are studying the role of co-receptor bound Lck, and perhaps 
ERK activation is more dependent on free-Lck or requires an additional step 
of recruiting and/or activating Lck.   
Indeed, recently emphasis has been given to the spatiotemporal arrangement 
of TCR signalosomes, and the involvement of membrane 
compartmentalisation in TCR signal transduction (Filipp et al., 2012; Rossy et 
al., 2013; Singleton et al., 2009). The importance of compartmentalisation of 
Lck, and other signalling molecules, is supported by data from Nika et al. 
that showed Lck in naïve cells exists in a doubly phosphorylated state and is 
heavily regulated (Nika et al., 2010). Lck is maintained in a poised state by 
constant but reciprocal activity of positive and negative regulators. Upon T 
cell activation the balance has to tip such that the positive regulation 
overcomes the negative. The plasma membrane is laterally segregated into 
distinct microdomains, also known as lipid rafts, providing an explanation as 
to how spatiotemporal arrangement of signalling molecules, particularly of 
Lck, could regulate TCR signalling (Horejsi, 2003). It was shown that in CD4 
T cells a pool of Lck, phosphorylated on Y394 and therefore in an activate 
state, was associated with high-density detergent-resistant membranes 
(heavy DRM) that also include CD4 and CD45 (Ballek et al., 2012). Upon 
TCR/CD4 activation Lck translocated from heavy DRMs to light DRMs that 
did not contain CD45, which in this context was sufficient for initiating 
downstream TCR signal transduction as the light DRMs contained the LAT 
signalosome (Ballek et al., 2012). Additionally, a recent report postulated an 
Lck-centric view of TCR activation where Lck conformational states were 
proposed to regulate its clustering, such that active and conformationally 
open Lck associated with other such Lck molecules leading to Lck hot-spots 
and enabling frequent TCR-Lck interactions, whereas, closed and inactive 
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Lck was released from such clusters (Rossy et al., 2013). Perhaps, when the 
abundance of Lck within a cell is low the arrangement of microdomains and 
Lck activity is different, such that Lck is less negatively regulated ensuring a 
rapid response upon TCR engagement. Indeed, the patterning of signalling 
molecules has been shown to be influenced by the strength and context of 
TCR signalling with physiologically distinct outcomes (Singleton et al., 2009). 
Additionally, reduced Lck abundance not only leads to reduced immediate 
phosphorylation events, as has been published (Methi et al., 2005) and also 
shown in this thesis (Fig.4.3), but somewhat counter-intuitively, this could 
prolong signal transduction by reducing the activation of negative regulatory 
pathways (Methi et al., 2007). This may also influence and contribute to the 
spatiotemporal arrangement of signalling molecules. 
Indeed, spatiotemporal regulation and compartmentalisation of signaling 
molecules is important for sequestration of negative regulators to the 
opposite pole of the IS, the distal pole complex (DPC) (Mosenden et al., 
2011). Type I protein kinase A (PKA), upon TCR triggering, normally 
phosphorylates and activates Csk which in turn phosphorylates Lck on the 
inhibitory Y505 residue reducing TCR signalling, but upon sustained 
activation, PKA was sequestered to the DPC, thereby enhancing Lck activity 
and TCR signalling (Mosenden et al., 2011). Perhaps in LckVA mice we would 
thus find altered activity of Lck, Csk or localisation of PKA, if indeed there is 
an absence of negative regulation that leads to sustained TCR signalling. It 
would be interesting to assess the relative ratios of total Lck and Lck Y505 
versus Y394 from which we might infer its activation status in LckVA mice, 
and whether there is a complementary change in Csk activity or localisation 
of PKA. 
There cannot, however, be a complete absence of negative regulation in LckVA 
mice, as they do not have overt lymphoproliferative disorders as might be 
expected from the enhanced proliferative capacity (Fig.4.9).  
During thymocyte development, T cells are selected based on their avidity 
for self-peptide MHC complexes. The interaction with self is important for 
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peripheral T cell survival and lymphopenic expansion (Sprent and Surh, 
2011).  Studies have shown that interactions with self-peptide MHC can 
‘prewire’ T cells and influence interactions of naïve T cells with foreign 
antigen-MHC complexes (Gascoigne et al., 2010; Krogsgaard et al., 2007; 
Persaud et al., 2014). In a recent report, Persaud et al. studied a pair of CD4+ T 
cells with different avidities for self-peptide, but shared avidity for a foreign 
immunodominant listeriolysin epitope (LLO) in Listeria monocytogenes 
infection in vivo (Persaud et al., 2014). They used CD5 expression as a marker 
for TCR affinity for self-peptide and found that CD5hiLLO56 cells, with 
stronger affinity for self, induced greater phosphorylation of ERK and IL-2 
production but underwent AICD upon secondary infection, whereas 
CD5loLLO118 cells accumulated more (Persaud et al., 2014).  Could higher 
affinity for self-peptides explain why we were potentially seeing more 
activation induced cell death in secondary response to Listeria in LckVA mice?   
Although, we did not assess CD5 expression in our Listeria experiments in 
LckVA mice, in chapter 3 we showed that mature CD4+ SP cells had only 
slightly lower CD5 expression than LckWT mice and in CD8+ SP thymocytes 
there was no difference, suggesting that the affinity to self should be similar 
between the strains (Fig.3.7). Although, our data showed enhanced IL-2 
production in F5LckVA T cells upon in vitro stimulation (Fig.4.8), LckVA T cells 
did not exhibit an enhanced response to in vivo infection as we showed that 
the primary and secondary Ova-specific responses were reduced in Listeria 
infection (Fig.5.2 and 5.7). Interestingly, however, we found that uninfected 
LckVA mice had higher proportions of TCR Vβ 5.1/2 expressing CD8+CD44hi T 
cells (Fig.5.18). This is the Vβ chain expressed predominantly by cells that 
recognise the immunodominant Ova-peptide in LmOVA with high affinity. 
Unlike in LckWT mice the proportions of TCR Vβ 5.1/2 expressing CD8 T cells 
did not increase upon infection. Thus, it is possible that the expansion of high 
proportions of CD44+ memory-phenotype cells in LckVA mice before infection 
results in increased proportions of TCR Vβ 5.1/2 expressing CD8+ T cells that 
are exhausted during Listeria infection (Fig.5.18). Indeed, Su et al. have 
shown that CD4+ memory-phenotype cells can be highly cross-reactive and 
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provide immunity for pathogens never encountered previously (Su et al., 
2013).  
At first sight, our results appear to be in contrast to data published by 
Caserta et al., that reported reduced exhaustion and enhanced memory 
development of CD4+ T cells with low Lck expression in the face of chronic 
antigen. However, we showed that both CD4+ and CD8+ T cells in LckVA mice 
maintained higher proportions of TEM cells (Fig.5.12 and 5.13) and also more 
CD8+ BrdU+ memory/effector T cells at day 42 following Listeria infection 
(Fig.5.9 and 5.14). More detailed analysis revealed that LckVA CD8+ T cells 
developed a unique effector-memory phenotype, with increased proportions 
of the CD127+KLRG-1+ (DPEC) population, compared to LckWT mice that was 
maintained better through the contraction phase (Fig.5.15).  Published data 
have shown that upon recall the DPEC population exhibits weaker 
proliferation than a true MPEC population, which was also in keeping with 
our results of reduced proliferation seen in secondary infection (Obar et al., 
2011). Other apparent discrepancies with the data of Caserta et al. could be 
due to the fact that very different antigens were being studied (tumours 
versus acute bacteria) and/or that they were following CD4+ T cell responses, 
whereas here the primary emphasis was on CD8+ T cell responses (Caserta et 
al., 2010). 
TCR signalling cascade is traditionally thought of as progressing linearly 
with one molecule activating the next. Our data, in agreement with 
published studies (Methi et al., 2005; Methi et al., 2007), suggest that reduced 
Lck expression, paradoxically, can lead to prolonged hyperactivation of some 
T cell signalling pathways but not all. Therefore, our results support the view 
that we are influencing particular branches of T cell signalling but not others 
(Brownlie and Zamoyska, 2013) and that the cumulative result of 
spatiotemporal regulation of positive and negative signalling units and the 
interplay between them determines the biological outcome upon T cell 
activation (Acuto et al., 2008).  
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The absence of Lck has severe consequences for the development and 
function of the immune system (Molina et al., 1992) thus the signalling 
network has potentially evolved to accommodate for scenarios with reduced 
Lck expression. Indeed, clinical reports of Lck deficiencies in humans 
highlight the importance of Lck. A complete Lck deficiency in a child, 
resulting from a genetic mutation that compromised the kinase function of 
Lck, led to severe T cell immunodeficiency and death at 30 months (Hauck et 
al., 2012). The phenotype was similar to LckKO mice with lymphopenia, 
reduced CD4+ and CD8+ T cell expression and function (Hauck et al., 2012). 
However, patients with aberrant splicing and expression of an abnormal 
splice variant Lck (without exon 7) had combined immunodeficiency (CID) 
with some T cell functions intact (Goldman et al., 1998; Hubert et al., 2000; 
Sawabe et al., 2001). Patients with alternative splice variant Lck lived to be 
adults and had CD4+ T cell lymphopenia, but intact Ca2+ flux and MAPK 
activation. The LckVA mouse strain is therefore of great value and clinical 
relevance for furthering our understanding of the branching of TCR 
signalling networks. 
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Chapter 7:  Appendices  
7.1 Appendix 1 
 
Fig. 7.1 LckVA and Lckind mice have reconstituted thymic development (Full Blot). 
Thymocyte lysates were analysed from age-matched (7-10 weeks) polyclonal LckWT, Lckind, and 
LckVA mice by western blot (pre-cast gel). The blot was probed with anti-Lck (Upstate) and 
anti-Tubulin antibodies overnight at 4°C, and then with anti-mouse (for Lck) and anti-rabbit 
(for Tubulin) fluorescent secondary antibodies for 1 hour. The blot was subsequently 
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7.2 Appendix 2 
 
Fig. 7.2 Low Lck expression in peripheral lymphocytes (Full Blot). 
Cell lysates from lymph node cells from polyclonal LckWT, Lckind, and LckVA mice were analysed 
by WB (pre-cast gel). The blot was first probed with anti-Lck (Upstate) and anti-Tubulin 
antibodies overnight at 4°C, and then with anti-mouse (for Lck) and anti-rabbit (for Tubulin) 
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7.3 Appendix 3 
 
Fig. 7.3 F5LckVA cells had equal phosphorylation of LckSer-59 to F5LckWT. 
LN cells were stimulated with 1 &M NP68 for the indicated times. Lysates were resolved by 
SDS/PAGE on a big gel overnight (Methods 2.11.4). F5LckWT and F5LckVA were probed with 
anti-Lck and anti-V5 tag, respectively, followed by detection with goat anti-mouse AF680. 
The ladder used was PageRuler Plus Prestained Protein Ladder (Cat. 26619; Thermo 
Scientific, USA). Blots were analysed using the Li-Cor Odyssey machine. Data are 
representative of three independent experiments.  
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7.4 Appendix 4 
Table 7.1 Summary of LmOVA infection experiments 
Exp LckWT 
nr. of mice 
LckVA 






Naïve Infected Naïve Infected 
1 4 12 3 12 7, 42, 46 10-13 
2 3 5 3 5 7 7-8 
3 4 8 4 8 42, 46 10-12 
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